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Wild birds are the natural reservoirs of Influenza A viruses (IAVs) which cause occasional
pandemics and seasonal epidemics. Avian IAVs can be transmitted from wild birds to domestic
poultry, low mammals, and humans. It is well accepted that avian IAVs prefer to sialic acids
(Sia) 2,3-linked galactose (SA2,3-Gal), whereas human IAVs to 2,6-linked galactose
(SA2,6-Gal). However, SA2,3-Gal in wild bird tissues is widely distributed with little
variation while some subtypes of avian IAVs have species preference. The different isolation
rates among wild bird species cannot be explained by avian IAVs binding to SA2,3-Gal alone.
Specifically, this dissertation had the following aims: Firstly, to determine distribution of glycan
receptors across respiratory and gastrointestinal tissues of wild birds and domestic poultry;
Secondly, to determine the viral-receptor binding specificity of avian IAVs; Thirdly, to
understand the role of glycan motifs in shaping virus evolution during the natural history of
IAVs, especially from wild bird to poultry transmission. We found that avian H7 and H10
viruses acquired the binding ability to SA2,6-Gal without adaptation, furthermore, we
evaluated one of these H10 virus that possess the ability of binding to SA2,6-Gal in ferret
model and found it could cause aerosol and contact transmissions. On the other hand, H7 viruses

have strong binding avidity to SLex which are present widely in epithelial cells of chicken
trachea, which could facilitate the transmission of avian H7 viruses from waterfowl to poultry.
Lastly, we found that H7 viruses from waterfowl bound both Neu5Ac and Neu5Gc while
chicken isolates from China only prefer to Neu5Ac. Of interest, we found Neu5Gc was found in
mallards but not in chickens, which indicated that viruses reduce or lost binding ability to
Neu5Gc by adapting in chicken. In summary, this dissertation focused on certain subtypes of
avian IAVs, which have caused threats to domestic poultry and public health, and primary avian
species for influenza risk. The glycan substructures may play an important role in avian IAVs
transmission and adaptation. The knowledge derived from this dissertation will help identify
species for influenza surveillance in wild birds and facilitate risk assessment of avian IAVs.
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CHAPTER I
INTRODUCTION

Classification of influenza viruses
Influenza viruses belong to Orthomyxoviridae family and are classified into four genera
including type A, B, C and recent emerging type D (Hause et al. 2013) (Hause et al. 2014) based
on their antigenic differences in nucleoprotein (NP) and matrix 1 (M1) proteins. Influenza
viruses contain segmented, negative-sense, single-stranded RNA genomes. Influenza A viruses
(IAVs) and influenza B viruses (IBVs) contain 8 viral RNA (vRNA) gene segments whereas
influenza C viruses (ICVs) and influenza D viruses (IDVs) have 7 vRNA gene segments. The
gene segments of influenza viruses are numbered in order of decreasing length. Segments 1
(PB1), 2 (PB2), 3 (PA), 5 (NP), 7 (MP), and 8 (NS) of IAVs and IBVs encode polymerase basic
protein 2 (PB2), polymerase basic protein 1 (PB1), polymerase acidic protein (PA), NP, matrix
proteins (M1 and M2), and non-structural proteins (NS1 and NS2), respectively, which will be
described in the subsequent sections.
For ICV and IDV, segments 1, 2, 3, 5 encode proteins PB2, PB1, P3, and NP,
respectively, and segment 4 encodes the only glycoprotein spiked on the viral envelope,
hemagglutinin-esterase fusion (HEF) protein, which functions in receptor binding, receptor
destruction, and membrane fusion (Rosenthal et al. 1998; Wang and Veit 2016; Hause et al.
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2013). Segment 6 encodes two proteins M1 and CM2 by alternative splicing of mRNA precursor
P42; however, the splicing mechanism is different between ICV and IDV: ICV introduces a
termination codon in mRNA whereas IDV has a 4-amino acid peptide in the preceding exon (M
Yamashita 1988) (Hause et al. 2014). Similar to segment 6, segment 7 encodes NS1 and NS2
proteins by mRNA splicing. The un-spliced mRNA produces NS1 whereas the spliced mRNA
produces shorter NS2 (nuclear export protein, NEP) (Nakada et al. 1985) (Nakada, Graves, and
Palese 1986) (Paterson and Fodor 2012) (Hause et al. 2014).
IAVs have been further categorized into different subtypes based on the antigenic
diversity of glycoproteins HA and NA, including 18 HA (H1-18) and 11 NA (N1-N11) subtypes.
There are 16 HA and 9 NA subtypes identified in the IAVs recovered from wild birds (Webster
et al. 1992). Recently, H17N10 (Zhu, Yu, et al. 2013; Tong et al. 2012) and H18N11 (Tong et al.
2013) were identified in influenza A-like viruses in bats (Ma, Garcia-Sastre, and Schwemmle
2015). The HA subtypes can be grouped into two groups on the basis of the phylogeny of the HA
genomic sequence: group 1 (which includes H1, H2, H5, H6, H8, H9, H11, H12, H13, H16,
IAV-like H17, and IAV-like H18) and group 2 (which includes H3, H4, H7, H10, H14, and H15)
(Air 1981) (Nobusawa et al. 1991; Wu et al. 2014).
Unlike IAVs, IBVs, ICVs, and IDVs do not have the HA and NA subgroup specific
nomenclature. However, IBVs have diverged into two different lineages: B/Victoria/2/1987-like
and B/Yamagata/16/1988-like, and the viruses are antigenically distinct (Rota et al. 1992) and
have been co-circulating in humans since 1983 (Rota et al. 1990). IDVs are genetically grouped
into D/OK-like, D/660-like viruses (Collin et al. 2015), and D/Japan-lineages (Murakami et al.
2016) (Odagiri et al. 2018) (Murakami et al. 2020) , and the viruses in D/OK-like, D/660-like
groups showed antigenic discrepancy but do have a high level of cross-reactivities in serological
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analyses of all three groups (Collin et al. 2015) (Odagiri et al. 2018). Our recent study showed
that 32 isolates recovered from the same facility between 2014 and 2016 have cross-reacted (HI
titers ranging from 20 to 640) to sera generated by representative IDVs from different clades
(Wan et al. 2020).These studies agree that IDVs have a certain levels of cross-reactivity between
viruses.
IAVs infect a wide range of animals including wild waterfowl, humans, pigs, horses,
canine, and sea mammals (Webster 1992; Payungporn et al. 2008), which poses significant risks
of zoonotic infection, inter-hosts, intra-host transmission, and pandemics. IBVs mainly infect
humans (Cox and Subbarao 2000), although limited spillovers to seals (Osterhaus et al. 2000)
(Bodewes et al. 2013) and pigs (Guo et al. 1983) have reported. Similar to IBVs, ICVs are
mostly found in humans, and sporadically found in pigs (Guo et al. 1983). Unlike the other three
types of influenza viruses, cattle have been considered the reservoir of IDVs (Hause et al. 2014;
Hause et al. 2017), although several serological studies showed that IDV specific antibodies have
been detected in other species including pigs (Hause et al. 2013; Chiapponi et al. 2016), small
ruminants (goats, sheep) (Quast et al. 2015), camels (Elias et al. 2017), equine (Nedland et al.
2018), and feral swine (Ferguson et al. 2018). However, IDVs have only been recovered from
swine and cattle so far.
Several studies have assessed infection risks of IDV in humans and serological evidence
suggested that IDVs might infect humans. When the IDVs were first identified and recovered
from swine in 2011, HI was performed against a set of 316 human serum samples. There were 4
seropositive although HI titers were low (20 to 40), which made 1.3% seropositivity rate (Hause
et al. 2013). Similarly another study identified 1% seroprevalence in a cohort of older people
who lived in a community with possible exposure to cattle, and found the HI measure against
3

IDVs was not specific (Eckard 2016). However, a different study for IDVs in humans surveyed a
total of 46 participants with 35 reported occupational exposure to cattle and 11 report no
exposure to cattle, which found high seroprevalence with HI among cattle-exposed (91%) and
non-cattle-exposed humans (75%) while the seroprevalence are 97% (cattle-exposed) and 18%
(non-cattle-exposed) with micro neutralization assay (White et al. 2016). Although the high
seroprevalence is from a limiting numbers of sampling study, these studies shown detectable
antibodies against IDVs in human serum and suggested IDVs may infect humans.

IAV structures
IAV is a pleomorphic virus, which is known to display different morphological states,
from filamentous to spherical (as shown by using electron microscopy), with the spherical forms
on the order of 80 to 120 nm in diameter or the filamentous forms often in of up to 20 m in
length [reviewed in (Bouvier and Palese 2008; Badham and Rossman 2016)]. IAVs are
enveloped with a host cell derived lipid bilayer membrane, with glycoproteins HA and NA
spiked on the envelop, and with matrix (M2) ion channels traversing the envelope. These three
integral membrane proteins overlay a matrix of M1 proteins, which form the virion skeleton of
IAVs.
The HA is a trimer that is synthesized as the inactive precursor HA0, while the NA
assembles as a tetramer of four identical polypeptides (Wilson, Skehel, and Wiley 1981)
(Colman, Varghese, and Laver 1983). Inside the viral envelope, there are NEP (also known as
NS2) and one of eight vRNA segments as viral ribonucleoprotein (vRNP) complexes. Each
vRNP is comprised of one of eight vRNAs wrapped around with NP and bound with the
heterotrimeric viral RNA-dependent RNA polymerase (RdRp) that consists of PB1, PB2 and PA
4

(Arranz et al. 2012; Moeller et al. 2012; Pflug et al. 2014). These vRNPs encode at least 10
proteins needed for infectious virions, which are PB2, PB1, PA, HA, NP, NA, M1 and M2
proteins, and non-structural (NS1) protein and NEP. Several strain-dependent accessory proteins
such as PB1-N40, PB1-F2, PA-N155, PA-N182, PA-X have also been discovered via alternative
machinery of mRNA splicing or transcription process (Chen et al. 2001; Briedis, Lamb, and
Choppin 1982; Lamb et al. 1980; Muramoto et al. 2013; Jagger et al. 2012).
vRNA contains noncoding regions at both 3’ and 5’ ends, at the end of which are highly
conserved among all IAVs segments. These conserved and semi-complimentary vRNA from
both ends form helical hairpin and bind to viral RdRp initiating replication (Fodor, Seong, and
Brownlee 1993; Pflug et al. 2014).

Biology of HA
HA is a trimer with two regions: a stem, comprising a triple-stranded coiled-coil of alphahelices, and a globular head of antiparallel beta-sheet, positioned atop the stem (Wilson, Skehel,
and Wiley 1981). HA binds to the receptors by receptor binding site (RBS) which located in the
globular head. The RBS contains four structural elements : the 130-loop, 150-loop, 190-helix,
and 220-loop, among which Tyr98, Trp153, His183, and Tyr195 (H3 numbering) are the highly
conserved amino acids in HAs across different HA subtypes (Skehel and Wiley 2000). Mutations
in RBS can switch the receptor binding specificity (Xiong, Coombs, et al. 2013; de Vries et al.
2011; Chen et al. 2012; Stevens, Blixt, Tumpey, et al. 2006), which is one of the determinants of
the virus host, tissue, and cell specificity.
HA has played an important role in the IAV life cycle and primarily functions in viral
attachment and fusion. IAVs initiate the infection process by using HA. Precursor glycoprotein
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HA0 enters a metastable conformation at neutral pH after enzymatic cleavage, comprising two
chains per subunit, HA1 and HA2, which comprise 328 and 221 residues, respectively (Wilson,
Skehel, and Wiley 1981). The HA attaches the virus to the glycoconjugates of host glycoproteins
that typically have terminal sialic acid (Sia) residues to trigger endocytosis of the virion (Rust et
al. 2004a). Once the virion gets into the cell, the virion is trafficked into the endosome where the
M2 ion channel can be activated by low pH (Rust et al. 2004b; Pinto and Lamb 2006;
Lakadamyali et al. 2003) and cause the confirmation change of HA, which facilitate the
membrane fusion and vRNA release. Fusion of the viral-endosomal membranes by HA occurs
through multiple steps. After the cleavage of HA0, the fusion peptide on the N-terminus of the
HA2 is exposed and inserts into the endosomal membrane, while the C-terminal transmembrane
domain anchors HA2 in the viral membrane. The HA2 trimers then fold back on themselves to
create a hairpin that brings the two membranes close to each other. The hairpin bundles further
collapse into a six-helix bundle, which makes the two membranes come closer enabling the
formation of the lipid stalk, and the subsequent fusion of the membranes.

Receptors for IAVs
HA of IAVs binds to glycoconjugates that typically contain terminal Sia residues. Sia is a
family of derivatives of neuraminic acid, a sugar with a nine-carbon backbone. Sia family
process a glycerol-like side chain from C-7 to C-9 but different in the substituent attached to C-5.
Two common forms of the Sia family include the N-acetylneuraminic acid (Neu5Ac) and Nglycolylneuraminic acid (Neu5Gc). The other forms of the family, such as
ketodeoxynonulosonic acid (Kdn) that have a hydroxyl at the C-5 carbon appears less abundant
(at least in mammals), or the neuraminic acid (Neu) with the free amine at the C-5 is rare present
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in nature (Varki A 2017). Avian IAVs have been shown to preferentially bind to Sia that are
linked to galactose by an α2,3 linkage (SAα2,3-Gal), whereas human IAVs show preference to
Sia that are linked to galactose by an α2,6 linkage (SAα2,6-Gal) (Matrosovich et al. 2000;
Gambaryan et al. 1997; Matrosovich et al. 2004). Although Neu5Gc is a common form of Sia, a
few studies have been performed to analyze Neu5Gc as IAV receptors (Masuda et al. 1999;
Higa, Rogers, and Paulson 1985b; Gambaryan et al. 2012; Wang, Tscherne, et al. 2012b;
Broszeit et al. 2019), whereas most studies have been focused on the role of Neu5Ac as IAV
receptors.
The major difference between Neu5Ac and Neu5Gc is that the latter is generated by the
hydroxylation of the N-acetyl moiety at C-5 of Neu5Ac. Researchers have been focusing on
receptor specificity between α2,3- and α2,6-link Sias, in most cases with Neu5Ac. Since 1985,
Higa, Rogers et al. had tested the HA binding to erythrocytes containing different forms of Sias
included Neu5Gc, which suggested that recognition of the various Sia is an important factor in
analysis of the receptor specificity of HA (Higa, Rogers, and Paulson 1985a). Few studies have
been followed up to explore the signiture residues for subtype H3, and H5 that affect the binding
specificity to Neu5Gc (Masuda et al. 1999; Takahashi et al. 2009; Wang, Tscherne, et al. 2012a)
. In 2012, Gambaryan et al. found an H7N7 isolated from equine bind exclusively to Nue5Gc
while another H3N8 from equine prefer to Neu5Ac (Gambaryan et al. 2012). Not only the
recognition of the Neu5Gc for IAVs, Broszeit, Tzarum et al. found that NA can cleave Nglycolyl efficiently which supported Neu5Gc can serve as receptor biologically and revealed
strict species specificity of binding to Neu5Gc(Broszeit et al. 2019). These studies have provided
insights into the recognition of Neu5Gc-containing glycans, which could be functional receptors
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and determinant of species specificity for IAVs. However, the limited numbers of studies are not
enough to understand the role of Neu5Gc plays in IAVs evolution and others.

IAVs reservoir
As mentioned previously, in addition to humans, IAVs can infect and circulate in a wide
range of animals, including avian, swine, equine, canine, and marine mammals (i.e. seals and
whales). In addition, IAVs were reported to infect other animals such as feline (Fiorentini et al.
2011; Hatta et al. 2018), minks (Klingeborn et al. 1985a). Low pathogenetic avian influenza
(LPAI) viruses have been isolated from at least 105 wild bird species belonging to 26 different
families (Olsen et al. 2006). Among such a wide range of wild bird species, the aquatic wild
birds and shorebirds such as Anseriformes (i.e. ducks, geese and swans) and Charadriiformes
(i.e. gulls, terns and waders) are considered the major natural reservoir of IAVs (Webster et al.
1992; Olsen et al. 2006). IAVs, except recently emerging Gs/Gd/96-like H5 HPAIV (Guo, Xu,
and Wan 1998; Wan 2012; Pantin-Jackwood and Swayne 2009), have been circulating in aquatic
wild birds asymptomatically, which offers the environment for reassortment and spreading of
these IAVs by migration (Wille et al. 2011; Huang et al. 2014; Olsen et al. 2006).
Several reports have indicated that the prevalence of IAVs in wild birds vary across
different wild bird species, different seasons, and different geographic areas. Based on a
surveillance study spanning from 1998 to 2006, the most abundant recovered subtypes are H6
(seropositivity, 17.8%), H4 (16%), N2 (19.9%), and N6 (17.8%) of a total of 332 isolates, thus
the most abundantly HA and NA combinations are H4N6 (13.6%), H7N7 (10.5%), and H6N2
(9.9%), respectively (Munster et al. 2007). Another surveillance study of North America's wild
ducks (26 years from 1976 to 2001) and shorebirds (16 years from 1985 to 2000) revealed
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differences in the prevalence of IAVs among mallard, northern pintail, blue-winged teal,
redhead, American green-winged teal, American wigeon, and other wild bird species (Krauss et
al. 2004). Shorebirds had a high frequency of IAV isolation during their northern migration,
whereas wild ducks had high virus isolation frequencies during their southern migration. HA
subtypes H1 to H12 were detected in both wild birds and shorebirds but H13 only in shorebirds.
H14 and H15 were detected neither in shorebirds nor in wild ducks (Krauss et al. 2004). Another
study suggested that H13 and H16 were primarily identified in gulls (Munster et al. 2007; Olsen
et al. 2006), which are genetically distinct from those of IAVs from ducks and geese (Fouchier et
al. 2005b). A 12-year surveillance study of avian IAVs in eastern Germany from 1977 to 1989
shown more than 40 combinations of HA/ NA were identified in a total of 124 isolates, of which
H6N1 was most predominant (23.6% of all samples), followed by H4N6 (11%). As of individual
species, the favorite recovered subtypes were H2N3 (20.8%) and H4N6 (20.3%) in wild ducks,
H7N7 (22.3%), H4N6 (24.4%) and H2N3 (10.4%) in Pekin ducks, and H6N1 (34.8%) and H6N6
(15.1%) in domestic ducks (Suss et al. 1994). Another European surveillance study sampling
from wild waterfowl in Sweden (from 2002 to 2005) found the similar results as in the previous
Germany study that the most prevalent subtype combinations H4N6, H7N7, and H6N2
(Wallensten et al. 2007). By aligning the surveillance results from European and North America,
subtypes H4N6 and H6N2 were the most common ones identified in wild. The differences are
the German study had higher numbers of H1 and H2 whereas the other two studies share a high
number of H6 isolations, (Suss et al. 1994; Krauss et al. 2004; Wallensten et al. 2007). However,
these differences maybe truly exited due to the nature of IAVs and environment and habitat of
wild birds, or because of the limitation of surveillance samples bias in collection time, date,
sample species and etc.
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Distribution of glycan receptors in mammals and birds
The most common ways to determine glycan receptors in the host is with the
immunofluorescent or immunohistochemistry assays. No monoclonal antibodies have been
developed that specifically bind α2-6-linked (SA2,6Gal) and α2-3-linked sialic acid (SA2,3Gal),
and instead lectins have been used to differentiate α2-6-linked sialic acid and α2-3-linked sialic
acid through binding specificity. For example, Sambucus nigra agglutinin [SNA] was shown
with a preferred binding to Neu5Acα2-6Galβ1-4GlcNAc (Shibuya et al. 1987) and Maackia
amurensis [MAA] with Neu5Acα2-3Galβ1 (Wang and Cummings 1988), respectively. MAA
contains two isoforms termed MAL (MAA-II) or MAH (MAA-I). MAL binds Neu5Acα23Galβ1-4GlcNAc whereas MAH does Neu5Acα2-3Galβ1-3GalNac (Konami et al. 1994; Geisler
and Jarvis 2011).
Distribution of SA2,3Gal and SA2,6Gal receptor in birds
Separate studies have shown that birds are highly susceptible to avian IAVs because
various species of birds, such as chickens, pekin ducks, and turkeys, express SA2,3Gal in both
the respiratory and gastrointestinal tracts (Costa et al. 2012; Kuchipudi et al. 2009; Pillai and Lee
2010b). SA2,6Gal are identified in respiratory tracts (nasal cavity, respiratory epithelium, trachea
and lungs) of chickens, turkeys and mallards with different abundance but they are only detected
in gastrointestinal tracts (duodenum, jejunum-ileum, cecum, colon) of chickens and turkeys (but
not mallards) (Costa et al. 2012). However, another study indicated SA2,6Gal can be found in
ileum/caeca of mallard (Franca, Stallknecht, and Howerth 2013). These contradicting results
suggest that, due to its low sensitivity and lack of quantitative nature, lectin histochemistry
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analyses may be inconsistent. Nevertheless, lectin histochemistry has provided a fast and
convenient method to reveal the general distribution of these receptors in wild birds.
To further evaluate the potential role of Sia receptors of wild birds in determining the
susceptibility to AIVs, a study had been performed to analyze the distributions of SA2,6Gal and
SA2,3Gal receptors in 37 species from 11 orders (Franca, Stallknecht, and Howerth 2013). They
reported that birds of Anseriformes (mallard, blue-winged teal, cinnamon teal, northern pintail,
red head, wood duck, black swan, bar-headed goose, cackling goose), Charadriiformes (dunlin,
sanderling, ruddy turnstone, herring gull, laughing gull, ring-billed gull), Ciconiiformes (great
blue heron), Gaviiformes (red-throated loon), Gruiformes (American coot, Stanley crane), and
Pelecaniformes (American white Pelican) express abundant SA2,3Gal in nasal turbinate, trachea,
lung (bronchi), duodenum/jejunum, ileum/caeca (Table 1), but there are large variations how
SA2,6Gal express among species (Table 2). This study suggested SA2,6Gal and SA2,3Gal may
not be species dependent but rather tissue dependent.
On the other hand, the distribution of these receptors are not only host and tissue
dependent but also cell type dependent. For instance, in quail, SA2,3Gal receptors are present
primarily in non-ciliated cells, whereas SA2,6Gal linked receptors are localized predominantly
on the surface of ciliated cells of trachea. In quail intestine, both types of receptors were found
on epithelial cells as well as in crypts (Wan and Perez 2006). SA2,3Gal and SA2,6Gal were
broadly detected in duodenum, jejunum-ileum, cecum and colon of chicken; however, the cell
types were found differently, for examples in chicken duodenum, SA2,6Gal were detected in
GALT lymphocytes whereas SA2,3Gal in columnar epithelial and goblet cells (Costa et al.
2012). Another example is that mallards have SA2,3Gal in trachea ciliated cells but in goblet

11

cells of duodenum/jejunum and enterocytes of ileum/caeca (Franca, Stallknecht, and Howerth
2013).

Table 1

Distribution of SA2,3Gal receptors in respiratory and intestine tracts in birds
Lectin binding/MAAa
Nasal

Species

Trachea

Ileum/caeca/ large

intestine

intestine

turbinates/cavity
cell
score

cell
score

types
Mallard

Duodenum/jejunum/small

Reference

Lung /bronchi
cell
score

types

cell
score

cell types

score

types

types

++/+++

Cil

+++

Cil

+++

Cil

+++

Gc

+++

Ent

+++

Cil

+++

Cil

+++

Cil

+++

Ent

+++

Ent

+++

MuG

+++

Cil

+++

Cil

+++

Ent

+++

Ent

+++

Cil

+++

Cil

+++

Cil

-/+

Gc

+++

Ent

Red head

+++

MuG

+++

Cil

+++

Gc

+

Ent

+++

Ent

Wood duck

+++

MuG

+++

Cil

+++

Cil

+++

Ent

+++

Ent

Black swan

+++

MuG

+++

Cil

+++

Cil

+

Ent

+++

Ent

Mute swan

+++

MuG

+++

Cil

+++

Cil

+++

Gc

+++

Ent

+++

MuG

+++

Cil

+++

Cil

+++

Gc

+++

Ent

Cackling goose

+++

MuG

+++

Cil

+++

Cil

+++

Gc

+++

Ent

Dunlin

NA

+++

Gc

+++

Gc

+++

Ent

+++

Ent

Sanderling

NA

+++

Cil

+++

Gc

+++

Gc

NA

NA

Red knot

+++

+++

Gc

+++

Gc

-

-

-

-

+++

Cil

+++

Gc

+++

Gc

Blue-winged
teal
Cinnamon teal
Northern
pintail

Bar-headed
goose

(Franca,
Stallknecht,
and Howerth
2013)

MuG

Ruddy
NA

NA

turnstone
Herring gull

-/+++

MuG

+++

Gc

++

Cil

+

Gc

++

Gc

Laughing gull

+++

MuG

+++

Cil

+++

Cil

+++

Ent

+++

Ent

+++

Cil

+++

Gc

+++

Gc

+++

Gc

+++

Gc

+

MuG

+++

Cil

+

Gc

+++

Gc

+++

Gc

Ring-billed
gull
Great blue
heron
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Table 1 (continued)
Red-throated
NA

+++

Cil

+++

Cil

+++

Gc

+++

Gc

loon
American coot

+++

MuG

+++

MuG

+++

Gc

+++

Ent

+++

Ent

Stanley crane

+++

Cil

+++

Cil

+++

Cil

+++

Gc

+++

Gc

+++

Cil

+++

Gc

+++

Gc

American
NA

NA

Chicken

NA

+++

NS

+++

NS

++

NS

+++

NS

Duck

NA

+++

NS

+++

NS

-

NS

+++

NS

Turkey

NA

+++

NS

+++

NS

+++

NS

+++

NS

Pigeon

NA

+/-

NS

+/-

NS

+/-

NS

+++

NS

Chicken

NA

+++

NS

+++

NS

+/-

NS

-

Chicken

+++

+++

Bep

+++

Cep, Gc

+

Cep, Gc

Bep

++

Cep, Gc

++

Cep

+

Cep

+

Cep

white pelican

(Pillai and Lee
2010a)

(Liu, Han, et
al. 2009)

Cil,
Cil

++
MuG

Common quail

+++

Cil

+

All

+

++

Cil

+

All

-

Red-legged
partridge
(Costa et al.

Cil,
Turkey

++

Cil

+++

++

Bep

+

Cep, Gc

+

Cep

+

Bep

++

Cep, Gc

++

Cep, Gc

MuG
Golden

2012)

Gc,
++

Cil

+

pheasant

MuG

Ostrich

+++

Cil

+

All

+

Bep

++

Cep, Gc

++

Cep, Gc

Mallard

++

Cil

++

All

+

Bep

+++

Cep

+++

Cep

a: The distribution of receptors was scored using lectin immunohistochemistry: ‘-’ no staining,
‘+’ mild, ‘++’ moderate, ‘+++’ strong, NA not available, NS not specified. Cell types: Cil is
ciliated cells, Gc is Goblet cells, MuG is mucous gland cells, Bep is bronchial epithelial cells,
Cep is columnar epithelial cells, all indicated all cell types. The blank cells indicated not applied.
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Table 2

Distribution of SA2,6Gal receptors in respiratory and intestine tracts in birds
Lectin binding/ SNAa
Nasal

Species

Trachea

Duodenum/jejunum/small

Ileum/caeca/ large

intestine

intestine

Lung /bronchi

Reference

turbinates/cavity
score
Mallard

cell types

score

cell types

score

cell types

score

-

+++

Cil

+++

Cil

-

-

+++

Cil

+++

Cil

+++

-

+++

Cil

+++

Cil

+++

-

cell types

score

cell types

+++

Ent

Ent

+++

Ent

Ent

+++

Ent

+++

Ent

Blue-winged
teal
Cinnamon
teal
Northern
+++

Cil

+++

Cil

+++

Cil
Cil

pintail
Red head

+++

Cil

+++

Cil

+++

Wood duck

+

Gc

+

Gc

-

Black swan

-

+++

Gc

+++

Mute swan

-

+++

Gc

+++

+++

Ent

++

Ent

+++

Ent

Gc

+++

Gc

+++

Ent

Gc

-

+++

Gc

-

+++

Ent

Ent

Bar-headed
+

MuG

+++

Gc

-

+++

MuG

+++

Gc

+++

Cil

-

+++

Cil

+++

Cil

-

-

(Franca,

NA

Stallknecht,
and Howerth

goose
Cackling
goose
Dunlin

NA

+++

Sanderling

NA

-

-

Red knot

-

-

++

Cil

-

-

NA

NA

+++

Gc

-

-

+++

Ent

2013)

Ruddy
turnstone
Herring gull

+++

Cil

+++

Cil

+++

Gc

-

+++

Cil

+++

Cil

+++

Cil

+

+++

Cil

+++

Gc

+++

Gc

-

+++

MuG

+++

Gc

+++

Gc

+

NA

+++

Cil

+++

Cil

-

-

-

+++

Gc

-

-

-

+++

Gc

+++

Gc

+++

+++

Cil

-

+++

NS

++

Laughing
Gc

+

Gc

+

Gc

gull
Ring-billed
gull
Great blue
Gc

-

heron
Red-throated
loon
American
coot
Stanley crane

+++

MuG

Gc

-

American
NA

NA

NA

+++

-

white pelican
Chicken

NS
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NS

+++

NS

Table 2 (continued)
(Pillai and
Duck

NA

+++

NS

+++

NS

-

-

Turkey

NA

+++

NS

++

NS

-

-

Pigeon

NA

+++

NS

+++

NS

-

-

(Liu, Han, et

Chicken

NA

+/-

NS

-

-

-

al. 2009)

Chicken

++

Cil

+

All

+++

Bep

+

Cep

++

Cep

+++

Cil

+++

All

+++

Bep

+

Cep, Gc

++

Cep, Gc

++

Cil

+

MuG

-

+

Cep

+

Cep, Gc

Lee 2010a)

Common
quail
Red-legged
partridge
Turkey

(Costa et al.
++

Cil

+

Gc, MuG

+++

Bep

+

++

Cil

++

All

+

Bep

+
+

+

Cep

Cep, Gc

++

Cep, Gc

Cep, Gc

+

2012)

Golden
pheasant
Ostrich

-

Mallard

+

Cil

++

Cil, Gc

+

Bep

-

-

a

: The distribution of receptors was scored using lectin immunohistochemistry: ‘-’ no staining,
‘+’ mild, ‘++’ moderate, ‘+++’ strong, NA not available, NS not specified. Cell types: Cil is
ciliated cells, Gc is Goblet cells, MuG is mucous gland cells, Bep is bronchial epithelial cells,
Cep is columnar epithelial cells, all indicated all cell types. The blank cells indicated not applied.

Distribution of SAα2,3-Gal- and SAα2,6-Gal-linked receptors in humans and other
mammals
Although lectins isoforms MAAI, MAAII shown different binding patterns to cell types,
SA2,3Gal receptors were detected in the upper and lower respiratory tract with MAAI and
alveolar epithelial cells of the lung with MAA II of human. SNA binding was detected in
bronchial and alveolar epithelial cells with variations between adults and children (Nicholls et al.
2007).
Compared with those in wild birds, the distributions of SA2,3Gal and SA2,6Gal were
characterized primarily in those animal models used in influenza research, such as ferrets, swine,
guinea pig. Because the high expression of SA2,6Gal linked receptors in the conducting airways
and the presence of SA2,3Gal linked receptors in the lung parenchyma, ferrets represent the
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respiratory system in humans (Leigh et al. 1995). Both SA2,3Gal and SA2,6Gal receptors were
detected in pig trachea (Ito et al. 1998), and in the nasal and tracheal areas of the guinea pig (Sun
et al. 2010). Comparative distribution of human and avian type sialic acid influenza receptors in
the pig (Nelli et al. 2010). Taking together, SA2,6Gal receptors found in guinea pig are believed
to be one of the reasons that it is susceptible to human influenza virus (Sun et al. 2010) and the
pig is the “mixing vessel” of the IAVs (Ito et al. 1998) (Nelli et al. 2010). Some extended
studies have been performed using mass spectrometry to analyze the glycan presented in
respiratory tracts of human (Walther et al. 2013), swine (Byrd-Leotis et al. 2014) and ferrets (Jia
et al. 2014), which were consistent with the staining results; in addition to the lineages of sialic
acids, these studies suggested structural complexity of these glycans located on these tissues.
In addition to SA2,3Gal and SA2,6 Gal, which were determined using lectins,
monoclonal antibodies have been developed detected other glycan substructures as well (Table
3) (Varki A 2017) , of which this study will focus on well-studied receptor of IAVs such as
SA2,3Gal and SA2,6Gal as well as other receptors such as SLex and Neu5Gc.
Table 3

Mammalian glycan antigens recognized by monoclonal antibodies

Glycan antigen

Glycan structure sequence

Sialyl Lewis x

Neu5Acα2,3Galβ1,4(Fucα1,3)GlcNAc

Sialyl-Lewis a

Neu5Acα2-3Galβ1-3(Fucα1-4)GlcNAc

Lewis x

Galβ1,4(Fucα1,3)GlcNAc

Lewis a

Galβ1-3(Fucα1-4)GlcNAc

Lewis b

Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc
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Table 3 (continued)
Lewis y

Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc

3’-Sulfo-Lewis x

sulfo-3Galβ1–4(Fucα1–3)GlcNAc

3’-Sulfo-Lewis a

sulfo-3Galβ1–3(Fucα1–4)GlcNAc

6-Sulfo-sialyl Lewis x

Neu5Acα2-3Galβ1-4(Fucα1-3)-(6-HSO3)GlcNAc

6-Sulfo-sialyl Lewis a

Neu5Acα2-3Galβ1-3(Fucα1-4)-(6-HSO3)GlcNAc

Sialyl T antigen

Neu5Acα2-3Galβ1-3GalNAc-O-Ser/Thr

Sialyl Tn antigen

Neu5Acα2-6GalNAcα-O-Ser/Thr

T antigen

Galβ1-3GalNAc-O-Ser/Thr

Tn antigen

GalNAcα-O-Ser/Thr

H antigen type 1

Fuc(a1-2)Gal(b1-3)GlcNAcβ

H antigen type 2

Fuc(a1-2)Gal(b1-4)GlcNAcβ

H antigen type 3

Fuc(a1-2)Gal(b1-3)GlcNAcα

H antigen type 4

Fuc(a1-2)Gal(b1-4)GlcNAcβ

A antigen type 1

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)b-GlcNAc

A antigen type 2

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)b-GlcNAc

A antigen type 3

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)a-GalNAc

A antigen type 4

Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-3)b-GalNAc

B antigen type 1

Gal(α1-3) [Fuc(a1-2)]Gal(b1-3)GlcNAcβ

B antigen type 2

Gal(α1-3) [Fuc(a1-2)]Gal(b1-4)GlcNAcβ
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Table 3 (continued)
B antigen type 3

Gal(α1-3) [Fuc(a1-2)]Gal(b1-3)GalNAcα

B antigen type 4

Gal(α1-3) [Fuc(a1-2)]Gal(b1-4)GalNAcβ

Galα 1-3Gal antigen

Gal(a1-3)Gal

HNK-1

GlcA3S(b1-3)Gal(b1-4)GlcNAc

Sda antigen

NeuAc(a2-3)[GalNAc(b1-4)]Gal(b1-4)GlcNAc(b1-3)Gal

Forssman antigen

GalNAc(a1-3)GalNAc(b1-3)Gal (a1-4)Gal (b1-4)Glcβ

Pk antigen

Gal(a1-4)Gal

P antigen

GalNAc(b1-3)Gal(a1-4)Gal

P1 antigen

Gal(a1-4)Gal(b1-4)GlcNAc(b1-3)

Distribution of Neu5Ac and Neu5Gc in avian, humans, and other mammals
In addition to Neu5Ac, Neu5Gc is another common form of Sia and could serve as a
receptor for IAVs (Higa, Rogers, and Paulson 1985b; Takahashi et al. 2014a). Neu5Gc is
created by the hydroxylation of the Neu5Ac moiety, which have been reported that hydroxylase
generated by cytidine monophosphate (CMP)-N-acetyl neuraminic acid hydroxylase (CMAH) is
required.
Although Neu5Gc is common exist in mammals including bonobos and chimpanzees, in
humans, Neu5Ac is the most common Sias because a loss-of-function deletion in CMAH
prevented Neu5Gc expression (Irie et al. 1998 ; Kawano et al. 1995), though, humans could
absorb Neu5Gc from exogenous sources (Tangvoranuntakul et al. 2003). Some mammals
include dogs, ferrets, seals lack the function of CMAH, which are expressing Neu5Ac instead of
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Neu5Gc (Wen et al. 2018; Ng et al. 2014; Peri et al. 2018). Others include cows, horses and pigs
have been reported to predominately express Neu5Gc (Pettersson et al. 1958; Naiki 1971; Wen
et al. 2018; Song et al. 2010).
Limited studies on Neu5Gc have been performed in respiratory and intestinal tracts of
wild birds since they are commonly express Neu5Ac. The first report appeared to show Neu5Gc
in duck intestine, mainly on the crypt epithelial cells of duck colon (Ito et al. 2000). Low
incidence of Neu5Gc in birds and reptiles and its absence in the platypus in tested tissues (liver/
muscle/ ovomucin/ eggs) (Schauer, Srinivasan, Coddeville, Zanetta, and Guérardel 2009). Highperformance liquid chromatography, and mass spectrometry analysis of chicken tissues indicated
that chickens did not synthesis Neu5Gc but limited amount of Neu5Gc detected in eggs may
come from the diet (Schauer, Srinivasan, Coddeville, Zanetta, and Guerardel 2009). On the other
hand, histological immunostaining could not detect Neu5Gc in chicken trachea (Suzuki et al.
2000).
Receptors as a determinant of host range
Receptor binding specificity of IAVs beyond SAα2-3Gal-linked receptors
Although AIVs were shown to bind preferentially to Neu5Acα2-3Gal receptors, the fine
receptor specificity of the viruses varies depending on the avian species. Previous studies
suggested sulfated and/or fucosylated Neu5Acα2-3Gal receptors have strong binding avidity to
IAVs (e.g. subtype H5, H6, H7 and H9) in terrestrial poultry but not those in ducks (Gambaryan
et al. 2008). Instead, IAVs in ducks displayed high avidity for Neu5Acα2-3Galβ1-3 (duck-type)
receptors rather than Neu5Acα2-3Galβ1-4 (Gambaryan, Yamnikova, et al. 2005; Gambaryan et
al. 2018). Viruses in gulls were shown to preferentially bind to receptors bearing fucose at Nacetylglucosamine residue, whereas viruses in both chicken and mammalian show increased
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binding avidity for glycans that have a sulfate group at C-6 of (β1–4)-linked GlcNAc. Unlike
other IAVs of aquatic birds, H16 IAVs showed efficient binding to Neu5Acα2-6Gal receptors
and bound poorly to duck-type receptors (Neu5Acα2-3Galβ1-3) (Gambaryan et al. 2018).
A small change of amino acids in RBS could affect the binding specificity of IAVs with
glycan receptors. For examples: a G225D mutation can switch binding specificity of an avian
H6N1 virus from SAα2,3Gal to SAα2,6Gal (de Vries, Tzarum, et al. 2017); Q226L, G228S are
believed to the reason of avian H2, H3 viruses switching from SAα2,3Gal to SAα2,6Gal (Xu et
al. 2010; Liu, Stevens, et al. 2009; Ha et al. 2003). The pandemic A/New York/1/1918 possessed
a mutation E190D different from convention avian H1N1, which enables the virus binding to
both SAα2,3 Gal and SAα2,6Gal (Stevens, Blixt, Glaser, et al. 2006; Glaser et al. 2005); threeamino-acid mutations (V186G/K-K193T-G228S or V186N-N224K-G228S) can switch the
receptor specificity of the H7N9 HA from SAα2,3Gal to SAα2,6Gal (de Vries, Peng, et al.
2017). A change in receptor-binding specificity may also result in pathogenic changes. A protein
of a novel clade 2.3.4.4 H5 bind to SLex because of substitutions K222Q and S227R, which are
unique for highly pathogenic influenza virus H5 proteins (Guo et al. 2017). Viral receptor
binding specificity also affects transmission of IAVs. The mutation G222D of H1N1pdm
(A/California/07/2009) results in a gain of binding avidity of long-chain SAα2,6 which is
believed to confer its airborne transmission in ferrets and it is proposed that loss of SAα2,3
binding is not necessary for airborne transmission (Lakdawala et al. 2015).
Formation of Sia is a determinant factor of host range of IAVs
Prior studies have found that equine H3N8 viruses prefer binding to Neu5Ac, whereas the
equine H7N7 exclusively binds to Neu5Gc (Gambaryan et al. 2012). Yang et al (Yang et al.
2013) reported that Neu5Gc was detected in the canine trachea but not in chicken trachea, which
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indicated that the Neu5Gc may play an important role in the interspecies transmission of avianlike H3N2 IAV from avian to canine species. An additional study found that mutation W222L at
the RBS of equine HA significantly increase binding avidity of the virus to glycans with Neu5Gc
and SLex motifs, combined with the results that these receptors are present in canine and horse,
indicated that this could facilitate viral adaption from equine influenza A(H3N8) virus to dogs
(Wen et al. 2018). An H5N1 A/Vietnam/1203/04 Y161A mutant has been shown to possess
binding specificity to Neu5Gc from Neu5Ac (Wang, Tscherne, et al. 2012a; Broszeit et al.
2019). The NA of IAVs are able to cleave Neu5Gc, and viral tissue-binding specificity to
Neu5Ac or Neu5Gc indicated this is a species barrier of selection (Broszeit et al. 2019). These
findings suggest that recognition of the Neu5Gcα2,3-Gal moiety plays an important role in the
interspecies tropism of avian influenza viruses. However, Neu5Gc has been reported as a decoy
receptor to prevent entry of IAVs that possess Neu5Gc binding ability (Takahashi et al. 2014b).

Knowledge Gaps
Substructures of sialic acid receptors affect tissue and host tropism
The substructures of Sia receptors have a huge diversity, such as the linkages between
Neu5Acα2-3Gal-disaccharide and GlcNAc, the fucosylation, sulfation of GlcNAc, and Neu5Gc
which affect virus binding specificity as well as tissue and host tropism. Additionally, the
SAα2,3Gal binding preference of IAV was reported to require host fibronectin, suggesting that
host proteins may also be involved in the receptor binding process of IAV, which remains largely
unknown. There are still gaps and questions in the field: 1) The distribution and intensity of Sia
receptors among tissues and hosts are not fully characterized. 2) The role of those substructures
of Sia in the adaption from waterfowl to poultry and infection of IAVs is not clear. 3) Besides
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Sia receptors, host factors that involved in the entry of IAV and how they regulated are not fully
understood.
Receptors in wild birds have been not systematically characterized
Several studies have focused on Neu5Acα2-3Gal receptors for avian IAVs and wild
birds, however, it is documented that viral binding specificity for other glycan substructures
mentioned above could affect the viral adaptation, replication, transmission and even
pathogenesis. However, there remains knowledge gaps in the field: 1) It is still not fully clear
how Neu5Gc receptors play a role in the evolution of IAVs in wild birds; 2) The distribution of
such glycan structures in wild birds is not systematically characterized; 3) The biological
outcome of the binding preference of avian IAVs to these glycan substructures is still unknown.

Objectives of this dissertation
The HA of IAVs binding to host glycan receptors is one of the key determinants for viral
host tropism. The receptor-binding pockets of the HA are known to affect the receptor binding
avidity, specificity, transmission ability of IAV. However, most studies have been focusing on
individual receptor binding sites (i.e. residues 226 and 228 (H3 numbering)) and their impacts on
two types of Sia receptors (SAα2,3Gal and SAα2,6Gal). Although prior reports have
demonstrated HA and NA of avian IAVs from chicken are different from those of wild birds, the
knowledge of how they evolved is lacking. More studies have been focusing on the fine Sia
receptor binding to different species of avian origin IAVs in order to understand this
phenomenon, however, although the binding linkage preferences for some of the species were
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discovered, the distribution of these Sia receptors in birds and biological meaning of these
receptors are largely unknown.
The objectives of this project are 1) to evaluate the spillover risks of emerging IAVs from
wild birds to domestic poultry, mammals, and humans; 2) to determine distribution of glycan
receptors across respiratory and gastrointestinal tissues of chickens and mallards and other wild
birds and domestic poultry; 3) to determine the role of glycan motifs in affecting the intra and
inter-species infectivity of avian IAVs; 4) to understand the role of glycan motifs in shaping
virus evolution during the natural history of IAVs, especially intra- and inter- species
transmission. Sialyl-Lewis X (SLex) and Neu5Gc, two common SA2,3Gal substructures were
the focus in this study.
The hypotheses of this project are 1) that glycan motifs SLex and Neu5Gc contribute to
host and tissue tropism of IAVs and 2) that distribution of such glycan receptor motifs in
different species play a role in the evolution of IAVs receptor binding specificity thus form
species barrier and 3) that the binding specificity of avian IAVs are species dependent regarding
glycans distribution of the host.
Three specific aims of the project are: 1) to determine public health risk of an emerging
gull-origin subtype H10N7 IAV; 2) to determine if the distribution of SLex receptors affects
tissue/host tropisms of avian H7 IAVs in birds; 3) to determine the role of Neu5Gc receptors in
adaptation, and evolution in avian IAVs.
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CHAPTER II
AEROSOL TRANSMISSION OF GULL-ORIGIN ICELAND SUBTYPE H10N7 IAVS IN
FERRETS

Subtype H10 IAVs have been recovered from domestic poultry and various aquatic bird
species, and sporadic transmission of these IAVs from avian species to mammals (i.e., human,
seal, and mink) are well documented. In 2015, we isolated four H10N7 viruses from gulls in
Iceland. Genomic analyses showed four gene segments in the viruses were genetically associated
with H10 IAVs that caused influenza outbreaks and deaths among European seals in 2014.
Antigenic characterization suggested minimal antigenic variation among these H10N7 isolates
and other archived H10 viruses recovered from human, seal, mink, and various avian species in
Asia, Europe, and North America. Glycan binding preference analyses suggested that, similar to
other avian-origin H10 IAVs, these gull-origin H10N7 IAVs bound to both avian-like and
human-like receptors. However, when the gull-origin viruses were compared with another
Eurasian avian–origin H10N8 IAV, which caused human infections, the gull-origin virus showed
significantly higher binding avidity to human-like glycan receptors. Results from ferret
experiment demonstrated that a gull-origin H10N7 IAV replicated well in turbinate, trachea, and
lung, but replication was most efficient in turbinate and trachea. This gull-origin H10N7 virus
can be transmitted between ferrets through the direct contact and aerosol routes, without prior
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adaptation. Gulls share their habitat with other birds and mammals, and have frequent contact
with humans; therefore, gull-origin H10N7 IAVs could pose a risk to public health. Surveillance
and monitoring of these IAVs at the wild bird-human interface should be continued.
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Introduction
IAVs belong to the family Orthomyxoviridae and are classified into different antigenic
subtypes based on their surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA).
Sixteen HA and nine NA IAV subtypes have been recovered from wild birds (Webster et al.
1992; Röhm et al. 1996; Fouchier et al. 2005a). In addition to infecting humans, IAVs infect a
wide range of natural hosts (e.g., avian, swine, canines, and equines), among which migratory
waterfowl, shorebirds, gulls, and terns serve as the major IAV reservoir and play important roles
in virus movement, transmission, and genetic reassortment because of their seasonal movements
(Huang et al. 2014; Wille et al. 2011).
Subtype H10 IAVs have been recovered from a range of avian and mammalian
species. Sporadic cases of H10 avian IAV infection in humans have been reported, but humanto-human transmission has not been established. In 2004, H10N7 virus caused fever and cough
in two infants in Egypt (World Health Organization, Communicable Diseases, and Containment
2004); in 2010, two abattoir workers in Australia were found to be H10 virus-positive during a
low pathogenic avian influenza outbreak among chickens (Arzey et al. 2012); and in 2013, an
H10N8 avian IAV infected three humans in China, resulting in two deaths (Xu et al. 2015). In
addition to humans, H10 IAVs have also been reported in other mammals, including mink
(Klingeborn et al. 1985b), seals (Zohari et al. 2014), and pigs (Wang, Zou, et al. 2012).
In 2014, dead harbor seals (i.e., Phoca vitulina) in Germany, Sweden, and Denmark were
found to be infected with a subtype H10N7 IAV (Krog et al. 2015; Zohari et al. 2014; Bodewes,
Bestebroer, et al. 2015). The virus caused respiratory diseases and transmitted efficiently among
harbor seals and gray seals (i.e., Halichoerus grypus), leading to multiple outbreaks across
multiple regions throughout Europe (Bodewes, Rubio Garcia, et al. 2015; Bodewes et al. 2016);
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from March through November 2014, the outbreaks led to 1,400 deaths among a population of
approximately 12,000 seals in these regions (Bodewes, Bestebroer, et al. 2015). Serosurveillance
suggested that up to 58% of adult harbor seals and 28% of adult gray seals were exposed to this
H10N7 virus (Bodewes, Rubio Garcia, et al. 2015). Laboratory studies in a ferret model showed
that this seal H10N7 virus caused respiratory tract inflammation extending from the nasal cavity
to bronchi, but not lung (van den Brand et al. 2016). Similar to the genomic segments of an
H3N8 virus isolated from dead North American harbor seals (Anthony et al. 2012), all eight
genomic segments of this virus were of avian origin. Prior study suggested that this H3N8 virus
could be transmitted among ferrets without adaptation through aerosol droplets (Karlsson et al.
2014). Of note, most low pathogenic avian IAVs replicate strictly in the gastrointestinal tracts of
avian hosts and replicate to only a limited extent in mammals.
In 2015, we isolated four H10N7 IAVs from gulls in Iceland; the risk these
viruses posed to the sea mammal population and, potentially, to humans was unknown. To assess
the risk to mammal populations in the North Atlantic, we characterized the four viruses in terms
of their genetic associations with the 2014 European seal virus and their antigenicity, receptor
binding preference, pathogenicity, and transmissibility.
Materials and Methods
Field sampling
Gulls were live-captured at Sandgerdi, Iceland (64.041° N, -22.714° W), during
November 10–18, 2015, using a cannon-propelled capture net (approximately 18 m long × 12 m
wide) as previously described(Hall et al. 2014). Briefly; captured birds were marked with
individual metal bands, identified to species, and ages were determined by plumage
characteristics (Larsson 2004). Birds were sampled using a combined oral and cloacal swab
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where the same swab was first used to swab the oral cavity and then the cloaca. Each swab
sample was immediately placed in an individual 2.0-ml cryovial containing 1.25 ml of virus
transport medium (Hall et al. 2014). Vials were held on ice for up to 5 hours prior to being stored
in liquid nitrogen or liquid nitrogen vapor. Samples were shipped by private courier from Iceland
to Madison, Wisconsin, USA, on dry ice in biosecure containers. Once received in the
laboratory, samples were stored at -80°C until analyzed.
Detection of IAV-positive samples and virus isolation
Viral RNA was extracted using the MagMAX-96 AI/ND Viral RNA Isolation Kit
(Applied Biosystems Foster City, CA, USA) following the manufacturer’s procedures. Real-time
RT-PCR was performed using previously published procedures, primers, and probe designed to
detect the IAV M gene (Spackman et al. 2002). All samples exhibiting a positive cycle threshold
from RT-PCR analysis were subjected to virus isolation in 9- to 11-day-old embryonated chicken
eggs (PR 2008).
Cells and virus propagation
MDCK cells, A549 cells, and DF-1 cells were obtained from American Type Culture
Collection (Manassas, VA, USA). The cells were maintained until use at 37°C under 5% CO2 in
Dulbecco’s Modified Eagle Medium (Gibco DMEM; Thermo Fisher Scientific, Waltham, MA,
USA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA,
USA).
Viral isolates were inoculated in 9-day-old SPF chicken embryonated eggs and incubated
at 37°C for 72 hours. Viruses used to generate HI results for antigenic cartography (Figure 2)
include Ck/34609, Seal/ 221, A/mallard/Northlands/1/2014 (H10N7),
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A/duck/Bangladesh/24035/2014 (H10N1), A/laughing gull/DE/209/2013 (H10N8),
A/duck/Hong Kong/562/1979 (H10N9), Mink/E12665, A/mallard/Netherlands/10240/2002
(H10N7), A/duck/Bangladesh/821/2009 (H10N7), A/duck/Bangladesh/824/2009 (H10N7),
A/chicken/Bangladesh/842/2009 (H10N7), A/duck/Bangladesh/8987/2010 (H10N2),
A/duck/Bangladesh/8988/2010 (H10N9), A/chicken/Queensland/1/2012 (H10N7), rg-A/JiangxiDonghu/346/2013[R] (6+1+1) inactivated (H10N8), A/ruddy turnstone/King
Island/7104CP/2014 (H10N8), A/northern shoveler/CA/27943/2007 (H10N7), A/ruddy
turnstone/DE/579/2008 (H10N7), A/shorebird/DE/327/2009 (H10N1), A/ruddy
turnstone/DE/6200/2009 (H10N7), A/American coot/MS/09OS615/2009 (H10N3), A/American
black duck/New Brunswick/00971/2010 (H10N6), A/northern shoveler/AR/12OS160/2012
(H10N3), A/mallard/MS/12OS443/2012 (H10N1), A/mallard/OH/13OS1979/2013 (H10N7),
A/red knot/DE/420/2013 (H10N7), A/spot-billed duck/Alberta/308/2016 (H10NX), and A/ruddy
turnstone/DE/409/2016 (H10N5). Viruses used in growth kinetics analyses, glycan receptor
binding analyses, and animal studies include Gg/4552, Ig/4402, Gg/4270, Ig/4266, Seal/221,
Mink/E12665, A/American black duck/New Brunswick/00971/2010(H10N6), Ck/34609,
A/California/01/2009(H1N1), and A/duck/Hunan/795/2002(HA, NA)A/Puerto Rico/8/34
(H5N1).
Ferret antisera
Ferret antisera used in HI assays to generate results for antigenic cartography (Figure 2)
include those raised against A/chicken/Jiangxi/34609/2013 (H10N8), A/laughing
gull/DE/209/2013 (H10N8), A/glaucous gull/Iceland/4552/2015 (H10N7),
A/seal/Netherlands/P14-221/2014 (H10N7), A/mallard/Netherlands/1/2014 (H10N7),
A/duck/Bangladesh/24035/2015 (H10N1), and A/chicken/Germany/N/49 (H10N7).
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RNA extraction and genomic sequencing
Viral RNA was extracted by using the KingFisher Pure Viral NA Kit (Thermo Fisher
Scientific, Asheville, NC, USA) according to the manufacturer’s instructions. Influenza
amplicons were obtained from the 2-step RT-PCR amplification and sequenced using an inhouse influenza targeted sequencing procedure using influenza primers and PCR amplification
conditions adapted from previous studies (Zhou et al. 2009; Hoffmann et al. 2001). Nextera XT
DNA Library Preparation Kit was utilized to prepare the next-generation sequencing (NGS)
libraries prior to sequencing with the MiSeq Reagent v3 600 cycles kit with a MiSeq sequencing
system (all from Illumina, San Diego, CA, USA) according to the manufacturer’s suggested (Xu,
Bailey, Spackman, Li, Wang, Long, Baroch, Cunningham, Lin, and Jarman 2016). The quality of
paired-end reads obtained from MiSeq sequencing was checked by FastQC (Babraham
Bioinformatics, https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and trimmed by
Trimmomatic version 0.36 (Usadel Lab, http://www.usadellab.org/cms/?page=trimmomatic)
using a quality score threshold of 20. After quality trimming was performed, all paired-end reads
were aligned to reference genome of a corresponding virus by using Bowtie 2 (Johns Hopkins
University, http://bowtie-bio.sourceforge.net/bowtie2/index.shtml).
In addition to the viruses obtained from viral isolation, the viruses propagated for
phenotype analyses were also sequenced to ensure no additional mutations acquired during virus
propagation before they are used in animal experiments and glycan binding.
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Sequence alignment and phylogenetic analysis
Multiple sequence alignments were generated using Muscle v3.8.31 (Edgar 2004). The
phylogenetic tree for each gene segment was inferred by using a maximum-likelihood method by
running RAxML v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized
time–reversible substitution model (Stamatakis 2014). Phylogenetic trees were visualized by
using FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/).
Virus titration
To quantify virus titer, TCID50 was determined on MDCK cells. Briefly, MDCK cells
were maintained as stock cultures in DMEM and re-plated 1 days before infection in 96 well
plates for TCID50 assays. Treated samples and their paired controls were thawed and
immediately serially diluted. Cell cultures were then infected for 1 h after three times of
phosphate buffered saline (PBS) (pH 7.4) washes. The media for dilution and infections was
Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA, USA)
supplemented with 100 U/ml Gibco penicillin-streptomycin (Thermo Fisher Scientific, Waltham,
MA, USA). Post infection TCID50 cultures were washed and fed with Opti-MEM medium
supplemented with 100 U/ml Gibco penicillin-streptomycin and 1 µg/ml TPCK treated Trypsin
from bovine pancreas (Sigma-Aldrich, St. Louis, MO, USA). After 72 hours of incubation postinfection, supernate from 96 well plates were determined by hemagglutination using 0.5% turkey
erythrocytes. Results were recorded and TCID50 were calculated by the Spearman-Karber
algorithm (Ramakrishnan 2016).
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Hemagglutination and HI assays
Hemagglutination and HI assays were performed using 0.5% turkey erythrocytes as
previously described (Sun et al. 2013).
Virus purification
The allantoic fluids were harvested and subjected to centrifugation at 1,200 × g for 30
minutes at 4°C. The viruses were then purified by ultracentrifugation at 45,000 × g for 3 hours at
4°C. The pellets were dissolved with 1 ml of phosphate buffered saline (PBS) (pH 7.4) and
subjected to sucrose gradient (30%/60%) centrifugation at 103,000 × g for 1.5 hours at 4°C. The
viruses in the intermediate phase were collected and subjected to centrifugation at 103,000 × g
for 1 hour at 4°C. The pellets were dissolved in 0.5 ml of PBS and stored at −80°C until use.
Quantification of viral concentration
The purified viruses were quantified by using the solid-phase ELISA method as described
elsewhere (Lin et al. 2012). In brief, ELISA was performed for each testing virus by mouse
monoclonal anti-NP antibody (NR-43899; BEI Resources, National Institute of Allergy and
Infectious Disease [NIAID], National Institutes of Health [NIH], Bethesda, MD, USA) against
Goat Anti-mouse IgG HRP Conjugate (Sigma-Aldrich, St. Louis, MO, USA) and 1-Step Ultra
TMB-ELISA Substrate Solution (Thermofisher, Rockford, IL).
Biolayer interferometry receptor binding assay and data analyses
Virus-receptor avidities were determined by biolayer interferometry receptor binding
assay using an Octet RED instrument (Pall FortéBio, Fremont, CA, USA). To test the potential
binding avidity to human- and avian-like receptors, we used two biotinylated glycan analogs,
3ʹSLN and 6ʹSLN (Lectinity Holdings, Moscow, Russia). The glycans were preloaded onto
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streptavidin-coated biosensors at up to 0.5 µg/ml for 3 minutes in 1 × kinetic buffer (Pall
FortéBio, Menlo Park, CA, USA). Each test virus was diluted to a final concentration of 100 pM
with 1 × kinetic buffer containing 10 µM oseltamivir carboxylate (American Radiolabeled
Chemicals, St. Louis, MO, USA) and zanamivir (Sigma-Aldrich, St. Louis, MO, USA) to
prevent cleavage of the receptor analogs by NA proteins from virus. Association was measured
for 30-50 minutes at 25°C as described elsewhere (Lin et al. 2012; Xiong, Coombs, et al. 2013;
Benton et al. 2015; Wen et al. 2017).
Responses were normalized by the highest value obtained during the experiment, and
binding curves were fitted by using the binding-saturation method in GraphPad Prism 7
(https://www.graphpad.com/scientific-software/prism/). The normalized response curves report
the fractional saturation (f) of the sensor surface as described in a previous study (Xiong, Martin,
et al. 2013). RSL0.5 was used to quantitate the binding avidity of two selected viruses against two
glycan analogs. The higher the RSL0.5, the weaker the binding avidity.
Virus growth kinetics in vitro
To determine the replication of the viruses in different cell lines, we infected A549,
MDCK, and DF-1 cells with viruses at a multiplicity of infection of 0.01. After absorption for 1
hour at 37°C, the cells were washed with PBS and incubated for 72 hours at 37°C in 5% CO2
with Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA, USA)
supplemented with 1 µg/ml TPCK treated Trypsin from bovine pancreas (Sigma-Aldrich, St.
Louis, MO, USA) and with 100 U/ml Gibco penicillin-streptomycin (Thermo Fisher Scientific,
Waltham, MA, USA). Supernatants were collected at 8, 24, 48, and 72 hours after infection and
titrated using the TCID50 in MDCK cells.
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Pathogenicity of H10N7 IAV from Iceland in ferrets
We studied the pathogenesis of Iceland H10N7 virus (Ig/4266) in ferrets. Fifteen 6month-old ferrets were purchased from Triple F Farms (Sayre, PA, USA). All ferrets were
seronegative for IAV, as determined by HI assay. Three inoculation group ferrets were each
intranasally administered 0.5 ml of 106 TCID50 of virus (0.25 ml/nose). At the same time, three
control ferrets were administered 0.5 ml of PBS. At 5 days post inoculation (dpi), necropsies
were performed on two infected and two control ferrets, and respiratory tissues were collected
for virus titration in MDCK cells and for immunohistochemistry staining. Tissues were collected
from the respiratory system (turbinate, soft palate; upper and distal trachea, left cranial and
caudal lung, right cranial and caudal lung, right middle lung, and right accessory lobes).
Transmission study in ferret model
We used 12 ferrets to evaluate the potential for contact transmission or aerosol
transmission of Iceland H10N7 IAV among humans. At 0 dpi, six of the 12 ferrets were each
intranasally administered 0.5 ml of 106 TCID50 of Ig/4266 virus. At one dpi, each of these ferrets
was randomly paired with an H10 IAV–seronegative ferret for study of aerosol transmission
(group I) and direct contact transmission (group II). Paired group I ferrets (i.e., inoculated and
aerosol transmission ferrets) were housed in the same cage but separated by a 1-cm-thick,
double-layered steel partition with 5-mm perforations (Allentown, Inc., Allentown, NJ). Paired
group II ferrets (i.e., inoculated and contact ferrets) were housed in the same cage without a
partition. Nasal wash fluids were collected on 1, 3, 5, 7, 10 dpi/dpe, and virus titers were
determined by TCID50 in MDCK cells. Blood samples were obtained on 0, 10, and 21 dpi/dpe to
test for seroconversion.
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Immunohistochemical staining
We performed immunohistochemical staining to confirm the presence of viral antigen in
ferret tissues. Tissues were fixed in 10% neutral buffered formalin solution, paraffin embedded,
and sectioned before being stained. The sections were deparaffinized by using 100% xylene,
50% ethanol in xylene, 100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol, and distilled
water. Antigen retrieval was performed by boiling in 1× antigen retrieval solution (Dako,
Carpinteria, CA, USA) in a steamer for 20 minutes. Sections were washed with PBST (PBS with
0.5% Tween 20) before endogenous peroxidase activity was quenched in 3% H2O2. Sections
were then blocked with 10% normal goat serum (Invitrogen, Carlsbad, CA, USA) for 1 hour at
room temperature before incubation with anti-NP monoclonal antibody (BEI Resources, NIAID,
NIH) (Hirata et al. 2014) for 20 hours at 4°C. Sections were treated with a biotinylated goat antimouse IgG polyclonal secondary antibody for 30 minutes before ABC reagent (Vectastain,
Burlingame, CA, USA) was applied according to the manufacturer’s instructions. Sections were
counterstained with hematoxylin, washed, dehydrated, and covered with cover slips.
Histologic tissue inflammation analysis
Tissues collected from ferrets at 5 dpi were sectioned as previously described and then
stained with hematoxylin and eosin. The following tissue sections were analyzed: turbinate, soft
palate; upper and distal trachea, left cranial and caudal lung, right cranial and caudal lung, right
middle lung, and right accessory lobes.
Statistical analysis
Student t-test was used to determine statistical difference between viral titers from
different tissues, and an alpha of 0.05 was used as the criteria for significance.
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Biosafety and animal handling
Laboratory and animal experiments were conducted under BSL-2 conditions in
compliance with protocols approved by the Institutional Animal Care and Use Committee of
Mississippi State University or the U.S. Geological Survey National Wildlife Health Center.
Accession numbers
Sequencing data has been deposited in the GenBank under accession number
MK100291-MK100319, MK100321-MK100323.
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Results
Genetic analyses of gull-origin H10N7 IAVs
We isolated and genetically sequenced IAVs from four gulls, all of which were sampled
on the western coast of Iceland during November 10-18, 2015. One of the four isolates
[A/glaucous gull/Iceland/4552/2015(H10N7), abbreviated Gg/4552] was from an adult glaucous
gull (Larus hyperboreus), and another [A/glaucous gull/Iceland/4270/2015(H10N7), abbreviated
Gg/4270] was from a hatch-year glaucous gull. One of the other two isolates [A/Iceland
gull/Iceland/4266/2015(H10N7), abbreviated Ig/4266] was from an adult Iceland gull (Larus
glaucoides), and the other [A/Iceland gull/Iceland/4402/2015(H10N7), abbreviated Ig/4402] was
from a hatch-year Iceland gull. Genetic sequencing showed that the isolates were >99.50%
similar to each other across all eight genetic segments. Furthermore, phylogenetic analyses
showed that all eight gene segments of these H10N7 IAVs from Iceland were of Eurasian lineage
and that four genes (i.e. HA, NA, PB2, MP) of these Icelandic H10N7 IAVs were genetically
similar to an H10N7 IAV isolate [A/harbor seal/Germany/1/2014(H10N7)] recovered from a
sick seal on November 7, 2014 whereas four other genes (i.e. PB1, PA, NP, and NS) of these
Icelandic H10N7 IAVs belong to at a genetic clade distinct from those of the seal origin isolates
(Figure 1). Molecular characterization suggested that the PB1, PA, and NP genes of the Iceland
gull-origin H10N7 IAVs (e.g. A/glaucous gull/Iceland/4270/2015) and those of seal origin
isolates shared nucleotide sequence identities 93.51%, 93.78%, and 95.49%, respectively
whereas those for all other 5 genes (HA, NA, PB2, MP, and NS) were > 96.00%. For example,
the HA, NA genes of the Iceland gull–origin H10N7 IAVs shared 97.69% and 98.68%
nucleotide sequence identity, respectively, with HA and NA genes of A/harbor
seal/Germany/1/2014(H10N7). Phylogenetic analyses suggested that the NS genes from the seal
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H10N7 and the gull viruses we recovered do not belong to the same genetic clade although they
shared a nucleotide sequence identity of 96.15%.
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Figure 1

Phylogenetic and antigenic analyses of subtype H10 IAVs

A) hemagglutinin gene, B) neuraminidase gene, and C) polymerase acidic protein. The
phylogenetic tree for each gene segment was inferred by using a maximum-likelihood method by
running RAxML v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized
time–reversible substitution model (Stamatakis 2014). The bootstrap values were labeled for the
selected representative branches with bootstrap values  70. Phylogenetic trees were visualized
by using FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). Scale bars represent
nucleotide substitutions per site. Red indicates the H10N7 IAV strain isolated from an Iceland
gull in 2015; green indicates the subtype H10N7 avian IAVs isolated from European seals in
2014; the virus marked in blue indicates the IAVs isolated from Iceland from other studies.

Sequence analyses showed that most amino acids at the HA receptor binding sites were
conserved among the Iceland gull-origin H10N7 isolates, the seal-origin H10N7 isolates, the
H10 isolates from Eurasia, and the H10 isolates from North America (Table 4). The Iceland gullorigin H10N7 isolates and other wild bird-origin H10 isolates had amino acid 222Q
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(corresponding to 226 at H3), which is identical to those at the HA sequences of two H10
isolates from the 2014 outbreak among European seals (Table 4). However, the other four seal
isolates from the 2014 outbreak among European seals have amino acid 222L instead (Dittrich et
al. 2018) (Table 4). All H10 isolates had amino acid 224G (corresponding to 228 at H3) (Table
4).
Table 4

Molecular characterization of receptor binding sites at hemagglutinin proteins of
H10 IAVs
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Antigenic analyses of gull-origin H10N7 IAVs
Results from hemagglutination inhibition (HI) assays suggested homologous titers of
seven prototype H10 IAVs from Eurasia, North America, and Australia, including
A/chicken/Jiangxi/34609/2013 (H10N8), A/laughing gull/DE/209/2013 (H10N8), A/glaucous
gull/Iceland/4552/2015 (H10N7), A/seal/Netherlands/P14-221/2014 (H10N7),
A/mallard/Netherlands/1/2014 (H10N7), A/duck/Bangladesh/24035/2015 (H10N1), and
A/chicken/Germany/N/49 (H10N7), ranged from 1:40 to 1:1280. The four Iceland gull-origin
H10N7 IAVs cross-reacted with ferret sera against these seven H10 prototype viruses, and the HI
titers varied from 1:40 to 1:320 (raw data not shown).
Antigenic cartography analyses using AntigenMap (Cai, Zhang, and Wan 2010; Barnett
et al. 2012) showed no clear antigenic clusters among 32 viruses: the 4 Iceland gull-origin
H10N7 IAVs, 2 mammalian origin (seal and mink) H10N7 IAVs, 10 domestic poultry-origin
(chicken and duck) IAVs, and 16 wild bird IAVs (Figure 2). The average antigenic distance
between all 32 H10 isolates we tested was 1.3569 (0.8247) units, the antigenic distances
between 16 wild bird-origin H10 isolates was 1.3228 (0.9137) units, and the antigenic distance
between the four gull H10N7 isolates was 1.2259 (0.5692) units; each unit corresponds to a
two-fold change in HI titer. The antigenic distance between A/seal/Netherlands/P14-221/2014
(H10N7) and four gull H10N7 isolates was 2.1107 (0.9278) units and that between domestic
poultry-origin isolates and four gull H10N7 isolates was 1.2700 (0.7246) units. Sequence
analyses showed that antibody binding sites were conserved among these H10 viruses (data not
shown).
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Figure 2

Antigenic map of 32 subtype H10 influenza A viruses (IAVs)

The map was constructed using hemagglutination inhibition (HI) data derived from ferret
antisera. The open triangles indicate viruses isolated from humans or other mammals; the open
cirlces indicate viruses isolated from domestic poultry; and the black circles indicate viruses
isolated from wild birds. IAVs with identical HI titers may have overlapping positions on this
antigenic map. The map was constructed using AntigenMap (Cai, Zhang, and Wan 2010;
Barnett et al. 2012). Each gridline (horizontal and vertical) in the map represents one antigenic
unit distance corresponding to a 2-fold difference in HI titers. Ig/4266, A/Iceland
gull/Iceland/4266/2015(H10N7); Gg/4552, A/glaucous gull/Iceland/4552/2015(H10N7);
Gg/4270, A/glaucous gull/Iceland/4270/2015(H10N7); Ig/4402, A/Iceland
gull/Iceland/4402/2015(H10N7); rg-A/Jiangxi-Donghu/346/2013[R] (6:2) (H10N8), a
reassortant with HA and NA genes from A/Jiangxi-Donghu/346/2013 (H10N8) and six other
genes from A/PR/8/1934(H1N1).
In summary, the above analyses suggested that the four Icelandic gull H10N7 isolates
(Gg/4552, Gg/4270, Ig/4266, and Ig/4402) are antigenically and genetically similar to each other
and that these H10N7 isolates do not have significant antigenic diversities from but do have
different levels of genetic diversity (e.g. internal gene segments) with the contemporary H10
isolates from avian, mammals, and seals we studied. Based on these results, from these four
Icelandic gull H10N7 isolates, Ig/4266 was randomly selected for detailed analyses on their
replication, glycan receptor binding, and transmission properties as described in the next
sections.
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Gull-origin H10N7 IAV had competitive replication in vitro
To determine the ability of gull-origin H10N7 IAV to replicate in different cells, we
infected Madin-Darby canine kidney (MDCK), chicken embryo fibroblast (DF-1), and
adenocarcinomic human alveolar basal epithelial (A549) cells with Ig/4266 virus and three other
representative H10 isolates [A/seal/Netherlands/P14-221/2014(H10N7) (abbreviated as
Seal/221); A/mink/Sweden/E12665/1984(H10N4) (Mink/E12665); and
A/chicken/Jiangxi/34609/2013(H10N8) (Ck/34609)] at a multiplicity of infection of 0.01. All
four testing viruses replicated efficiently in MDCK, A549, and DF-1 cells, reaching peak virus
titers at 48 or 72 hours after inoculation (Figure 3). In general, these viruses grew better in
MDCK cells than in the other cell lines but showed similar growth patterns in MDCK and DF-1
cells. However, in A549 cells, the mink-origin H10N4 virus had a higher virus titer than the
other three viruses.
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Replication kinetics of four subtype H10 IAVs in vitro

Growth curves for influenza A/Iceland gull/Iceland/4266/2015(H10N7) virus
(Ig/4266);A/chicken/Jiangxi/34609/2013(H10N8) (Ck/34609) virus;
A/mink/Sweden/E12665/84(H10N4) virus (Mink/E12665); and A/seal/Netherlands/P14221/2014(H10N7) virus (Seal/221) in Madin-Darby canine kidney (MDCK), adenocarcinomic
human alveolar basal epithelial (A549) and chicken embryo fibroblast (DF-1) cells. Cells were
infected with viruses at a multiplicity of infection of 0.01; dashed lines indicate the limit of virus
detection, 1.50 log10 [50% tissue culture infective dose/ml (TCID50/ml)]. Virus titers are
expressed as mean ± standard deviation of log10 TCID50/ml.
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Gull-origin H10 IAV had strong binding avidity to alpha 2,6-linked sialic acids and alpha
2,3-linked sialic acids.
To understand the receptor binding properties of these isolates, we tested their receptor
binding avidities to two glycan analogs [i.e., Neu5Acα2-3Galβ1-4GlcNAcβ (3ʹSLN, an avianlike receptor) and Neu5Acα2-6Galβ1-4GlcNAcβ (6ʹSLN, a human-like receptor)] for eight
representative H10 viruses from various hosts: gull, seal, mink, duck, and chicken, and two
prototype influenza viruses, A/California/01/2009(H1N1) and A/Duck/Hunan/795/2002 (HA,
NA) × A/PR/8/34(H5N1)(Figure 4). All of the 8 tested H10 viruses had binding avidities to
3ʹSLN at a sugar-loading concentration of 0.5 µg/ml; however, at the same sugar-loading
concentration, isolates from all hosts also showed strong binding responses to 6ʹSLN.

43

FIG. S2

3sln

Response(nm)

8

6sln

6
4
2
0
5
1
1
2
2
0
6
9
1
1
55 440 427 426 l/22 266 097 460 1N 5N
4
/
/
H H
g/ Ig
g/ Ig ea /E1 k/0 k/3
S k uc C
G
G
in D
M

Figure 4

Glycan binding screening of H10 IAVs to biotinylated glycan analogs

To further determine the testing IAVs’ binding preference (i.e., to 3ʹSLN or 6ʹSLN), we
quantified and compared the 50% relative sugar loading (RSL) concentration (RSL0.5) at half the
fractional saturation (f = 0.5) of the tested virus against 3ʹSLN and 6ʹSLN. The higher the RSL0.5,
the smaller the binding avidity. Quantitative analyses showed that Ig/4266 virus had an RSL0.5 of
0.0835 (±0.0072 standard deviation [SD]) for 3ʹSLN and 0.2917 (±0.0019) for 6ʹSLN, whereas
Ck/34609 virus had an RSL0.5 of 0.0996 (±0.0178) for 3ʹSLN and 0.3398 (±0.0004) for 6ʹSLN.
As expected, our results showed that A/California/01/2009(H1N1) showed binding avidities only
to 6ʹSLN (RSL0.5 = 0.1076 ± 0.0097) but not to 3ʹSLN whereas A/duck/Hunan/795/2002 (HA,
NA) × A/PR/8/34 (H5N1) 3ʹSLN (RSL0.5 = 0.07822 ± 0.0068) but not to 6ʹSLN (Figure 5).
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Glycan binding specificity of subtype H10 IAVs

A) biotinylated α2,3–linked sialic acid (3ʹSLN) and B) α2,6–linked sialic acid (6ʹSLN) glycan
analogs as determined by biolayer interferometry using an Octet RED instrument (Pall FortéBio,
Fremont, CA, USA). Streptavidin-coated biosensors were immobilized with biotinylated glycans
at different levels. Sugar loading–dependent binding signals were captured in the association step
and normalized to the same background. Binding curves were fitted by using the saturation
binding method in GraphPad Prism 7 (https://www.graphpad.com/scientific-software/prism/).
Horizontal dashed line indicates half of the fractional saturation (f = 0.5); vertical dashed line
indicates relative sugar loading (RSL0.5) at f = 0.5; the higher the RSL0.5, the smaller the binding
avidity. Virus abbreviations: A/Iceland gull/Iceland/4266/2015(H10N7), Ig/4266;
A/chicken/Jiangxi/34609/2013 (H10N8), Ck/34609; A/California/04/2009(H1N1), H1N1; and
A/duck/Hunan/795/2002(HA, NA) × A/PR/8/34 (H5N1), H5N1.
Gull-origin H10 IAV caused infections in ferrets
To determine the infectivity and pathogenesis of the gull-origin H10N7 IAV in
mammals, we inoculated 6 seronegative ferrets (One group of 3 ferrets where each ferret was cohoused with an uninoculated ferret [to examine contact transmission] and another group of 3
ferrets where each ferret was co-housed with an uninoculated ferret but not in direct contact [to
examine aerosol transmission]; Table 5) with Ig/4266 virus. Three additional ferrets were
maintained in a separate room to serve as controls. Two ferrets inoculated with Ig/4266 (from the
three contact-transmission groups) and two control ferrets were euthanized and necropsied at 5
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days post inoculation (dpi) to determine viral pathogenesis and tissue tropism. Virus shedding
levels and seroconversion was determined for the remaining four ferrets.

Table 5

HI titers in serum samples from ferrets inoculated with or exposed to animals
inoculated with A(H10N7)
Titera,b

Group no., virus exposure
route, ferret ID (cage no.)

0 dpi or dpe

10 dpi or dpe

21 dpi or dpe

E4129 (4)

<10

NA

NA

E4130 (5)

<10

NA

NA

E4132 (6)

<10

80

80

E4133 (4)

<10

<10

40

E4136 (5)

<10

<10

<10

E4137 (6)

<10

160

160

E4126 (1)

<10

160

160

E4127 (2)

<10

160

320

E4128 (3)

<10

160

160

I
Inoculation

Direct contact

II
Inoculation

Aerosol
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Table 5 (continued)
E4138 (1)

<10

<10

<10

E4139 (2)

<10

320

160

E4140 (3)

<10

<10

<10

E4141 (7)

<10

NA

NA

E4142 (7)

<10

NA

NA

E4143 (8)

<10

<10

<10

III
Control

Abbreviations: dpe, days post exposure; dpi, days post inoculation; ID, identification; NA, not
available because ferrets were euthanized for pathogenicity study.
a
Hemagglutination inhibition assays were performed using turkey erythrocytes.
During the entire experimental period, influenza-like clinical signs (i.e. sneeze) were
observed in neither the ferrets inoculated with Ig/4266 nor those exposed to Ig/4266 through
direct contact or aerosol droplets. Compared with ferrets in the control group, the results from
body temperature monitoring through implant Transponder sensor (BioMedic Data Systems,
Inc., Seaford DE) did not show significant consistent temperature elevation in the ferrets
inoculated with Ig/4266 or in the ferrets exposed to Ig/4266 through both direct contacts and
aerosol droplets (data not shown). The results from body weight monitoring did not show weight
loss in all three control ferrets and five out of six ferrets inoculated with Ig/4266 (one ferret
[#E4128] inoculated with Ig/4266 had a body weight loss [~5%] on 3 dpi recovered quickly on 5
dpi) (data not shown). The body weight in the transmission ferrets were not monitored to avoid
any potential contaminations.
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All four remaining inoculated ferrets seroconverted by 10 dpi; at 21 dpi, HI titers ranged
from 1:80 to 1:320 (Table 5). Virus titration in MDCK cells suggested that all six inoculated
ferrets shed virus from 3 dpi to 5 dpi and had peak titers of up to 5.00 log10 50% tissue culture
infective dose (TCID50)/ml at 3 dpi (Figure 6). To determine the tissue tropism of Ig/4266 virus,
we quantified viral titers at 5 dpi in 10 tissue sections from each of the two ferrets’ respiratory
tracts; tissues sections were from the turbinate; soft palate; upper and distal trachea; and lung
(i.e., left cranial and caudal lungs and right cranial, caudal, middle lungs, and right accessory
lobes). Except for the left cranial and left caudal lung sections, all tissue samples had H10 IAVpositive titers ranging from 3.75 to 6.25 log10TCID50/g of tissue. Turbinate sections had an
average titer of 5.87 log10 TCID50/g of tissue, whereas accessory sections had an average titer of
3.88 log10 TCID50/g of tissue (Figure 7). Immunohistochemistry staining of the H10-positive
tissue sections showed that IAV-specific antigen was multifocally presented within epithelium
cells of the nasal turbinate, trachea, and lung (Figure 8), a finding consistent with virus titration
results (Figure 7; Table 6). In summary, the average viral loads in turbinate were significantly
higher than those in lungs (P < 0.05), and the turbinate has the highest viral loads among all the
tested tissues: soft palates (4.63 ± 0.37 log10TCID50/ml), turbinate (5.88 ± 0.38 log10TCID50/ml),
trachea (upper and distal trachea) (4.69 ± 0.31 log10TCID50/ml), and lung (left cranial and caudal
lungs, and right cranial, caudal, middle lungs, and right accessory lobes) (3.25 ± 0.38
log10TCID50/ml).
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Table 6

Viral titers (log10 TCID50/ml) in tissue sections from ferrets inoculated with
A(H10N7)

Tissue

E4129

E4130

Turbinate

5.50

6.25

SP

4.25

5.00

TR-U

5.50

4.50

TR-D

4.75

4.00

RA

4.00

3.75

LCR

a

ND

ND

LCD

ND

ND

RCR

5.00

4.25

RMD

3.75

4.00

RCD

4.25

4.00

Note: aND, Not detected. The results shown are log10 TCID50/gram. The tissue abbreviation is
listed below: soft palate (SP), upper trachea (TR-U), distal trachea (TR-D), left cranial lung
(LCR), left caudal lung (LCD), right cranial lung (RCR), right caudal (RCD), right middle lung
(RMD), and right accessory lobes (RA).
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Ferrets
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Virus titer (log10 TCID50/ml)

A

Days post infection/exposure

Mean titers of IAV recovered from nasal wash fluids of virus-inoculated and contact
ferrets in transmission experiments

Ferrets (n=3 per group/experiment) were inoculated with 106 tissue culture infectious doses/ml
(TCID50/ml) of influenza A/Iceland gull/Iceland/4266/2015(H10N7) virus. Twenty-four hours
later, naïve ferrets (n=3) were each randomly paired with an inoculated ferret and either housed
in same cages but on a different side of a 1 cm–thick, double-layered, steel partition with 5-mm
perforations (aerosol transmission group. Panels A, B, and C represent each direct contact
transmission group (white bars = inoculated ferrets; grey bars = naïve ferrets), and Panels D, E,
and F represent each aerosol transmission group (white bars = inoculated ferrets; black bars =
naïve ferrets). Nasal wash fluids were collected on the indicated days after inoculation or
exposure for virus quantification using endpoint titration in Madin-Darby canine kidney cells;
ending titers were expressed as log10TCID50/ml. Each panel represents a set of paired ferrets.
Dashed lines indicate the limit of detection, log10101.5 TCID50/ml. Ferrets represented by the
individual panels correspond to those listed in Table 5: A) ferrets in cage 4, B) ferrets in cage 5,
C) ferrets in cage 6, D) ferrets in cage 1, E) ferrets in cage 2, and F) ferrets in cage 3.
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Mean titers of influenza virus recovered from respiratory tract tissues of ferrets
nasally inoculated with 106 50% tissue culture infectious doses (TCID50) of
A(H10N7) virus

Two ferrets were euthanized 5 days post inoculation (dpi), and virus titers in the respiratory
tissues of each ferret were determined by using end-point titration in Madin-Darby canine kidney
cells. The results shown are log10 TCID50/gram. The tissue abbreviation is listed below: soft
palate (SP), upper trachea (TR-U), distal trachea (TR-D), left cranial lung (LCR), left caudal
lung (LCD), right cranial lung (RCR), right caudal (RCD), right middle lung (RMD), and right
accessory lobes (RA). Dashed line indicates the limit of detection, 1.50 log10TCID50/ml.
Results for tissues from the control group were negative (data not shown).
To further demonstrate the pathogenesis of Ig/4266 in ferrets, we performed hematoxylin
and eosin staining on tissue sections from all locations. Ferrets inoculated with Ig/4266 virus
showed moderate inflammatory changes within the ethmoid turbinates with scattered to small
51

clusters of neutrophils within the epithelium and luminal aggregates of degenerate neutrophils,
macrophages, cellular debris and occasional hemorrhage (Figure 8B, D). One inoculated ferret
(E4130) had rare areas of luminal neutrophils and cellular debris within terminal bronchioles
(data not shown).
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Figure 8

Pathogenic changes in respiratory tract tissues of ferrets inoculated with A(H10N7)
at 5 dpi

Immunohistochemistry staining showed the presence of H10 antigen in respiratory epithelium
cells within nasal turbinate (A, brown staining), ciliated epithelial cells within the trachea (B,
brown staining), and scattered ciliated epithelial cells in bronchioles tissue were immunoreactive
(C, arrows). D–G) Hematoxylin and eosin–stained ethmoid turbinate sections at 5 dpi in control
(D, F) and infected (E, G) ferrets. Ethmoid turbinates from virus-inoculated ferrets had
intraluminal aggregates of degenerate neutrophils, macrophages and, cellular debris. In addition,
there are scattered neutrophils within the epithelium (G, arrows). Bars = 20 µm / 100 µm (in D,
E).
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Gull-origin H10 IAV is transmitted by direct contact and by exposure to infectious aerosol
droplets.
To determine the transmission ability of Ig/4266 virus through direct contact, we used
three sets of ferrets, each comprising a subtype H10 IAV-seronegative contact ferret and an
Ig/4266 virus-inoculated ferret (6 ferrets total) (Table 5, group I). The three sets of ferrets were
separately housed in partition-free cages. At 21 days post exposure (dpe), two of the three
contact ferrets had seroconverted (HI titers of 1:160 and 1:40, respectively) (Table 5). At 5 and 7
dpe, one of the seropositive contacts had a peak virus titer of 3.50 log10 TCID50/ml in nasal wash
fluids (Figure 6C); virus was not detected in nasal wash fluids from the other two contact ferrets
(Figure 6A, B). All three virus-inoculated ferrets had detectable virus titers in their nasal wash
fluids (range, 3.00–5.00 log10 TCID50/ml). By integrating data from both virological and
serological analyses, two out of three direct contact-exposed-ferrets became infected with
Ig/4266.
We also used three sets of ferrets to determine the transmission ability of Ig/4266 virus
through aerosol droplets; each set comprised a subtype H10 IAV-seronegative ferret and an
Ig/4266 virus-inoculated ferret (6 ferrets total) (Table 5, group II). The two ferrets in each set
were housed in the same cage but separated by a 1-cm-thick, double-layered steel partition with
5-mm perforations. Nonrecirculating air in the cages flowed from the side housing the inoculated
ferret through the partition to the side housing the exposure ferret and exhausted to room air
through HEPA filtration. All three virus-inoculated ferrets had detectable virus titers in their
nasal wash fluids (range, 3.00-5.00 log10 TCID50/ml). By 10 dpe, one of the three aerosolexposed ferrets had seroconverted (HI titer of 1:160) (Table 5), and the same ferret shed virus
from 3 to 7 dpe; peak titers (5.50 log10 TCID50/ml) were detected at 5 dpe (Figure 6E). No virus
was detected in nasal wash fluids from the other two aerosol-exposed ferrets (Figure 6D, F). By
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integrating data from virological and serological analyses, one out of three aerosol-exposed
ferrets became infected with Ig/4266.
A total of three control ferrets (Table 5, group III) were housed in two cages in a separate
room from the experimental ferrets. Virus titration of collected tissues, nasal wash fluids,
immunohistochemical staining, and serologic assays remained negative for the control ferrets.

Discussion
In this study, we isolated four H10 IAVs from two gull species in Iceland, Iceland gulls
and glaucous gulls. Genomic sequence analyses suggested that these isolates were genetically
related to Eurasia lineage H10 IAVs, including those that caused the 2014 outbreak among
European seals (Dusek et al. 2014; Hall et al. 2014; van den Brand et al. 2016). Although genetic
connections have been reported among avian IAVs isolated from North America and Iceland
(Dusek et al. 2014), none of the gene segments among the four H10 IAVs we isolated for this
study were associated with those from North America. However, in previous studies both
Eurasian and American lineages of AIV have been reported in Iceland including an H10 subtype
of mixed Eurasian and American lineage (Dusek et al. 2014; Hall et al. 2014).
Human IAVs preferentially bind to α2,6-linked sialic acids (SAα2,6GA), whereas avian
IAVs prefer α2,3-linked sialic acids (SAα2,3GA) (Connor et al. 1994; Rogers et al. 1983; Rogers
and D'Souza 1989). In this study, biolayer interferometry analyses on the gull-origin H10N7
isolate we recovered (Ig/4266 virus) showed that the isolate bound to both SAα2,3GA and
SAα2,6GA, as also shown with three other H10 isolates from chicken, seal, and mink (Figure 4).
These results are consistent with other studies that also used biolayer interferometry analyses to
determine binding avidity for avian-origin H10 viruses (Vachieri et al. 2014), and they are
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consistent with results for a study, using turkey erythrocytes expressing both SAα2,3GA and
SAα2,6GA or only SAα2,6GA receptors, of seal-origin H10 IAVs that showed significant
binding ability to SAα2,3GA and SAα2,6GA (Dittrich et al. 2018). However, our results showed
that the binding avidities to SAα2,6GA could vary to some extent, depending on the virus strain,
but sequence analyses for the reported HA receptor binding sites were mostly conserved among
the isolates (Table 4). Of note, a mutation, Q220L (corresponding to 226 in H3 numbering),
which was reported to have been acquired in the 220 loop of the HA receptor binding site during
the subtype H10N7 IAV outbreaks among European seals, increased replication ability in
mammalian cells (A549 cells) and retained replication efficiency in the avian cells (chicken
embryo kidney primary cells)(Dittrich et al. 2018). This mutation seems to increase the binding
avidity of avian-origin H10N7 IAV to SAα2,6GA (Dittrich et al. 2018). Mutations Q226L and
G228S (in position H3) can increase the ability of avian IAV to infect humans (Ha et al. 2003;
Liu, Stevens, et al. 2009; Bateman et al. 2008; Connor et al. 1994; Nobusawa and Nakajima
1988; Vines et al. 1998; Wan and Perez 2007). Our results suggest that replication of minkorigin H10N4 virus in mammalian cell line A549 and MDCK cells (but not in avian DF-1 cells)
was more efficient than that of gull-origin H10 IAVs, although receptor binding properties of
these H10 viruses were similar. It is unclear whether the NA or internal genes of mink virus
could also contribute to such phenotypic differences in growth analyses (Figure 3). Nevertheless,
the binding ability of the gull-origin H10 IAVs to SAα2,6GA could facilitate viral infection of
mammal hosts (e.g., ferrets and humans) expressing SAα2,6GA and facilitate the generation of a
more transmissible virus.
Antigenic analyses showed a lack of significant antigenic diversity among 32 H10 IAVs
that we tested (Figure 2); this finding is similar to that from a prior study, in which the antigenic
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properties of 20 IAVs were compared (Sutton et al. 2017). Sequence analyses showed that the
amino acids across the HA antibody binding sites were conserved (data not shown). The limited
antigenic diversity for H10 avian IAVs is consistent with the concept of evolutionary stasis in
natural reservoirs of IAVs (i.e., aquatic birds, such as migratory waterfowl and shorebirds)
(Sturm-Ramirez et al. 2005). These results are consistent with those from other studies of other
subtypes of waterfowl-origin IAVs, such as subtype H3 (Bailey et al. 2016) and H7 viruses (Xu,
Bailey, Spackman, Li, Wang, Long, Baroch, Cunningham, Lin, Jarman, et al. 2016; Munster et
al. 2005; Campitelli et al. 2008).
As one of the key natural reservoirs of IAVs, gulls play an important role in transmission
and dissemination of various subtypes of IAVs, including subtypes H5 and H7 (Benkaroun
2016). Prior studies suggested that gull species seem to be involved in transportation of avian
IAVs in the North Atlantic and in the reassortment of these viruses into new genetic
combinations (Wille et al. 2011; Hall et al. 2013). The habitat variety of gulls certainly create the
possibility of acquiring a variety of IAVs from multiple sources because they are consummate
generalists and can be found in practically any habitat, including coastal, marine, brackish,
freshwater, agricultural, and even human urban and suburban environments. Glycan receptor
characterization showed that gulls (herring gull, laughing gull, ring-billed gull) had abundant
expression of α2,3-linked sialic acid in the respiratory tract (nasal turbinate, trachea, bronchi,
lung) and intestinal tract (duodenum/jejunum, ileum/caeca). In addition, α2,6-linked sialic acid
was abundantly expressed in gulls’ respiratory tracts; however, little or no expression of α2,6linked sialic acid was detected in the gulls’ intestinal tracts (Franca, Stallknecht, and Howerth
2013). Previous reports indicated that gulls, when infected with highly pathogenic avian IAV,
exhibited a variety of clinical and pathologic phenotypes: some IAV strains caused severe
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disease and even death, whereas other strains caused mild lesions and no deaths (Wood,
Webster, and Nettles 1985; Ramis et al. 2014; Brown et al. 2006; Perkins and Swayne 2002;
Brown, Stallknecht, and Swayne 2008). Gulls experimentally infected with low pathogenic avian
IAVs showed no signs of disease, and none died (Bahl and Pomeroy 1977; Brown et al. 2012;
Curran et al. 2013). Most of these infected gulls shed virus from the oropharynx and cloaca
(Perkins and Swayne 2002; Brown et al. 2006; Brown, Stallknecht, and Swayne 2008; Ramis et
al. 2014; Bahl and Pomeroy 1977; Brown et al. 2012; Curran et al. 2013). Of note, a gull-origin
H16N3 IAV was shown to attach to the human respiratory tract, cornea, and conjunctiva, and a
human virus was shown to bind to the trachea of gull species tested (Lindskog et al. 2013). In
summary, prior studies suggest that gulls could be infected with avian or human IAVs and serve
as asymptomatic carriers facilitating virus transmission. In this study, the Eurasian lineage H10
viruses, which were associated with outbreaks among seals (Figure 1) and have been identified
in at least two gull species in Iceland. Thus, gulls could facilitate spillover of viruses to other
hosts within the IAV ecologic environment and to other geographic regions, including North
America.
Ferrets have been used as a model of human infection in this study as their physiology
and immune system and the influenza-associated glycan receptor distribution in their respiratory
tracts are similar to those in humans (Maher and DeStefano 2004; van Riel et al. 2007); thus,
ferrets have been used widely as a model of influenza infection in humans for influenza risk
assessment (e.g., pathogenesis and virus transmission) and to evaluate influenza vaccines
(Houser et al. 2013; Vela et al. 2012; Govorkova et al. 2006; Belser, Katz, and Tumpey 2011).
Human seasonal influenza virus infections in ferrets primarily occur in the upper respiratory tract
(Renegar 1992; Smith and Sweet 1988). Instead, avian IAVs (e.g. subtype H5N1) can cause
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upper respiratory tract and lower respiratory tract manifestations in humans (Beigel et al. 2005).
In laboratory conditions, many avian IAVs, including subtype H5N1 and H7N9, can cause
infections in both upper and lower respiratory tracts in ferrets (Zhu, Wang, et al. 2013) (Lipatov
et al. 2009). However, most of these laboratory studies in ferrets involve in a high dose (e.g. 105
to 107 plaque-forming units, TCID50, or 50% egg infectious doses) usually, through intranasal or
intratracheal inoculation. Recent studies suggest that the method of virus administration and
dosage in the challenges affects the pathogenesis and the tissues where the challenging virus can
be recovered (Bodewes et al. 2011; Lipatov et al. 2009; Belser et al. 2016; Moore et al. 2014).
Human seasonal and pandemic influenza viruses typically can be transmitted efficiently between
ferrets through direct contact or aerosol droplets. In our study, gull-origin subtype H10N7 IAV
replicated primarily in the upper respiratory tract of ferrets, although some virus was also
identified in the lower respiratory tracts of ferrets inoculated with H10N7 virus (Figure 7; Table
6). In addition, H10N7 virus infection caused moderate histologic changes in ferrets (Figure 8).
In a prior study, pathogenesis was evaluated in ferrets that had been infected with one of 20
subtype H10 IAVs from different host species in Eurasia and North America: domestic poultry
(chicken, turkey, duck, quail), wild birds (mallards, ruddy turnstone, northern pintail, American
black duck, Eurasian wigeon, unidentified shorebird species), and mammals (mink, seal, human)
(Sutton et al. 2017). Results showed that the 20 H10 IAVs had robust viral replication in the
nasal turbinate and various degrees of replication in the lungs (Sutton et al. 2017); those findings
are consistent with our findings for gull-origin H10N7 virus. Furthermore, gull H10N7 virus can
be transmitted between ferrets through both direct contact and aerosol droplets, although aerosol
transmission is less efficient than direct contact transmission (Table 5). Our findings suggest that
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the gull-origin H10 IAVs have the potential to infect mammals, including humans, and possibly
even result in human-to-human transmission.
Evaluation of the replication and transmission ability of avian-origin IAVs in mammals is
a key component of influenza pandemic preparedness. This study supported that preparedness
component, showing that, similar to subtype H1, H3, H5, H6, H7, and H9 avian IAVs, subtype
H10 avian IAVs can infect mammals, including humans (World Health Organization,
Communicable Diseases, and Containment 2004; Arzey et al. 2012; Xu et al. 2015), minks
(Klingeborn et al. 1985b), seals (Zohari et al. 2014), and pigs (Wang, Zou, et al. 2012). In
addition, our findings suggest that avian H10 IAVs could potentially be transmitted among
mammals through direct contact, aerosol droplets, or both, as was confirmed by the outbreaks
among European seals (Dusek et al. 2014; Hall et al. 2014; van den Brand et al. 2016). Thus,
monitoring the enzootic dynamics and evolutionary patterns of H10 IAVs among wildlife,
including gulls, would facilitate influenza pandemic preparedness, and continuing surveillance of
avian IAVs at wildlife–domestic animal interface and the animal–human interface is warranted.
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CHAPTER III
UNDERSTAND THE CORRELATION BETWEEN DISTRIBUTION OF SLEX RECEPTOR
WITH HOST/TISSUE TROPISMS OF AVIAN H7 IAVS IN CHICKENS AND MALLARDS

Avian IAVs are enzootic in wild birds and cause sporadic spillovers into domestic
poultry and humans. Prior studies suggested that certain avian IAVs prefer to fucosylated
sulfated α2,3 sialoglycan. The goal of this study is to determine receptor binding specificity of
H7 IAVs and the host/tissue tropisms of H7 viruses in chickens and mallards, and we will focus
on fucosylated α2,3 sialoglycan in this study. We hypothesize that H7 IAVs would bind to
fucosylated α2,3 sialoglycan and that fucosylated α2,3 sialoglycan would be expressed distinctly
among the respiratory and gastrointestinal tracts of wild bird species. Results from bio-layer
interferometry of 10 wild bird origin H7 isolates from North America, one human and one turkey
H7 isolates from Eurasia showed binding to the glycans that terminated with either
Neu5Aca2,3Gal or Neu5Aca2,6Gal, but with the binding preference to the ones with a Sialyl
Lewis X (SLex) motif, a fucosylated Neu5Aca2,3Gal glycan. Of interest, Glycan receptor
distribution analyses suggested that SLex is widely distributed in the trachea, cloaca, and colon
of chickens as well as in the trachea and cloaca but not colon of mallards. SA2,3Gal is abundant
in all tissues while SA2,6Gal is less expressed in chickens and mallards. More specifically,
SA2,6Gal were detected in all tested tissues except in trachea-middle, trachea-distal, cloaca of
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chickens; but only in duodenum and caecum of mallards were expressed SA2,6Gal. The animal
challenge experiment using A/mallard/New Jersey/A00926089/2010 (H7N3) showed that viruses
are detected in the tissues with or without SLex expression. Mallards had much higher shedding
loads (p<0.001) and a longer shedding span than chickens. In addition, we found SLex were
found in the trachea of H7 susceptible wild bird species but not in sea ducks and wood ducks in
which rare H7 infections occurs. In summary, this study suggested that SLex may contribute to
host tropism of avian H7 IAVs. Further studies are needed to reveal the relations between
receptors in hosts and the binding avidity to counterpart glycans among avian IAVs.

62

Introduction
Subtype H7 avian IAVs are enzootic in wild birds and have been reported to spread
sporadically into domestic poultry, lower mammals (e.g. harbor seals (Webster et al. 1981; Lang,
Gagnon, and Geraci 1981; Kwon et al. 2011), swine (Kwon et al. 2011)), and humans (Banks,
Speidel, and Alexander 1998; Campbell, Webster, and Breese 1970; DeLay, Casey, and Tubiash
1967; Kurtz, Manvell, and Banks 1996; Taylor and Turner 1977; Webster et al. 1981; Koopmans
et al. 2004; Fouchier et al. 2004b; Tweed et al. 2004; Dudley 2008). To date, all H7 avian IAVs
identified from wild birds are low pathogenic (LP) but can mutate to high pathogenic (HP) after
being transmitted to domestic poultry. The HP H7 IAVs has caused a number of outbreaks
(Selleck et al. 2003; Hirst et al. 2004; Fouchier et al. 2004b; Berhane et al. 2009; Lopez-Martinez
et al. 2013; Lee et al. 2017) with devastating economic loss to the poultry industry (Lee et al.
2017; Mannelli, Ferrè, and Marangon 2006; Mulatti et al. 2007) . Prior studies showed that,
although interactions with wild birds exposed H7 IAVs to wild mammals (e.g. seals (Lang,
Gagnon, and Geraci 1981) and feral swine (Martin et al. 2017) and humans (Koopmans et al.
2004), the majority of H7 spillover cases were associated with direct contact with infected
domestic poultry (Dudley and Mackay 2013; Kurtz, Manvell, and Banks 1996; Fouchier et al.
2004b; Koopmans et al. 2004; Tweed et al. 2004; Lopez-Martinez et al. 2013). Typically, after
being introduced and becoming enzootic in domestic poultry, these H7 avian IAVs can increase
the opportunities to interact with domestic mammals, such as swine, and humans. Thus, it is
important to perform spillover risk assessment of H7 avian IAVs to understand how avian H7
IAVs can spillover from wild birds to domestic poultry.
Surveillance studies suggested that the prevalence of subtype H7 IAVs in wild birds are
not universally distributed across wild bird species (Krauss et al. 2004; Munster et al. 2007;
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Olsen et al. 2006; Krauss et al. 2015). For example, a long-term surveillance of IAVs in
migratory ducks in Alberta, Canada, from 1976 to 2012 and in shorebirds and gulls at Delaware
Bay, United States, from 1985 to 2012 showed that H7 IAVs were more likely to be isolated in
shorebirds and gulls (6.18%) rather than in ducks (1.11%) (Krauss et al. 2015). The limitation of
these studies is that number of samples across various bird species are not evenly distributed and
thus it is difficult to conclude H7 IAVs are host dependent across wild bird species. On the other
hand, under laboratory conditions, H7 IAVs can infect a large number of wild and domestic
avian species, including chicken, Pekin ducks, turkeys (Spackman et al. 2010; Yu et al. 2019),
mallards (Pantin-Jackwood et al. 2016), Japanese quail, rock pigeons, and Embden geese
(Pantin-Jackwood et al. 2014). Clinical signs, pathogenesis and shedding patterns varied greatly
among these tested species. For example, an avian origin isolate A/Anhui/1/2013 (H7N9)
infected chickens, Japanese quail, pigeons, Pekin ducks, Mallard ducks, Muscovy ducks, and
Embden geese; while with no apparent clinical signs, chickens and Japanese quail shed more
viruses and have a longer period than the other five species. Of interest, the viral shedding was
higher in oropharyngeal swabs than in cloacal swabs from all these tested species (PantinJackwood et al. 2014). These data suggested that there were species barriers when H7 IAVs
transmitted from one wild bird species to another and from wild birds to domestic poultry. There
is a need to understand the molecular mechanism affecting how H7 avian IAVs host tropisms
across various avian species, especially from wild birds to domestic poultry.
Receptor binding has been shown to be one of key factors determining the host tropisms
of IAVs. The surface glycoprotein hemagglutinin (HA) of IAVs enter the cells by attaching the
sialic acids (Sias) on the cell surface. It has been well accepted that avian IAVs bind to receptors
containing terminal sialyl-galactosyl residues linked by an α2-3 linkage (Neu5Acα2-3Gal, avian64

like receptor), whereas human viruses bind to receptors which contain terminal α2-6-linked
sialyl-galactosyl moieties (Neu5Acα2-6Gal, human-like receptor) and swine viruses to both
Neu5Acα2-3Gal and Neu5Acα2-6Gal (Connor et al. 1994; Gambaryan, Karasin, et al. 2005;
Matrosovich et al. 2000; Matrosovich et al. 1997). Switching the binding specificity to receptors
with different lineages can help change the host tropism of influenza viruses. For example, a
change of the binding specificity from avian-like to human-like receptor for an IAV is one of key
factors for the emergence of an endemic virus in humans (Baigent and McCauley 2003;
Matrosovich, Gambaryan, and Klenk ; Malik Peiris 2009). Glycan distribution analyses
demonstated that presence of Neu5Acα2-3Gal among various wild birds (e.g. mallards, mute
swans) and domestic poultry species (e.g. chickens, turkeys) (Franca, Stallknecht, and Howerth
2013; Guo et al. 2007; Liu, Han, et al. 2009). Thus, the linkage to the terminal sialyl-galactosyl
residues in the glycan alone cannot be the cause of variations in the susceptibility of H7 IAVs
across avian species.
A number of studies investigated whether IAVs can bind differently to certain glycan
substructures, so called glycan motifs, in addition to the well-known linkage to the terminal
sialyl-galactosyl residues. In one study, all tested avian IAVs bound to Neu5Acα2-3Galβ14GlcNAcβ (3’SLN), but the duck origin viruses preferred Neu5Acα2-3Galβ1-3GalNAcα
(SiaTF), the gull origin viruses preferred SLex, and the chicken origin viruses preferred
Neu5Acα2-3Galβ1-4-(6-O-Su)GlcNAcβ (6-O-Su-3’SLN) (Gambaryan, Yamnikova, et al. 2005;
Gambaryan et al. 2018). Another study showed that viruses originated from chicken, turkey,
goose bind to Neu5Acα2-3Galβ1-4(Fucα1-3)-(6-HSO3)GlcNAcβ (Su-SLex) (Gambaryan et al.
2008). Chicken, turkey, ostrich, mallard, green-winged teal, ruddy turnstone origin H7 IAVs had
preferential binding to SLex and to both 6-O-Su-3’SLN and Su-SLex, two sulfated
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oligosaccharides (Gambaryan et al. 2012). In summary, these studies suggested avian IAVs had
variations in binding preferences among glycan substructures in addition to the linkage to the
terminal sialyl-galactosyl residues. However, most of these studies are limited to glycan binding
but without functional analyses. A recent study suggested that a chicken origin H5N2 virus had a
higher binding preference to SLex than SA2,3Gal whereas a duck origin H5N2 virus to SA2,3
than SLex. The chicken virus replicated more efficiently in the SLex expressed MDCK cells than
in the SLex deficient MDCK cells. In addition, SLex is highly expressed in the upper respiratory
tracks of chicken but not in colon of ducks, suggesting that SLex could a potential glycan
receptor for avian H5 (Hiono et al. 2014). However, it is unclear whether SLex could play a role
in affecting tissue and host tropism of avian IAVs, especially in how virus is transmitted from
wild birds to domestic poultry.
In this study, we hypothesize that SLex would be distributed differently across the tissues
of avian species and that such a distribution would cause different viral and shedding patterns
between birds. We focused on subtype H7 avian IAVs in this study. To test these hypotheses, we
analyzed the distribution of SLex across both respiratory and gastrointestinal tracts of a set of
wild bird and domestic poultry species, which are commonly related to H7 infections during
influenza surveillance, and then performed glycan binding analyses of a set of H7 avian IAVs
from these birds. Through animal experiments using susceptible bird species, we correlated the
glycan binding data with the viral abundance across tissues and in viral shedding, in mallard (a
wild bird species) and chicken (a domestic poultry species).

66

Materials and methods
Viruses, virus propagation, and purification
Viruses used in this study include two reassortant viruses [A/Shanghai/2/2013 (H7N9)
(HA,NA)×PR8 (H7N9) (IDCDC-RG32A; SH2) (BEI resources, https://www.beiresources.org),
A/turkey/Virginia/4529/2002 (H7N2)×PR8 (H7N2) (IBCDC-5; Turkey/2002) (International
Reagent Resource, https://www.internationalreagentresource.org)] and 11 avian IAV isolates
listed in Table 7.
All viruses were propagated for a single passage in specific pathogen free (SPF) 9-day
old embryonated chicken eggs (Charles River, Norwich, CT) at 37 °C for 72 hours, and the
allantoic fluids were harvested and stored at -80°C until use. The viruses used in biolayer
interferometry receptor binding analyses were purified through sucrose density gradient
ultracentrifugation and then quantified by solid-phase ELISA method as described elsewhere
(Wen et al. 2018).
Table 7

Viruses used in the study

Viruses

Abbreviation

A/Shanghai/2/2013 (H7N9) (HA,NA)×PR8 (H7N9) (IDCDC-RG32A

SH2

A/turkey/Virginia/4529/2002 (H7N2)×PR8 (H7N2) (IBCDC-5)

Turkey/2002

A/American black duck/Delaware/A00870108/2010 (H7N3)

Duck/2010

A/mallard/New Jersey/A00926089/2010 (H7N3)

Mallard/2010

A/blue-winged teal/Taxes/A00463679/2010(H7N3)

Teal/2010

67

Table 7 (continued)
A/bufflehead/Virginia/A00120022/2008 (H7N2)

Buff/2008

A/domestic duck/West Virginia/A00140913/2008 (H7N3)

Duck/2008

A/American green-winged teal/Utah/A00654391/2009 (H7N3)

Teal/2009

A/mute swan/Rhode Island/A00325125/2008 (H7N3)

Swan/2008

A/northern pintail/Texas/A00466052/2009 (H7N3)

Pintail/2009

A/northern shoveler/Utah/A00468766/2009 (H7N3)

Shoveler/2009

A/ring-necked duck/Texas/A00766403/2009 (H7N1)

Ring/2009

Hemagglutination and hemagglutination inhibition (HI) assays
Hemagglutination and HI assays were performed by using 0.5% turkey erythrocytes as
described in the Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza
by the World Health Organization (WHO) Global Influenza Surveillance Network (WHO 2011).
The serum was first treated with washed-pack turkey erythrocytes with final concentration of
10%, after which the serum-erythrocytes were mixed and incubate for 30 minutes at room
temperature. Briefly, 2-fold serial dilutions of 25 μL of serum after turkey erythrocytes
absorption with were made in 25 μl of phosphate buffered saline (PBS). Diluted sera were
incubated with 8 hemagglutination units of viruses (in a volume of 25 μl) for 15 minutes at room
temperature, and then 50 μL per well of 0.5% turkey erythrocytes were added. The results were
recorded after 30 minutes of incubation at room temperature. HI titers were calculated as the
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reciprocal of the last HI-positive serum dilution, and samples with a HI titer lower than 1: 10
were considered negative.

Virus titration
The 50% tissue culture infectious dose (TCID50) was determined on MDCK cells.
Briefly, MDCK cells were maintained as stock cultures in DMEM and re-plated 1 day before
infection in 96-well plates for the TCID50 assays. Cell cultures were then infected for 1 hour after
three times of PBS (pH 7.4) washes. The media used for dilution and infections was Opti-MEM I
Reduced Serum Medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 100
U/mL Gibco penicillin-streptomycin (Thermo Fisher Scientific, Waltham, MA). Post infection
TCID50 cultures were washed and fed with Opti-MEM medium supplemented with 100 U/mL
Gibco penicillin-streptomycin and 1 µg/mL TPCK treated Trypsin from bovine pancreas (SigmaAldrich, St. Louis, MO). At 72 hours post inoculation, supernatant from 96 well plates were
determined by hemagglutination using 0.5% turkey erythrocytes. Results were recorded and
TCID50 were calculated by the Reed and Muench algorithm (Ramakrishnan 2016).

H7 sequence data and molecular characterization
The HA protein sequences of the tested virus isolates used in binding experiments were
downloaded from GenBank, National Center for Biotechnology Information database. Multiple
sequence alignments were generated using Muscle v3.8.31 (Edgar 2004). The amino acid
residues in the HA receptor binding site were compared.

69

Biolayer interferometry receptor binding assay
The virus receptor binding avidities with three receptors were determined by biolayer
interferometry assay with an Octet RED instrument (Pall ForteBio, Menlo Park, CA). Three
biotinylated glycan analogs, Neu5Acα2-3Galβ1-4GlcNacβ-PAA-biotin (3’SLN), Neu5Ac α26Galβ1-4GlcNacβ-PAA-biotin (6’SLN) (Lectinity Holdings, Moscow, Russia) and and Neu5Ac
α2-3Galβ1-4GlcNacβ (β1-3Fuc)-PAA-biotin (SLex) were synthesized and kindly provided by
Dr. Lei Li from Georgia State University. The glycans were preloaded onto streptavidin-coated
biosensors at up to 0.3 µg/ml for 5 minutes in 1 × kinetic buffer (Pall FortéBio, Menlo Park, CA,
USA). Each test virus was diluted to a final concentration of 100 pM with 1 × kinetic buffer
containing 10 µM oseltamivir carboxylate (American Radiolabeled Chemicals, St. Louis, MO)
and zanamivir (Sigma-Aldrich, St. Louis, MO) to prevent cleavage of the receptor analogs by
NA proteins of virus. Association was measured for 30 minutes at 25°C as described elsewhere
(Guan, Hall et al. 2019). Responses were normalized by the highest value obtained during the
experiment, and binding curves were fitted by using the binding-saturation method in GraphPad
Prism 8 (https://www.graphpad.com/scientific-software/prism/). The normalized response curves
report the fractional saturation (f) of the sensor surface as described in elsewhere (Xiong,
Tuzikov, et al. 2013). The RSL0.5 and SD were calculated by the software as mentioned above.
RSL0.5 was used to quantitate the binding avidity of two selected viruses against two glycan
analogs. The higher the RSL0.5, the weaker the binding avidity.

RNA extraction, sequencing, and quantitative RT-PCR
Before the tested virus isolates were used in the phenotypic analyses, their HA sequences
were sequenced and confirmed that no mutations were developed during virus propagation. To
70

sequence HA, viral RNAs were extracted from the allantoic fluid of SPF embryonated chicken
eggs with GeneJET Viral DNA/RNA purification kit (Thermo Fisher Scientific, Waltham, MA)
following the manufacturer’s instruction. The RNAs were subjected to cDNA synthesis by using
the SuperScriptTM III Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA) according
to the manufacturer’s instruction. PCR products of the full length HA were generated with IAV
specific primers (Hoffmann et al. 2001). The parameters of the PCR were set as follows: one
cycle at 98°C for 30 seconds, followed by 40 cycles at 98°C for 10 seconds, 55°C for 30 seconds
and 72°C for 2 minutes, then one cycle at 72°C for 10 minutes. The PCR products were sent for
Sanger sequencing by Eurofins Genomics LLC (Louisville, KY).
To quantify the viruses shed by each bird and those in each tissue section, RNA was
extracted from a swab or tissue sample by using Applied Biosystems 5×MagMAXTM Pathogen
RNA/DNA Kit (Thermo Fisher Scientific, Waltham, MA). One-step qRT-PCR was performed to
determine the viral RNA copy numbers by TaqMan Fast Virus 1-Step Master Mix (Thermo
Fisher Scientific, Waltham, MA). The IAV matrix gene-based primers, including forward primer
(5’- GACCRATCCTGTCACCTCTGAC -3’), reverse primer (5’- AGGGCATTY
TGGACAAAKCGTCTA -3’), and TaqMan® Probe (5’TGCAGTCCTCGCTCACTGGGCACG), were used in the qRT-PCR reaction. TaqMan® probes
are labeled at the 5'-end with the reporter molecule 6-carboxyfluorescein (FAM) and with the
quencher, Blackhole Quencher 1 (BHQ1) (Biosearch Technologies, Inc., Novato, CA) at the 3'end. The parameters of the qRT-PCR were set as follows: one cycle at 50°C for 5 minutes, 1
cycle at 95°C for 20 seconds, followed by 40 cycles at 95°C for 3 seconds and 60°C for 30
seconds.
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Determine the number of viral copies using standard curve
To quantify our RNA copy numbers in our samples, M-gene based standard curve were
included in each one-step qRT-PCR plate with a detection limit of 10 viral RNA copies/l. The
standard curves were generated based on M-gene plasmids, which are subjected to 10-fold serial
dilutions ranging from 10 to 107 copies/L. Average of threshold cycle (Ct) values were
recorded and plotted against plasmid concentration by linear regression. The average Ct were
recorded and viral concentrations in samples were calculated based on the standard curve
constructed as above. To better understand the viral concentrations, the units of liquid samples
(swabs) were converted into copies/mL and solid samples (tissues) were converted into copies/g
tissues and shown as log10 copies/mL for swabs or log10 copies/g for tissues. After the
conversion, the limit of detection is 4.17 log10 copies/g and 3.65 log10 copies/mL for tissues and
swabs, respectively.

Glycan receptor distribution in respiratory tracts and intestines of chicken and mallard
Tissues were prepared for histopathology and immunofluorescence staining. Briefly, a
tissue was fixed by submersion in 10% neutral buffered formalin and embedded in paraffin.
Sections were made at 5 μm. The sections were deparaffinized by dipping into the following
solutions: 2 times of 10 minutes in xylene, 3 minutes of 1:1 xylene:100% ethanol, 100% ethanol,
100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol and rinse in ddH2O. Antigen was then
heat-induced target retrieved with diluted Target Retrieval Solution, Citrate pH 6.1 (10x)
following the manufacturer’s manual (Dako, Carpinteria, CA). The sections were blocked by
3.5% Bovine Serum Albumin for 2 hours at room temperature and then blocked with
streptavidin/biotin blocking kit (Vector laboratories, Burlingame, CA) by following the user
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guide. The sections were rinsed with PBS and incubated with the Alexa Fluor 488 anti-human
Sialyl Lewis X (dimeric) antibody (1:100; BioLegend, San Diego, CA) overnight at 4°C. The
tissue sections were incubated with the biotinylated Maackia Amurensis Lectin II (MAA II)
(10g/mL; Vector laboratories, Burlingame, CA), followed by incubation with cy3-streptavidin
(1:50 in 10% goat serum) for 30 minutes at room temperature. The sections were subjected to
incubation with Cy5-conjugated Sambucus Nigra Lectin (SNA, EBL) (10g/mL; Vector
laboratories, Burlingame, CA) for 2 hours at room temperature then counterstained with DAPI
(4′,6′-diamidino-2-phenylindole; Thermo Scientific, Rockford, IL). The sections were washed
three times of 5 minutes with PBST (PBS with 0.05% TWEEN 20) after every steps of antibody
incubation. The slides were air dried and covered with coverslips by using Prolong antifade
reagent. Pictures were captured with the Leica SP8 LCS diode confocal microscope (Leica
Microsystems Inc, Buffalo Grove, IL).

Animal experiments
To examine the variations in virus shedding and tissue tropism of subtype H7 avian IAVs
in chicken and mallard, 56 3-week old chicken and 56 3-week old mallards were included in this
study. The 1-day-old chicken and 1-day-old mallards were purchased from Murray McMurray
Hatchery (Webster City, IA) and housed before the experiments. Before the experiment, all birds
were confirmed to be seronegative using HI assays against the epidemic human seasonal IAVs
[A/California/04/2009 (H1N1), A/Switzerland/9715293/2013 (H3N2), and A/Hong
Kong/4801/2014 (H3N2)] and the testing avian IAV [Mallard/2010 (H7N3)].
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The chicken or mallard experiments, 32 birds were used in the treatment group and 24 in
the negative control group. Each bird in the treatment groups was inoculated with an inoculum
containing 106 TCID50 (in a volume of 0.1 mL) of Mallard/2010 (H7N3) by administrating the
drops into eyes and nostrils of the birds. Each negative control bird was inoculated with PBS.
The clinical signs for the birds were monitoring twice a day until the end of this experiment.
Oropharyngeal and cloacal swab specimens were collected at 0, 1, 3, 5, 7, 9, 11, 14 and 21 dpi,
and blood at 0, 14, 21 dpi. At 1, 3, 5, 7, 9, 11, 14, 21-day post inoculation, four birds in each
treatment group and three in each control group were euthanized, and the tissues cross both
respiratory tracts and gastrointestinal tracts were collected, including trachea-upper, tracheamiddle, trachea-distal, duodenum, jejunum, ileum, colon, caeca, cloaca. One set of the tissues
were collected for virological analyses, and the other set was fixed in 10% formalin for
histological analyses.

Distribution of SLex in wild bird population
To understand the distribution of SLex across wild bird species, tissue sections from
trachea (trachea-upper, trachea-middle, trachea-distal) and gastrointestinal tracts (duodenum,
jejunum, ileum, colon, caeca, cloaca) from six bird species, including sea duck (n=1), gadwall
(GADW) (n=1), green-wing teal (GWTE) (n=1), wood duck (WODU) (n=2) and northern
shoveler (NOSH) (n=1) were kindly offered by our collaborate from U.S. department of
agriculture. The tissues were fixed and prepared for immunofluorescent staining as mentioned
above. Deparaffinization and heat-induced target retrieved with diluted Target Retrieval
Solution, Citrate pH 6.1 (10x) following the manufacturer’s manual (Dako, Carpinteria, CA)
have been performed before incubation with the Alexa Fluor 488 anti-human Sialyl Lewis X
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(dimeric) antibody (1:100; BioLegend, San Diego, CA) overnight at 4°C. As control, we also
applied SAα2,3Gal staining at sea ducks and wood ducks as describe above. At the end, the
sections were counterstained with DAPI, air dried and covered with coverslips by using Prolong
antifade reagent. Pictures were captured with the Leica SP8 LCS diode confocal microscope
(Leica Microsystems Inc, Buffalo Grove, IL). Results presented in the study are based on three
independent experimental repeats with similar results.

Biosafety and animal handling
Laboratory and animal experiments were conducted under BSL-2 conditions in
compliance with protocols approved by the Institutional Animal Care and Use Committee of
Mississippi State University (IACUC 17-719).

Statistical analyses
The influence of species and days post inoculation on oral and cloacal shedding were
analyzed using generalized linear mixed models (GLIMMIX). Results of shedding were log
transformed and fitted to a GLIMMIX using a gaussian distribution. Denominator degrees of
freedom were calculated using the Kenward-Roger option, and day post inoculation was a
repeated measure and modeled with an autoregressive covariance structure. The
GROUP=species option was used to account for different covariance in the shedding between
species. Residual plots demonstrated an approximately normal distribution, least square means
(LSM) were calculated and back transformed for comparison. A priori comparisons were
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planned between species at each timepoint and between contiguous timepoints within each
specie. No adjustment was made for LSM multiple comparisons.
The same approach was used to model effects of species, days post inoculation, and
tissue location on log transformed viral loads in tissues obtained at necropsy. Subject within
species was considered a random effect to account for within subject clustering. A priori
comparisons were planned between species for each of the 9 tissues. No adjustment was made
for the 9 LSM multiple comparisons. Residual plots demonstrated an approximately normal
distribution, LSM were calculated and back transformed for comparison.
HI titer measures obtained at days 0, 14, and 21 were log transformed and modelled as a
function of time and species using Proc Mixed. Because measurement intervals differed in
length, a spatial power covariance structure for the longitudinal time effect was chosen, and the
GROUP option was used to allow for different variance between species in the random effect.
LSM were calculated and compared.
To investigate the relationship of viral load and presence of glycan type (SLex or
SA2,6Gal) in different tissues, a GLIMMIX was employed, using log transformed viral load as
the outcome. Tissues were aggregated into 4 anatomic regions (Upper Respiratory Tract, Lower
respiratory tract, upper GI tract and lower GI tract). Denominator degrees of freedom were
calculated using the Kenward-Roger option. Day post inoculation, specie, region, glycan SLex,
glycan SA2,6Gal and 2- way interactions were tested. Tissue samples within subject were
clustered and accounted for through a random statement with compound symmetry. Residual
plots demonstrated an approximately normal distribution, LSM were calculated and back
transformed.
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P-values of 0.05 were considered significant, and 95% confidence limits were calculated
in all analyses.

Results
Subtype H7 avian IAVs bound to both avian-like and human-like receptors but prefer to
fucosylated avian-like receptor
To determine the binding avidities of H7 IAVs to SLex, we performed bio-layer
interferometry glycan binding analyses for a total of 11 avian H7 IAVs, including one isolate
from human and each other from domestic duck, mallard, American black duck (ABDU), ringnecked duck (RNDK), BWTE, American green-winged teal (AGWT), NOSH, Bufflehead
(BUFF), mute swan (MUSW), and NOPI. As a comparison, two glycan analogs, 3’SLN and
6’SLN, were also included. Results showed that all virus isolates showed varying binding
avidities to SLex, 3’SLN, and 6’SLN (Figure 9).
To further differentiate the binding avidities of H7 IAVs among three glycan analogs, we
quantified and compared the 50% relative sugar loading concentration (RSL0.5) at half the
fractional saturation (f = 0.5) for three representative H7 viruses against each glycan analog. The
higher value of the RSL0.5 indicates the weaker of the binding avidity. Results showed that
Turkey/2002 has an RSL0.5 of 0.238 (± 0.005 standard deviation [SD]) for 3ʹSLN, 0.612 (±
0.046) for 6’SLN, 0.117 (± 0.004) for SLex; Mallard/2010 has a RSL0.5 of 0.070 (± 0.003) for
3’SLN, 0.429 (± 0.008) for 6’SLN, 0.0177 (± 0.0002) for SLex; and SH2 has an RSL0.5 of 0.218
(± 0.004) for 3’SLN, 0.236 (± 0.009) for 6’SLN, and 0.080 (± 0.002) for SLex. The negative
control, Ca/04, a 2009 H1N1 virus, shown binding signals to only 6’SLN but to neither SLex nor
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3’SLN (data not showed). Overall, quantitative analyses showed the H7 IAVs had the lowest
RSL0.5 to SLex compared to 3’SLN, and the highest RSL0.5 to 6’SLN (Figure 10).
In summary, bio-layer interferometry glycan binding analyses showed that avian H7
IAVs bind to human-like receptor 6’SLN, but more to avian-like receptor 3’SLN, and the most
to SLex.
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Figure 9

Glycan binding specificity of H7 influenza A viruses

Glycan binding specificity of H7 influenza A viruses to biotinylated α2,6–linked sialic acid
(6’SLN, white bars), α2,3–linked sialic acid (3’SLN, black bars) and SLex glycan (white bars
filled with dots) analogs as determined by Bio-Layer Interferometry (Pall ForteBio LLC,
Fremont, CA). Streptavidin-coated biosensors were immobilized with biotinylated glycans at a
concentration of 0.3-0.5 µg/mL, and a virus load of 100 pM was used in binding analyses. x axis
showed different viruses in the test, the y axis is the endpoint binding values (response) to the
glycan analogs, which represents the higher binding signals detected. Virus abbreviations:
Duck/2010: A/American black duck/Delaware/A00870108/2010 (H7N3), Mallard/2010:
A/mallard/New Jersey/A00926089/2010 (H7N3), Teal/2010: A/blue-winged
teal/Taxes/A00463679/2010(H7N3), Duck/2008: A/domestic duck/West
Virginia/A00140913/2008 (H7N3), Teal/2009: A/American green-winged
teal/Utah/A00654391/2009 (H7N3), Shoveler/2009: A/northern shoveler/Utah/A00468766/2009
(H7N3), Buff/2008: A/bufflehead/Virginia/A00120022/2008 (H7N2), Swan/2008: A/mute
swan/Rhode Island/A00325125/2008 (H7N3), Pintail/2009: A/northern
pintail/Texas/A00466052/2009 (H7N3), SH2: A/Shanghai/2/2013 (H7N9) (HA,NA)×PR8
(H7N9), and Ring/2009: A/ring-necked duck/Texas/A00766403/2009 (H7N1).
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Figure 10

Characteristic of receptor binding property of H7 viruses

Glycan binding specificity of three subtype H7 IAVs A) Turkey/2002 (H7N2), B) Mallard/2010
(H7N3), C) SH2 (H7N9) to biotinylated α2,3-linked sialic acid (3’SLN, square) , α2,6-linked
sialic acid (6’SLN, triangle) , and SLex (circle) glycan analogs as determined by biolayer
interferometry using an Octet RED instrument (Pall FortéBio, Fremont, CA). Streptavidin-coated
biosensors were immobilized with biotinylated glycans at different levels. Sugar loadingdependent binding signals were captured in the association step and normalized to the same
background. Binding curves were fitted by using the saturation binding method in GraphPad
Prism 8 (https://www.graphpad.com/scientific-software/prism/). Horizontal dashed line indicates
half of the fractional saturation (f = 0.5); vertical dashed line indicates relative sugar loading
(RSL0.5) at f = 0.5; the higher the RSL0.5 indicated the lower binding avidity. The RSL0.5 and SD
were calculated by the fitting model in the software. The name of virus tested is listed on top of
each figure. The structures of glycan analogs tested are shown at the right bottom. The
A/California/04/09 (H1N1) (Ca/04) was used as negative controls for SLex and 3’SLN (data not
showed).
Distribution of SLex glycan in the respiratory and gastrointestinal tract tissues in wild
birds and domestic poultry
To evaluate whether the SLex glycan could be present differently across different tissues
and different bird species, by using SLex specific monoclonal antibody, we performed
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immunofluorescence staining on three sections of respiratory tracts (i.e. trachea-upper, tracheamiddle and trachea-distal and six sections of intestines tracts (i.e. duodenum, jejunum, ileum,
colon, caeca and cloaca). We categorized the glycan receptor abundance by three groups: none
or limited staining (-), moderate and sporadic staining (+), and strong staining (++) (Table 8, 9).
In this study, we focused on chicken (n=3) and six wild bird species, including mallard (n=3),
sea duck (n=1), GADW (n=1), GWTE (n=1), WODU (n=2) and NOSH (n=1). The glycan score
listed among the six testing wild bird species, mallard, GADW, GWTE, and NOSH are common
species detected with H7 infections (Munster et al. 2007; Krauss et al. 2015) whereas H7 IAVs
were rarely recovered from sea duck and WODU (Table 10).
Results showed that distinct patterns of SLex among the testing avian species and even
among the tissue sections from the same avian species (Table 9). Specifically, in mallard, SLex
was mainly expressed on the ciliated epithelial cells of trachea-middle (Figure 11), trachea-distal
but with limited signals in trachea-upper. In GI tract of mallard, SLex was strongly showed on
the epithelium of cloaca (Figure 13) and no detectable signals in the other five gastrointestinal
tissues [i.e. duodenum, jejunum, ileum, colon (Figure 12), and caeca. In chicken, SLex was
detected also on the ciliated epithelial cells across three sections of trachea (Figure 11), colon
(Figure 12) and cloaca (Figure 13) but not in four other sections of GI tissues (i.e. duodenum,
jejunum, ileum, and caeca). The cell types expressed SLex are also different among GI tract.
SLex primary is expressed in muscularis layer in colon while cloaca express SLex in crypts cells.
In sea ducks and wood duck, there is no detectable signals of SLex whereas strong expressions
were found in trachea (upper, middle, distal) of gadwall, green-wing teal and northern shoveler.
We can also find SLex in caeca of northern shoveler (Table 9). As controls, we also found strong
SA2,3Gal staining in trachea and all GI tract from sea ducks and wood ducks (data not showed).
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Table 8

Summary of Glycan distribution scores among tissues in chicken and mallarda

Glycan receptors
SA2,3Gal

Tissue

SA2,6Gal

SLex

Chicken

Mallard

Chicken

Mallard

Chicken

Mallard

Tracheaupper
Tracheamiddle
Trachea-distal

+

+

+

-

++

-

++

++

-

-

++

++

++

++

-

-

++

++

Duodenum

++

++

+

+

-

-

Jejunum

++

++

+

-

-

-

Ileum

++

++

++

-

-

-

Caecum

++

++

+

+

-

-

Colon

++

++

++

-

+

-

Cloaca

++

++

-

-

+

+

a

, the staining score was graded as mild (+), strong (++) and negative (-). The results are
representative of three replicates.
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Table 9

Summary of SLex distribution among tissues in wild bird populationsb
Mallard

NOSH

GADW

GWTE

WODU

Sea duck

-

++

++

+

-

-

++

++

++

+

-

-

++

++

++

+

-

-

Duodenum

-

-

-

-

-

-

Jejunum

-

-

-

-

-

-

Ileum

-

-

-

-

-

-

Colon

-

-

-

-

-

-

Caeca

-

-

-

-

-

-

Cloaca

+

-

-

-

-

-

Tracheaupper
Tracheamiddle
Tracheadistal

b

, the staining score was graded as moderate (+), strong (++) and negative (-)
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Table 10

H7 distributed in bird species

Species

Isolate numbers

Percentage

Mallard

458

19.32%

Chicken

1352

57.05%

Quail

31

1.31 %

Turkey

324

13.67 %

Wood duck

0

0%

Sea duck

9

0.38%

Green-winged teal

71

3.00 %

Blue-winged teal

125

5.27 %

Total

2370

100%

Data are collected on Nov 1st, 2020 in the influenza research database (https://www.fludb.org).
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Figure 11

Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in trachea of chicken and
mallard

Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal
(magenta), SAα2,6Gal (green) in trachea-middle of chicken (upper panel) and mallard (bottom
panel). Nuclei were stained with DAPI (blue). The scale bars are located at the right bottom of
each picture.
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Figure 12

Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in colon of chicken and
mallard

Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal
(magenta), SAα2,6Gal (green) in colon of chicken (upper panel) and mallard (bottom panel).
Nuclei were stained with DAPI (blue). The scale bars are located at the right bottom of each
picture.

86

Figure 13

Distribution of SLex, SA2,3Gal and SA2,6Gal receptors in cloaca of chicken and
mallard

Immunofluorescence staining of glycan receptors were performed to test SLex (red), SAα2,3Gal
(magenta), SAα2,6Gal (green) in cloaca of chicken (upper panel) and mallard (bottom panel).
Nuclei were stained with DAPI (blue). The scale bars are located at the right bottom of each
picture.
On the other hand, our results demonstrated that SA2,3Gal are widely distributed in
chickens and mallards (Figures 11, 12 and 13). For both species, SA2,3Gal is found in lamina
propria and submucosa layer of the trachea, as well as in crypts and submucosa layers of GI
tract. In the cloaca of mallard, SA2,3Gal is also found in the epithelium where express SLex as
well. In contrast, although SA2,6Gal were also detected in all nine tissue sections for both
mallard and chicken, only the signals of SA2,6Gal in duodenum were strong in the two species,
as similar to SA2,3Gal, and those of SA2,6Gal in other eight tissue sections are much weaker
than those for SA2,3Gal. Similar to SA2,3Gal, SA2,6Gal is found in lamina propria and
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submucosa layer of the trachea as well as in epithelial cells, and in crypts and submucosa layers
of GI tract.
In summary, distribution of SLex was distinctly distributed across the same tissue section
from different avian species and from different tissue sections from the same avian species
whereas such patterns were less apparent for SA2,3Gal and SA2,6Gal. Of particular interest,
SLex was detected neither in trachea nor in gastrointestinal tissues of wood duck and sea duck,
both of which were rarely detected with H7 infection.

A mallard origin H7 IAV infected both mallard and chicken but shed more viruses in
mallards than in chickens
To determine the impacts of glycan distribution on the tissue and host tropisms of H7
avian IAVs, we infected chicken and mallard with Mallard/2010 (H7N3) to determine the viral
shedding patterns and the viral loads across different tissues. Results showed that mallards had a
peak titer of 5.87 log10 copies/ml with higher titers than chicken with a peak titer of 4.48 log10
copies/ml of oral shedding at 1 dpi. As for cloacal shedding, mallards had a peak titer of 6.47
log10 copies/ml at 3 dpi higher than chicken with a peak titer of 4.81 log10 copies/ml at 7 dpi.
Chickens and mallards have the same time span of oral shedding from 1 to 7 dpi, whereas
mallards (1-9 dpi) have longer shedding time than chicken (3-9 dpi) did.
To compare the shedding patterns of Mallard/2010 (H7N3) chicken and mallard, we
fitted the oral and cloacal shedding data into a GLIMMIX (P=0.0145) with repeated measure,
respectively. Type 3 tests of fixed effects indicated species (P<0.0001) and time (P<0.0001)
affect the oral shedding significantly. Comparing oral swabs (Figure 14A), mallards have
significantly higher oral shedding viral titers than chicken at 1 dpi [(4.48: 5.86; P<0.001);
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expressed as (log10 (viral copy numbers) of chicken swabs: log10 (viral copy numbers) of
mallard swabs; P values)], 3 dpi (4.50: 5.87; P<0.0001), 5 dpi (4.15: 4.71; P=0.0019),
respectively, and have no significant difference at 7 dpi (3.79: 4.00; P=0.2757), 9 dpi (all
collected samples are under the detect of limit). As for the cloacal swabs (Figure 14B), type 3
tests of fixed effects indicated species (P< 0.0014) and time (P<0.0001) affect the cloacal
shedding significantly. Mallards have significant higher cloacal shedding than chicken at 1 dpi
(3.65: 4.18; P=0.0196), 3 dpi (4.47: 6.47; P<0.0001), 5 dpi (4.60: 6.00; P<0.0001), respectively,
and they have no significant difference at 7 dpi (4.81: 4.51; P= 0.5244), 9 dpi (4.30: 4.16; P=
0.5876), 11 dpi (all collected samples are lower the limit of detection), respectively. Besides, we
found that mallards have a longer shedding time through cloacal (1 to 9 dpi) than through oral
shedding (1 to 7 dpi) (Figure 14D), whereas chicken have oral shedding (1 to 7 dpi) and cloacal
shedding (3 to 9 dpi) (Figure 14C). In summary, the viral shedding in mallards is higher than
chicken in both oral and cloacal swabs.
In addition, we compared viral loads in the oral swabs and those in the cloacal swabs
for chicken (Figure 14C) or mallards (Figure 14D) by using student’s t test. In chicken, cloacal
shedding is significantly higher than oral shedding at 7 (P=0.0003), 9 dpi (P=0.0124),
respectively. In mallard, whereas cloacal shedding is significantly higher than oral shedding at 3
(P=0.0031), 5 (P<0.0001),7 (P=0.0196), and 9 dpi (P=0.0068), oral shedding is significantly
higher than cloacal shedding at 1 dpi (P<0.0001).
Serological data (HI) showed that both mallards and chickens seroconverted after
infection. At 21 dpi, infected mallards had HI titers ranging from 20 to 80 whereas infected
chickens had a range from 20 to 640 (Table 11). The HI results were fitted in a mixed model
(P=0.0002) for repeated measure. Type 3 tests of fixed effects indicated species (P=0.0192) and
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time (P=0.0001) significantly affect seroconversion of the infection. The geometric mean titer
(GMT) for mallards was 33.64 at 21 dpi whereas GMT for chickens were 160 at 21 dpi.
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Viral shedding of chicken and mallards of H7 IAV infection.

Mean titers of IAVs were detected by qRT-PCR from oral (in pink) and cloacal swabs (in blue)
of infected chicken (shown as circles) and mallards (shown as triangles) in the challenge study.
Birds were inoculated with 106 TCID50/mL of Mallard/2010 (H7N3). Swabs were collected
every other day during the infection course. Mean titers of IAVs from oral of infected birds (A)
and cloacal swabs of infected birds (B) are to compare the shedding patterns between chicken
(left side within each dash line group in A, B; as in color circles) and mallards (right side within
each dash line group in A, B; as in color triangles). Mean titers of IAVs from swabs of infected
chicken (C) and mallards (D) are to compare the shedding patterns between oral and cloacal
swabs within the same species. Statistical results comparison within each dash line group shown
as: no * as not significant different (P>0.05); P<0.05 as *; P<0.01 as **; P<0.001 as *** and
P<0.0001 as ****.
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HI titer of infected birdsb.

Table 11
Species

Chicken

Mallard

b

ID

Days post-inoculation
0

14

21

49

<10

<10

20

50

<10

40

160

170

<10

40

640

171

<10

160

320

78

<10

320

NA

47

<10

1280

NA

163

<10

40

NA

90

<10

NA

NA

128

<10

40

40

129

<10

80

80

130

<10

40

20

131

<10

20

20

110

<10

40

NA

117

<10

20

NA

119

<10

80

NA

127

<10

40

NA

NA, not available due to sacrifice for pathogenicity study.

The viral loads in mallard respiratory and gastrointestinal tissues are tissue and host
dependent
To compare the viral loads across tissues in the same host and between mallard and
chicken, we quantified the viral copy numbers in tissues using one-step qRT-PCR. Results
showed that, in mallard, with a peak titer on 3 dpi of 7.06 (±1.31) log10 copies/g, as well as in
chicken, with a peak titer on 5 dpi of 6.05 (±1.30) log10 copies/g, decreased in trachea as the
viral loads increased in intestinal tracts during the course of viral infection.
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To determine the factors affecting viral loads across tissues of chicken and mallard, the
results were fitted into a GLIMMIX (P<0.0001). Type 3 tests of fixed effects indicated that
species (P=0.0009), tissues (P<0.0001) and dpi (P<0.0001) have significant impacts in viral
loads from tissues. By comparing the average viral loads of all collected samples on each day, a
peak viral load at 3 dpi of 7.06 ±1.31 log10 copies/g for mallards, while a peak of 6.05 ±1.30
log10 copies/g for chicken at 5 dpi. For mallard at 3 dpi which had the highest average viral
loads, we found the highest viral loads in ileum and colon with the average titers of 8.88 ±1.19
log10 copies/g and 8.74 ±0.37 log10 copies/g, respectively. The lowest viral loads were found in
duodenum (5.74 ± 0.67 log10 copies/g) and jejunum (5.88 ± 1.01 log10 copies/g), which were
significantly different from ileum and colon viral loads, respectively (P<0.0001). Although the
highest viral loads presented in different tissues during infection, we found that the duodenum
and jejunum always had the low viral loads compared to other tissues, which are 4.19 ± 0.13
log10 copies/g and 5.13 ± 2.14 log10 copies/g on 5 dpi, respectively, and under the limit of
detection on 7 dpi. There are limited or no viral loads detected on 1 and 11 dpi tissues for both
chickens and mallards.
However, infections in chicken showed a different story. At 5 dpi which had the highest
average viral loads for chickens, we found comparative viral loads in the last sections of the
intestinal tracts including ileum (7.44 ± 0.99 log10 copies/g), caeca (6.49 ± 1.01 log10 copies/g),
colon (6.72 ± 1.30 log10 copies/g), cloaca (6.97 ± 1.45 log10 copies/g). As similar found in
mallard, the duodenum and jejunum had low replication efficiency in chicken, which showed
titers of 4.53 ± 0.49 log10 copies/g and 4.70 ± 0.69 log10 copies/g at 3dpi, 5.32 ± 1.49 log10
copies/g and 5.93 ± 1.26 log10 copies/g on 5dpi, respectively (Figure 15).
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To further determine the viral load patterns in chickens or mallards, the least-square
means were obtained and systematically compared. Overall, mallard have significantly higher
viral loads than chicken in caeca (P=0.0010), cloacal (P=0.0005), colon (P<0.0001), upper
trachea (P=0.0175) but no significant differences for duodenum (P=0.7096), jejunum
(P=0.8911), lower trachea (P=0.1284), middle trachea (P=0.1639) comparing the LSM. For
chicken, the significant differences were found at 5 and 9 dpi. As of for mallards, the significant
differences were found on 3, 5, 7, 9 dpi. For both species, we found that the H7 virus favors
growing in the lower gas gastrointestinal tract (LGI, e.g. ileum, caeca, colon, cloaca) than trachea
and upper GI tracts (UGI, e.g. duodenum, jejunum) of both species (Tables 12, 13, 14).
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Log10 (RNA copies)/g

A

Viral loads in tissues of H7 infection

Viral loads of 3 dpi (A), 5 dpi (B) in tissues of infected chicken (black bars) and mallard (white
bars) was showed. The y axis is the log10 (viral copies number)/ gram of tissues, the x axis is the
list of tissues detected. The statistics analysis differences are listed in tables 12, 13, 14.
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Table 12

Viral load differences in the counterpart tissues comparing chickens and mallards

Trachea-

Trachea- Trachea- Duodenum Jejunum Ileum Caeca

upper

middle

Colon

Cloaca

distal

P=0.0175 NS

NS

NS

NS

NS

P=0.0010 P<0.0001 P=0.0005

NS indicated the statistical differences are not significant.

Table 13
dpi

Viral load differences among the tissues from chickens

Higher

Ileum

Caeca

Colon

Cloaca

Trachea-upper

0.0012

NS

NS

NS

Trachea-middle

0.0002

NS

NS

0.022

Trachea-distal

<0.0001

NS

0.0429

0.0046

Duodenum

0.0008

NS

NS

NS

Trachea-upper

NS

<0.0001

NS

NS

Trachea-middle

NS

0.002

NS

NS

Trachea-distal

NS

0.0007

NS

NS

Duodenum

NS

0.0110

NS

NS

titer

5

9

The values in table indicated the P values calculated by the statistical analysis used in the method
section comparing viral load in tissues collected at the same day. NS indicated non significantly
different.
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Table 14
dpi

3

5

Viral load differences among the tissues from mallards

Higher titer

Ileum

Caeca

Colon

Cloaca

Trachea-upper

0.0006

NS

0.0023

NS

Trachea-middle

0.0003

NS

0.0010

NS

Trachea-distal

0.0001

NS

0.0004

NS

Duodenum

<0.0001

NS

<0.0001

0.0309

Jejunum

<0.0001

NS

<0.0001

NS

Trachea-upper

<0.0001

0.0002

0.0002

NS

Trachea-middle

<0.0001

<0.0001

<0.0001

0.0002

Trachea-distal

<0.0001

<0.0001

<0.0001

<0.0001

Duodenum

NS

<0.0001

<0.0001

<0.0001

Jejunum

<0.0001

<0.0001

<0.0001

0.0005

Duodenum

NS

NS

NS

0.0124

Jejunum

NS

NS

NS

0.0124

Trachea-upper

0.0001

NS

NS

NS

Trachea-middle

0.0001

NS

NS

NS

Trachea-distal

0.0001

NS

NS

NS

Duodenum

0.0001

NS

NS

NS

Jejunum

0.0017

NS

NS

NS

7

9

The values in table indicated the P values calculated by the statistical analysis used in the method
section comparing viral load in tissues collected at the same day. NS indicated non significantly
different.
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The viral loads in respiratory and gastrointestinal tissues are associated with the
distribution of SLex in chicken and mallards
To correlate the distribution of receptors and viral loads in the counterpart tissues, we
fitted the viral loads of tissues into a mixed model with species as random effect, and the least
squares means were obtained for each glycan level and compared. To fit the glycan levels into
the model, we graded glycan levels by 0 (absent) or 1 (present). The results indicated that
SA2,6Gal did not contribute effects on viral loads [LSM (1): LSM (0)= 4.93: 5.11; P=0.1352)
while the distribution of SLex showed decreasing association with tissue viral loads [(LSM (1):
LSM (0)= 4.87: 5.16;P=0.0084).
Discussion
In this study, to understand how H7 avian IAVs transmit from wild birds to domestic
poultry and how avian IAVs infect differently among wild birds, we investigated the role of
SLex in tissue and host tropisms of H7 IAVs across both domestic and wild bird species. Our
results showed that H7 IAVs have stronger binding avidities to SLex than both SA2,3Gal and
SA2,6Gal, and that, among the birds we analyzed, SLex was detected only in those bird species
commonly reported with H7 infection.
In our study, the tested H7 IAVs bind much stronger to SLex than 3’SLN, which is to
some extent agree with prior study that H7 IAVs have comparable binding avidity to SLex and
3’SLN (Gambaryan et al. 2012). Molecular model of H7 HA-glycan complex showed that there
is no steric clashes from amino acid 222 for the fucosylated receptors or their nonfucosylated
counterparts (Gambaryan et al. 2012). Unlike H7, majority subtypes of avian IAVs, such as H1,
H2, H3, H4, H5, H9, H11, H12 and H14, showed varying binding avidity to SLex with
consistent 5-20 times weaker binding avidities to SLex than to 3’SLN, which is explained by the
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molecular model of the HA-glycan complex that fucose moiety located relatively close to the
amino acid 222, changes in the HA structure in this region could lead to steric interference
(Gambaryan, Yamnikova, et al. 2005). For example, subtype H5 which has also caused HP
outbreaks in poultry and fatal human infections especially the HP H5 of novel clade 2.3.4.4
(Shen et al. 2016; Saito et al. 2015; Ip et al. 2015), which has acquired the binding avidity to
SLex compare to its ancestral clade 2.3.4 H5 proteins (Guo et al. 2017). The ability of LP IAVs
binding to SLex has been speculated a poultry-specific adaptation although extensive studies on
sufficient numbers of isolates across different HA subtypes are lacking (Gambaryan,
Yamnikova, et al. 2005; Gambaryan et al. 2006; Hiono et al. 2014; Hiono et al. 2016). These
findings implied that H7 IAVs have higher risks in poultry compare to many other HA subtypes
of IAVs.
Molecular epidemiological analyses showed that chickens and mallards are important
avian species for avian IAVs (Krauss et al. 2004; Olsen et al. 2006; Verhagen et al. 2017) (Table
10). We found that SLex was present in trachea and cloaca of both chickens and mallards as well
as colon of chicken. Others found a similar distribution of SLex (Wen et al. 2018; Hiono et al.
2014). In addition to the chicken and mallard, we also found that the SLex expressed lining in
the epithelial cells of trachea of H7 susceptible wild bird species [i.e. GADW (trachea), GWTE
(trachea), NOSH (trachea, caeca)] whereas sea duck and WODU, which have rare H7 isolations
(Table 10), has no SLex detected but widely expressed SA2,3Gal in their trachea and GI tract,
which are consistent with prior findings (Franca, Stallknecht, and Howerth 2013). Others had
identified the expression of SLex in other poultry such as turkey, pheasant, guinea fowl and
pigeon (Guo et al. 2017). Prior study showed that chicken and ducks could infect IAVs by both
respiratory or alimentary routes of exposure (Pantin-Jackwood et al. 2013), however, they were
97

more susceptible to the infection by low infectious viral doses when exposed by intranasal as
compared to alimentary routes of inoculation (Kwon and Swayne 2010). These findings
suggested that SLex expressed in these bird species especially in trachea facilitates the H7 IAVs
attachment for initial infection. Further, we performed a challenge study by inoculating a
mallard-origin virus, which prefer binding to SLex over SAα2,3Gal, in chickens and mallards.
Previous studies showed that chickens were rarely infected directly with viruses isolated from
ducks, even though most influenza viruses isolated from chickens recognize SAα2,3Gal,
similarly to the viruses of duck origin (Kishida et al. 2004; Matrosovich et al. 1997). One study
found similar results that when inoculated in chickens with a duck H5 IAV that prefers
SAα2,3Gal than SLex, no virus could be recovered from tissues or swabs (Hiono et al. 2014). In
our study, evidences of HI, viral shedding and viral titers of tissues confirmed that chicken is
susceptible to and successfully infected by the mallard origin H7 IAV. These evidences
supported that virus with high binding avidity to SLex and the presence of SLex in trachea
facilitate the H7 infections from duck to chicken.
Although chicken is susceptible to the mallard origin H7 IAV, the virus replicated better
in mallards than in chickens for both shedding and tissue viral loads. Similar shedding results
have been reported that when wild bird origin-IAV infected mallards and chickens, mallards had
higher shedding titer, longer shedding time span and higher percentage of shedding animal
numbers than in chicken (Spackman et al. 2007; Spackman et al. 2010). The facts that mallards
shed high virus in cloacal swabs during infection confirmed that its importance as IAVs
reservoir. Plus, we found the virus prefer cloacal shedding in both species during the late
infection period. Similar results were showed that the LP avian IAVs from wild birds are
typically shed primarily through cloaca (Webster et al. 1978; Costa et al. 2011). However, when
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these viruses adapted into gallinaceous poultry, they changed to shed a much higher level in the
respiratory tract (Spackman et al. 2010; Pantin-Jackwood et al. 2014; Pantin-Jackwood et al.
2016; Claes et al. 2013; Marche et al. 2012). Prior study showed that intranasal or intracloacal
infection of IAVs have similar oral shedding patterns (Pantin-Jackwood et al. 2013). Of interest,
we found that chickens have higher average oral shedding at 1 and 3 dpi as well as mallards at 1
dpi compare to cloacal shedding. These may correlate to the strong expression of SLex in the
epithelial cells in all sections of trachea (upper, middle and distal) of chickens whereas SLex
expressed in epithelial cells of the middle- and distal- trachea but not in the upper-trachea of
mallards. However, the overall shedding patterns of higher in mallards suggested that host
factors were involved.
One study showed that LP IAVs had low viral titers present in duodenum compare to the
lower tract in ducks (small intestines close to the caecal end or rectum) (Webster et al. 1978).
Previous study showed that in the LP IAV infected mallard tissues, there is no antigen-positive
staining in duodenum/jejunum, but in ileum, ceca and colon (Franca et al. 2012), which indicated
duodenum/jejunum have lower replication than others. Prior studies showed that the tropism and
pathogenicity of IAVs infecting human are associated with the distribution of SA2,3Gal and
SA2,6Gal in human airways (Zeng et al. 2013; Kumlin et al. 2008), however, whether the virus
receptor binding properties affect avian IAVs tissue tropism in wild birds and poultry are still not
clear. In this study, our results showed viral loads in tissues reveals that the virus prefers
replicating in lower GI tract (i.e. ileum, caecum, colon and cloaca) for both chickens and
mallards and much less viral load in upper GI tract (i.e. duodenum and jejunum). On the other
hand, although with abundance of SA2,3Gal and SLex in respiratory tract, the viral loads in
trachea are relatively less by comparing to those in lower GI tract tissues in both species, and our
99

statistical analysis showed that the viral loads in tissues are not significantly related to neither the
distribution of SA2,3Gal nor SA2,6Gal, but showed a negative association with SLex expression
of chickens and mallards. However, the viral roads we determined in this study may not reflect
the virus in a specific tissue, and thus interpretation of tissue tropism by directly correlating total
viral loads with glycan concentration needs to be careful, and quantitative analyses of tissue
specific viral replication would be needed. Nerveless, in order to confirm virus replication was
present in tissues, we performed immunochemistry staining for nuclear protein of influenza with
one pair of infected birds from 3 dpi. We did identify positive staining in distal-trachea, caeca,
colon of chicken as well as jejunum and ileum of mallards although data are only qualitative
rather than quantitative (Appendix A). Of note, in addition to glycan receptor, other tissue
specific host factors could also contribute to variations in virus replication in various tissues.
This study suggested there are variations in SLex expression across the tested wild bird
species, supporting a large extent of variations of IAVs associated glycan receptor distributions
in avian species, which have been reported in various domestic poultry (Guo et al. 2017). Prior
studies showed that the subtype of H7 distributions in wild birds varied by time and by
epidemiological factors of wild bird species (e.g. avian species, age, and pre-existing immunity)
(Kaleta, Hergarten, and Yilmaz 2005; Olsen et al. 2006; Krauss et al. 2015; Latorre-Margalef et
al. 2017). Understanding host factors such as glycan receptor distribution could help identify
specific species for avian influenza surveillance and increase the effectiveness of avian IAVs
surveillance, especially for establishment of avian IAVs alert program targeting risky subtypes
such as H7.
In conclusion, we have identified subtype H7 avian IAVs favor SLex than 3’SLN, in
addition, the presence of SLex in susceptible poultry of H7 indicated that SLex plays a role in
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determining host tropism. The systematic characterization of SLex expression in wild bird
species is needed and surveillance tactics of avian H7 should be optimized to collect both oral
and cloacal swabs from birds that possess SLex receptors.
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CHAPTER IV
THE ROLE OF NEU5GC AS RECEPTOR FOR AVAIN IAVS

It is well accepted that a species barrier from avian to human for influenza A viruses
(IAVs) is the terminal sialic acids linkage to galactose, which either is α2,3-linkage for avian or
α2,6-linkage for human viruses. Another potential factor that determines host specificity is the
modification of sialic acid. The hosts of IAVs can express the species-dependent sialic acids, one
important of which is modified with N-glycolyl (Neu5Gc) instead of the dominant modification
of N-acetyl (Neu5Ac) at C-5. Prior studies have demonstrated that Neu5Gc can serve as a
receptor for IAVs and shown strict species-specificity in mammals. However, the role Neu5Gc
plays in avian IAVs remains unknown. We have performed the hemagglutination assay, glycan
array, biolayer interference assay to evaluate H7 avian IAVs in binding specificity to Neu5Gc
and Neu5Ac, which suggested that isolates from North America wild birds could bind both
Neu5Gc and Neu5Ac with variations while the H7 IAVs from chickens in China exclusively
bind Neu5Ac. Further, we detected the NeuGc expression in the tissues of chickens and mallards
by immunofluorescent staining assay, and known that mallards express Neu5Gc in intestinal
tracts but not in chicken. These results suggested that H7 avian IAVs have a binding diversity to
Neu5Gc, which may play a role in IAVs cross-species and adaptation from wild birds to poultry.
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Introduction
In addition to humans, influenza A viruses (IAVs) have been isolated from variety of
animal species, such as avian, swine, equine, canine, marine mammals (e.g. seals and whale),
mink, and feline. Low-pathogenic (LP) IAVs have been isolated from at least 105 wild bird
species across 26 different families, of which waterfowl and shorebirds are thought to be the
natural reservoir, especially Anseriformes (e.g. ducks, geese, and swans) and Charadriiformes
(e.g. gulls, terns, and waders) (Webster 1992). In influenza surveillance of migratory waterfowl,
IAVs were more frequently recovered from dabbling ducks [e.g. as mallards (Anas
platyrhynchos)] than from others (Olsen et al. 2006).
The genome of IAVs consists of eight gene segments of negative-stranded RNA which
encode for at least 11 proteins. IAVs are classified based of two of these proteins budding on the
surface of virions; the hemagglutinin (HA) and neuraminidase (NA) glycoproteins (Webster
1992). To date, in wildfowl and poultry, there are 16 HA and 9 NA antigenic subtypes that have
been detected (Röhm et al. 1996; Fouchier et al. 2005a), which can be found in numerous
combinations.
Among all subtypes of avian IAVs, subtype H7 virus has one of the primary subtypes
causing disease burdens in domestic poultry and threats to public health. LP H7 avian IAVs can
mutate to high pathogenic (HP) after being introduced into domestic poultry, such as chickens or
turkeys (Richard et al. 2017), and HP H7 avian IAV typically emerged after a precursor LP H7
virus was detected first in domestic poultry. In the past decades, HP H7 viruses have caused a
number of outbreaks in domestic poultry (Selleck et al. 2003; Hirst et al. 2004; Fouchier et al.
2004b; Berhane et al. 2009; Lopez-Martinez et al. 2013; Lee et al. 2017) and resulted in
devastating large economic losses to poultry industry (Lee et al. 2017; Mannelli, Ferrè, and
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Marangon 2006; Mulatti et al. 2007). Most of these H7 viruses were eliminated after being
introduced into domestic poultry by depopulating the infected birds followed by biosafety
management. However, H7 viruses introduced into domestic poultry can remain enzootic, such
as those reported in Italy (H7N7) (Bonfanti et al. 2014) (Mulatti et al. 2017) , Mexico (H7N3)
(FAO 2012) , and China (H7N9) (Fan et al. 2014).
The LP H7N9 avian IAVs emerging in China since 2013 have been detected primarily in
chickens and less frequently in domestic ducks, pigeons and quails (Chen et al. 2013; Wang et al.
2013; Pantin-Jackwood et al. 2014; Millman et al. 2015). This LP H7N9 virus was mutated to
HP during the fifth epidemic wave (October 2016 to September 2017) when an insertion
occurred introducing the multi-basic amino acids at the LP HA cleavage site (LP form,
PEIPKG/GLF; HP form, PEVPKRKRTAR/GLF) (Zhang et al. 2017) (Ke et al. 2017) (Chen et
al. 2017). HP H7N9 IAVs caused number of outbreaks in poultry (FAO 2019)
(http://www.fao.org).
In addition to those in domestic poultry, these H7 avian IAVs caused a number of
reported human infections, including H7N2 (Ostrowsky et al. 2012), H7N3 (Tweed et al. 2004),
H7N7 (Koopmans et al. 2004; Fouchier et al. 2004a; Belser et al. 2009), most recently, H7N9
(Gao et al. 2013). Of these H7 IAVs, H7N9 caused 1,568 confirmed human cases, 616 of which
were fatal (as of Dec 4th, 2019), and H7N9 has become one of the targets in the influenza
pandemic preparedness by the World Health Organization (WHO 2017). Majority of H7
spillover cases were associated with the direct contacts with the domestic poultry infected with
H7 avian IAVs (Dudley and Mackay 2013; Kurtz, Manvell, and Banks 1996; Fouchier et al.
2004b; Koopmans et al. 2004; Tweed et al. 2004; Lopez-Martinez et al. 2013). Thus,
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understanding how subtype H7 avian IAVs are transmitted from wild birds to domestic poultry
will be a key to influenza risk assessment and pandemic preparedness.
Surveillance studies suggested that the prevalence of subtype H7 IAVs in wild birds are
not universally distributed across wild bird species (Krauss et al. 2004; Munster et al. 2007;
Olsen et al. 2006; Krauss et al. 2015). For instance, one long-term surveillance of IAVs in
migratory ducks in Alberta, Canada, from 1976 to 2012 and in shorebirds and gulls at Delaware
Bay, United States, from 1985 to 2012 showed that H7 IAVs were more likely to be isolated in
shorebirds and gulls (6.18%) rather than in ducks (1.11%) (Krauss et al. 2015). A 12-year
surveillance study of avian IAVs in eastern Germany from 1977 to 1989 showed as of individual
species, H7N7 seems to be one of the primary subtypes detected in various duck species: H2N3
(20.8%, recovery rate) and H4N6 (20.3%) in wild ducks, H7N7 (22.3%), H4N6 (24.4%) and
H2N3 (10.4%) in Pekin ducks, and H6N1 (34.8%) and H6N6 (15.1%) in domestic ducks (Suss et
al. 1994). These data suggested that there would be species barriers when H7 avian species
transmitted from one wild bird species to another and from wild birds to domestic poultry. It is
important to understand the molecular mechanism affecting how H7 avian IAVs cross over to
various avian species, especially from wild birds to domestic poultry.
Neu5Ac and Neu5Gc are the two common forms of sialic acids (Sias). Neu5Gc is
created by the hydroxylation of the Neu5Ac moiety, and it has been reported that the
hydroxylase generated by cytidine monophosphate (CMP)-N-acetyl neuraminic acid hydroxylase
(CMAH) is required. In some mammals, such as dogs, ferrets, seals, lack the function of CMAH,
thus express Neu5Ac instead of Neu5Gc (Wen et al. 2018; Ng et al. 2014; Peri et al. 2018);
Others, such as cows, horses and pigs, have been reported to predominately express Neu5Gc
(Pettersson et al. 1958; Naiki 1971; Wen et al. 2018; Song et al. 2010). There is a low incidence
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of Neu5Gc in birds and reptiles and it is absent in the platypus in tested tissues (liver/ muscle/
ovomucin/ eggs) (Schauer, Srinivasan, Coddeville, Zanetta, and Guérardel 2009). In avian
species, Neu5Gc was reported in duck intestine, mainly on the crypt epithelial cells of duck
colon (Ito et al. 2000); in the chicken, histological immunostaining could not detect Neu5Gc in
the trachea (Suzuki et al. 2000), and such results were supported by the analyses by highperformance liquid chromatography, and mass spectrometry analysis of chicken tissues that
indicated that chickens did not synthesize Neu5Gc and that limited amount of Neu5Gc detected
in eggs may come from the diet (Schauer, Srinivasan, Coddeville, Zanetta, and Guerardel 2009).
However, there is a lack of systematic analyses of Neu5Gc and Neu5Ac in respiratory and
gastrointestinal tracts of avian species, especially those in wild birds.
Prior studies suggested that both Neu5Ac and Neu5Gc could serve as receptors for IAVs
infection (Higa, Rogers, and Paulson 1985b; Takahashi et al. 2014a), though little knowledge
about Neu5Gc receptor has been reported. Broszeit, Tzarum et al. reported that Neu5Gc is
suggested to be a functional receptor for IAVs infection because the NA from
A/Vietnam/1203/04 (H5N1), A/CA/04/09 (H1N1), A/Shanghai/2/13 (H7N9) was able to cleave
Neu5Gc, albeit with lower enzymatic activity compare to Neu5Ac. Besides, equine H7 and H5
HA mutant Y161A showed binding exclusively to Neu5Gc and only bound to the Neu5Gc-rich
horse trachea but not the Neu5Ac-rich canine trachea and revealed strict species specificity by
Neu5Gc (Broszeit et al. 2019). We previously found that A(H3N8) canine IAV increased
binding to GLex (Neu5Gcα2-3Galβ1-4[Fucα1-3]GlcNAcβ), which could have facilitated the
adaptation of the equine-origin A(H3N8) virus to dogs (Wen et al. 2018). Knowledge of Neu5Gc
in avian IAVs is lacking. In birds, six duck origin IAVs were shown to bind to the α2,3-linked
Neu5Gc whereas the human viruses [e.g. A/Udorn/307/72 (H3N2)] bound only to α2,3-linked
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Neu5Ac; in addition, a reassortant virus with HA from A/Udorn/307/72 (H3N2) but NA and
other six genes from A/mallard/New York/ 6750/78 (H2N2) did not replicate in the duck
intestine where Neu5Gc is expressed (Ito et al. 2000). These results suggested that Neu5Gc could
serve an important role in the species barrier of IAVs. Avian IAVs had a large variation in
binding avidities to Neu5Gc and Neu5Ac (Ito 2000), however, the role of Neu5Gc and Neu5Ac
in avian host tropisms, especially in influenza transmission at the interface of wild birds and
domestic poultry is unclear.
In this study, we hypothesized that avian H7 IAVs in wild birds can bind to both Neu5Gc
and Neu5Ac, and that those viruses with binding avidities to Neu5Ac are more likely to infect
domestic poultry. To test these hypotheses, we characterized Neu5Gc and Neu5Ac binding
avidities using hemagglutination assays, glycan microarray, and biolayer interferometry assays.
The HA variation determining binding specificity to Neu5Gc were identified and validated. In
addition, the distribution of Neu5Gc in chicken, a common species of domestic poultry, and
mallard, a common species of wild birds, was determined with immunofluorescent staining.

Materials and methods
Data, molecular and phylogenetic analyses
A total of 3,387 unique H7 sequences of IAVs were obtained on July 22nd 2020 from the
Influenza Research Database (www.fludb.org) and GISAID EPIFLU™ database
(https://www.gisaid.org). Multiple sequence alignments were generated using Muscle v3.8.31
(Edgar 2004). The phylogenetic tree for each gene segment was inferred by using a maximumlikelihood method by running RAxML v8.2.9 and by using a Gamma model of rate
heterogeneity and a generalized time–reversible substitution model (Stamatakis 2014) with 1,000
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bootstraps. Phylogenetic trees were visualized by using FigTree v1.4.3
(http://tree.bio.ed.ac.uk/software/figtree/).

Viruses, virus propagation and purification
The influenza viruses were propagated in 9-day-old specific pathogen free embryonated eggs
at 37 °C for 72 hours, and the allantoic fluids were collected and stored at -80°C until use.
Viruses used in the study were listed in Table 15. The viruses included 1) 5 H7N9 from 1-5
waves in human outbreaks in China and 2) contemporary H7 viruses circulating in wild birds and
detected in domestic poultry from both North America and Eurasia (Figure 16).
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Figure 16

Phylogenetic analyses of subtype H7 IAVs of hemagglutinin (HA) protein.

The phylogenetic tree was inferred by using a maximum-likelihood method by running RAxML
v8.2.9 and by using a Gamma model of rate heterogeneity and a generalized time–reversible
substitution model (Stamatakis 2014). The bootstrap values were labeled for the two selected
representative branches with bootstrap values. Phylogenetic trees were visualized by using
FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). Scale bars represent amino acids
substitutions per site. The green dots (the five at top of the tree are H7N9 from China) indicated
viruses selected for glycan array analysis. Clades in red indicated isolates from Asia, clades in
brown are equine H7N7, clades in blue are from North America.

Viruses were purified by sucrose gradient ultracentrifuge for BLI and glycan array purpose.
In brief, allantoic fluids were centrifuge by 4,000 × g for 30 minutes to remove cell debris after
harvesting from eggs. The remaining cellular debris were removed by ultracentrifugation at 4 °C
for 30 minutes at 18,000 × g, then the virions were pelleted by ultracentrifugation at 4 °C for 90
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minutes at 112,000 × g. The virus was pelleted after sucrose gradient ultracentrifugation with
four layers (30%, 40%, 50% and 60%) and stored at -80°C until use.
Table 15

Viruses used in this study.
Experiments$

Virus*

Abbreviation

Type#
Array

BLI

HA

Y

Y

A/chicken/Wuxi/0405005/2013 (H7N9) (HA) PR8 (H7N1)

rg-CK/WX

RG

Y

A/chicken/Dongguan/3418/2013(H7N9) (HA)  PR8 (H7N1)

rg-CK/3418

RG

Y

Y

A/chicken/Wenzhou/RAQL01/2015(H7N9) (HA)  PR8 (H7N1)

rg-CK/QL01

RG

Y

Y

A/chicken/Wenzhou/HATSLG01/2015(H7N9) (HA)  PR8 (H7N1)

rg-CK/2015

RG

Y

Y

A/chicken/Heinan/ZZ01/2017(H7N9)(HA mutated to low path)  PR8 (H7N1)

rg-CK/2017

RG

Y

Y

A/mallard/Netherlands/12/2000(H7N7) (HA)  PR8-IBCDC-1 (H7N1)

rg-Md/12

RG

Y

A/mallard/New Jersey/A00926089/2010 (H7N3)

Md/2010

WT

Y

A/domestic duck/West Virginia/A00140913/2008 (H7N3)

Dk/2008

WT

Y

A/mute swan/Rhode Island/A00325125/2008 (H7N3)

MS/5125

WT

Y

A/mute swan/Rhode Island/A00325125/2008 (HA)  PR8 (H7N1)

rg-MS/5125

RG

Y

A/Chicken/CA/1002/2000(H6N2)

Y

A/Chicken/CA/B18/2005(H6N2)

Y

A/mute swan/Rhode Island/A00325117/2008 (H7N3)

Y

A/mute swan/Rhode Island/A00325114/2008 (H7N3)

Y

A/mute swan/Rhode Island/A00325125/2008 (H7N3)

Y

A/mute swan/Rhode Island/A00325105/2008 (H7N3)

Y

A/mallard/Iowa/A00558620/2008 (H7N3)

Y

A/mallard/Wisconsin/A00465618/2008 (H7N3)

Y

A/mallard/Kansas/A00523306/2008 (H7N3)

Y

A/mallard/South Dakota/A00649542/2008 (H7N3)

Y
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Table 15 (continued)
A/mallard/Oklahoma/A00749161/2009 (H7N3)

Y

A/mallard/Nebraska/A00709657/2009 (H7N3)

Y

A/mallard/Oklahoma/A00744383/2009 (H7N3)

Y

A/mallard/New York/A00723400/2009 (H7N4)

Y

A/mallard/Michigan/A00869519/2009 (H7N3)

Y

*

, PR8: A/Puerto Rico/8/1934 (H1N1). #, RG: reverse genetic virus, WT: wild type virus. $, Y:
used in experiments.
Hemagglutination assays
Hemagglutination were performed by using 0.5% turkey RBC or 1% horse RBC as
described in the Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza
by the WHO Global Influenza Surveillance Network (WHO 2011).

RNA extraction, PCR, qRT-PCR, and sequencing
Viral RNA was extracted from the allantoic fluid of SPF embryonated chicken eggs with
GeneJET Viral DNA/RNA purification kit (Thermo Fisher Scientific, Waltham, MA). The RNA
was subjected to cDNA synthesis by using the SuperScriptTM III Reverse Transcriptase (Thermo
Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. PCR products of
full length HA were generated with IAVs specific primers (Hoffmann et al. 2001). The PCR
products were confirmed without additional mutations by using Sanger sequencing.

Gene synthesis, molecular cloning and virus rescue
The HA genes of five H7N9 viruses, including A/chicken/Wuxi/0405005/2013(H7N9),
A/chicken/Dongguan/3418/2013(H7N9), A/chicken/Wenzhou/RAQL01/2015(H7N9),
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A/chicken/Wenzhou/HATSLG01/2015(H7N9), A/chicken/Heinan/ZZ01/2017(H7N9) (in which
the PEVPKRKRTAR/GLFGA cleavage sites were mutated to PEIPKGR/GLFGA to remove
multiple basic cleavage sites), were synthesized, and cloned into the pHW2000 vector by Gene
Universal Inc.( Newark, DE). HA of A/mallard/New Jersey/A00926089/2010 (H7N3),
A/domestic duck/West Virginia/A00140913/2008 (H7N3), A/mute swan/Rhode
Island/A00325125/2008 (H7N3) were cloned into pHW2000 vector by using a universal primer
described elsewhere (Hoffmann et al. 2001).
7+1 reassortants viruses were rescued by including a HA gene from above H7 viruses and
seven other gene segments from A/Puerto Rico/8/1934 (H1N1) (PR8) by using reverse genetics
(Hoffmann et al. 2000) (Table 15). The nucleotide sequences of the HA gene in each rescued
virus was confirmed with unexpected mutations by using Sanger sequencing.

Glycan microarray and data analyses
The 83 N-glycans (41) were printed on N-hydroxysuccinimide (NHS)-derivatized slides
as described previously (42). All glycans were printed in replicates of six in a subarray, and
sixteen subarrays were printed on each slide. All glycans were prepared at a concentration of 100
pM in phosphate buffer (100 mM sodium phosphate buffer [pH 8.5]). The slides were fitted with
a sixteen-chamber adapter to separate the subarray into individual wells for assay. Before the
assay, slides were rehydrated for 5 minutes in TSMW buffer (20 mM Tris-HCl, 150 mM NaCl, 2
mM CaCl2, and 2 mM MgCl2, 0.05% Tween, pH 7.4). A 15 μl aliquot of 1.0 M sodium
bicarbonate (pH 9.0) was added to 150 μl of purified virus, and the virus was incubated with 25
μg of Alexa Fluor 488 NHS Ester (succinimidyl ester; Invitrogen) for 1 hour at 25°C. After
overnight dialysis to remove excess Alexa 488, the virus HA titer was checked and then bound to
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the glycan array. Labeled viruses were incubated on the slide at 4°C for 1 hour, washed, and
centrifuged briefly before being scanned with an InnoScan 1100 AL fluorescence imager
(Innopsys, Carbonne, France). Mean relative fluorescent units (RFU) and standard deviation
were calculated for six replicates per virus. A threshold of 500 RFU was set to determine as
background.
BLI receptor binding assay
The receptor binding avidity of viruses was determined by the BLI assay with an Octet
RED instrument (Pall ForteBio, Menlo Park, CA). Biotinylated glycan analogs (listed in Table
16) of 6’SLN was obtained from Lectinity Holdings (Moscow, Russia), and 3’GLN, 3’SLN,
GLex, and SLex were synthesized and kindly provided by Dr. Lei Li from Georgia State
University. The glycans were preloaded onto streptavidin-coated biosensors at up to 0.3 µg/ml
for 5 minutes in 1 × kinetic buffer (Pall FortéBio, Menlo Park, CA, USA). Each test virus was
diluted to a final concentration of 100 pM with 1 × kinetic buffer containing 10 µM oseltamivir
carboxylate (American Radiolabeled Chemicals, St. Louis, MO) and zanamivir (Sigma-Aldrich,
St. Louis, MO) to prevent cleavage of the receptor analogs by NA proteins of virus. Association
was measured for 30 minutes at 25°C as described elsewhere (Guan et al. 2019). Responses were
normalized by the highest value obtained during the experiment, and binding curves were fitted
by using the binding-saturation method in GraphPad Prism 8
(https://www.graphpad.com/scientific-software/prism/). The normalized response curves report
the fractional saturation (f) of the sensor surface as described in a elsewhere (Xiong, Martin, et
al. 2013). The RSL0.5 and SD were calculated by the software as mentioned above. RSL0.5 was
used to quantitate the binding avidity of two selected viruses against two glycan analogs. The
higher the RSL0.5, the weaker the binding avidity.
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Table 16

Biotinylated glycan analogs used in BLI assay and their structure sequences.
Analogs

Structure sequences

3’GLN

Neu5Gcα2-3Galβ1-4GlcNAcβ

3’SLN

Neu5Acα2-3Galβ1-4GlcNAcβ

GLex

Neu5Gcα2-3Galβ1-4[Fucα1-3]GlcNAcβ

SLex

Neu5Acα2-3Galβ1-4[Fucα1-3]GlcNAcβ

6’SLN

Neu5Acα2-6Galβ1-4GlcNAcβ

Distribution of the Neu5Gc receptor in respiratory tracts and intestines of chicken and
mallard
Tissues were prepared for histopathology and immunofluorescence staining. Briefly,
collected tissues were fixed by submersion in 10% neutral buffered formalin and embedded in
paraffin. Sections were made at 5 μm. The sections were deparaffinized by dipping into the
following solutions: 2 times of 10 minutes xylene, 3 minutes of the following solutions: 1:1
xylene:100% ethanol, 2 times of 100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol, rinse in
ddH2O. Heat-induced target retrieved with diluted Target Retrieval Solution, Citrate pH 6.1
(10x) following the manufacturer’s manual (Dako, Carpinteria, CA) was performed. The sections
were blocked by 3% BSA for 1 hour at room temperature then washed three times with PBST
(PBS with 0.05% Tween 20). Diluted purified anti-Neu5Gc antibody was incubated with slides
for 2 hours at room temperature. All sections were washed three times each with PBST and PBS;
the slides were then counterstained with DAPI (4′,6′-diamidino-2-phenylindole; Thermo
Scientific, Rockford, IL) for 5 minutes. The slides were air dried and covered with coverslips by
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using Prolong antifade reagent. Pictures were captured with the Leica SP8 LCS diode confocal
microscope (Leica Microsystems Inc, Buffalo Grove, IL).

Site-directed mutagenesis
To validate the mutations being responsible for glycan binding, we generated H7 mutants
to validate receptor binding by using site-directed mutagenesis and reverse genetics. Specifically,
Phusion™ Site-Directed Mutagenesis Kit (Thermo Scientific, Rockford, IL) was used to create
specific mutations in the plasmid of HA from A/chicken/Wuxi/0405005/2013(H7N9) in
pHW2000 vector by using primers listed in Table 17. In brief, primers were treated with T4
Polynucleotide Kinase (Thermo Scientific, Rockford, IL) for 5' phosphorylation following the
manufacturer’s manual before PCR amplification. The site-directed mutagenesis PCR
amplification mixture contains: 23.5μl of water, 10μl of 5× Phusion HF buffer, 1μl of dNTPs
(10mM), 5μl of each T4 Polynucleotide Kinase treated primer (5μM), 0.5μl of Phusion hot start
DNA polymerase (2U/μl), 5μl of HA plasmid of A/chicken/Wuxi/0405005/2013 (1ng/μl). The
parameters of the site-directed mutagenesis PCR were as follows: one cycle at 98°C for 30
seconds, followed by 24 cycles at 98°C for 10 seconds, 69°C for 30 seconds, and 72°C for 2
minutes then incubate at 72°C for 5 minutes. The PCR products were digested with 1μl of
FastDigest DpnI at 37 °C for 15 minutes. The ligation reaction was performed at room
temperature for 5 minutes after the digestion. Ligation mixture contained 2μl of PCR products,
2μl of 5×rapid ligation buffer, 5.5μl of water, 0.5μl of T4 DNA ligase. The ligation products
(5μl) were transformed into DH10B Competent Cells (Thermo Scientific, Rockford, IL)
following the manufacturer’s protocol. The plasmids were then extracted with GeneJET Plasmid
Miniprep Kit (Thermo Scientific, Rockford, IL), and the mutant viruses were rescued by
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plasmid-based reverse genetics methods, as described above. The HA gene of each rescued virus
was confirmed without unexpected mutations by using Sanger sequencing.
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Table 17

Primers for site-directed mutagenesis.

A122N-F

5'-cagagaatcaggcggaattgacaaggaaaatatgggattcacatacagtg-3'

A122N-R

5' agaatttgcctcagagcttcttcattcacgaatttccc-3'

S128T-F

5'-acaaggaagcaatgggattcacatacactggaataagaacta-3'

S128T-R

5'-caattccgcctgattctctgagaatttgcctcagagc-3'

I130V-F

5'-gggattcacatacagtggagtaagaactaatggagcaac-3'

I130V-R

5'-attgcttccttgtcaattccgcctgattctctgag-3'

A135E-F

5'-ggaataagaactaatggagaaaccagtgcatgtaggaga-3'

A135E-R

5'-actgtatgtgaatcccattgcttccttgtcaattccg-3'

A159G-F

5'-gtcaaacacagataatggtgcattcccgcagatg-3'

A159G-R

5'-aggagccatttcatttctgcatagaatgaagatcc-3'

A160V-F

5'-tcaaacacagataatgctgtattcccgcagatgactaag-3'

A160V-R

5'-caggagccatttcatttctgcatagaatgaagatcc-3'

R172K-F

5'-gcagatgactaagtcatataaaaatacaaaaaaaagcccagctctaatagta-3'

R172K-R

5'gggaatgcagcattatctgtgtttgacaggagccatttcatttctgc-3'

K173R-F

5'-gcagatgactaagtcatataaaaatacaagaagaagcccagctctaatag-3'

K173R-R

5'gggaatgcagcattatctgtgtttgacaggagccatttcatttctg-3'

S174E-F

5'-cgcagatgactaagtcatataaaaatacaagaaaagagccagctctaatagtatgg-3'

S174E-R

5'ggaatgcagcattatctgtgtttgacaggagccatttcatttctgc-3'

V179I-F

5'-caagaaaaagcccagctctaataatatgggggatcca-3'

V179I-R

5'-tatttttatatgacttagtcatctgcgggaatgcagc-3'

K193R-F

5'-atcaactgcagagcaaaccaggctatatgggagtg-3'

K193R-R

5'-acggaatgatggatcccccatactattagagc-3'

-F: forward primer, -R: reverse primer.
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Results
H7 viruses showed variations in hemagglutination activities to horse RBCs
To examine variations of avian IAVs in binding Neu5Gc, we performed
hemagglutination assays for a total of 42 viruses including 8 from northern shoveler, 4 from
mute swan, 9 from mallard, 4 from blue winged teal, 9 from American green winged teal and 8
from chicken by using horse RBCs which express primarily Neu5Gc, and turkey RBCs which
express primarily Neu5Ac (Gentsch and Pacitti 1987; Ustinov et al. 2017; Jankowski et al.
2019). Results showed that all viruses showed different binding avidities to turkey RBCs, and
that 40 of 42 testing viruses showed high binding avidities to horse RBCs whereas two H6N2
chicken IAVs did not bind to horse RBCs.
To understand the variations of IAV binding avidities between horse and turkey RBCs,
we compared the hemagglutination activities for each tested strain with the same amount of
virus. HA titers dropped from turkey RBCs to horse RBCs indicated the reduced binding
avidities to Neu5Gc. Of particular interest, chicken origin IAVs had the highest differences, with
an average 8.72-fold loss, in hemagglutination activities by using horse RBCs. The losses vary
greatly among the avian IAVs of wild bird origin, e.g. mallard (2.51-folds), mute swan (2-folds),
blue winged teal (2.83-folds), American green winged teal (3.43-folds), and northern shoveler
(3.08-folds)] (Figure 17, Table 18).
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Figure 17

Hemagglutination with different RBCs.

Hemagglutination with chicken (left), mute swan (middle), and mallard isolates (right) using
turkey RBCs (black bars) and horse RBCs (white bars).
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Table 18

HA using different species IAVs

Species of viruses

Numbers of viruses

Mean fold changes (Turkey/horse)

Chicken

8

8.72

American green winged teal

9

3.43

Blue winged teal

4

2.83

Mallard

9

2.51

Mute swan

4

2.00

Northern shoveler

8

3.08

H7 avian IAVs in wild birds showed large variations in receptor binding avidities to
Neu5Gc but those detected in domestic poultry exclusively bind to Neu5Ac
To characterize the receptor binding diversity of H7 avian IAVs to Neu5Ac/Neu5Gc, we
performed glycan arrays for four H7 IAVs from waterfowl and five from chicken. Results
showed that all of the nine avian IAVs bind to α2,3 linked-Sias (glycan 1-28) with diverse mean
binding signals ranging as low as 524.5 to a highest mean RFU of 29,255.25. The binding signal
can vary from 0 to 65,536, and a binding signal of 500 was treated as negative in this study. On
the other hand, the H7 IAVs did not bind (mean RFU<500) to non-Sias glycans (glycan 52-75,
black rectangle of Figure 18) or glycans with the α2,6 linked-Neu5Gc (glycan 36-41) but can
bind 5 glycans with the α2,6 linked-Neu5Ac (glycan 31-35).
Further, we found that Sias types affect the binding pattern of these viruses even with the
same inner structures, which is that chicken viruses bind exclusively to Neu5Ac but not to
Neu5Gc. More specifically, rg-CK/WX binds to α2,3 linked-Neu5Ac with mean RFU from
524.75 to 9723.25 (glycan 1-17, purple rectangle in Figure 18, e.g. glycan 1) but not to α2,3
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linked-Neu5Gc (RFU<500, blue rectangle of Figure 18, e.g. glycan 18) (Figure 18A). Similar
findings were identified with the other four chicken viruses. Rg-CK/3418 has the mean RFU
from 617.5 to 14421.25 to α2,3 linked-Neu5Ac but not to α2,3 linked-Neu5Gc [except very low
binding signals to two glycans: glycan 19 (RFU= 574.5) and glycan 21 (RFU= 614.75)] (Figure
18B). Rg-CK/QL01 has the mean RFU from 558 to 16732.75 to α2,3 linked-Neu5Ac but no
binding to α2,3 linked-Neu5Gc (RFU < 500) (Figure 18C). Rg-CK/2015 has the mean RFU from
700.25 to 4310.75 to α2,3 linked-Neu5Ac and no binding to α2,3 linked-Neu5Gc (RFU<500)
(Figure 18D). Rg-CK/2017 has a mean RFU from 1365 to 12807.5 with α2,3 linked-Neu5Ac and
no binding to α2,3 linked-Neu5Gc (RFU<500) [except a low RFU of 524.5 to glycan 19] (Figure
18E).
Of interest, we found that waterfowl origin viruses can bind to both Neu5Gc and
Neu5Ac. The rg-Md/12 has both binding signals to α2,3 linked-Neu5Ac (RFU from 784.5 to
7739.5) and α2,3 linked-Neu5Gc (RFU from 784.5 to 7539.5) (Figure 18F). Similarly, the other
three wild bird viruses: Md/2010 (Figure 18G), Dk/2008 (Figure 18H), and MS/5125 (Figure
18I) bind to both α2,3 linked-Neu5Ac (RFU from 852 to 8942.5 for Md/2010, 610.75 to 7658.75
for Dk/2008, 584 to 8210.5 for MS/5125, respectively) and α2,3 linked-Neu5Gc glycans (RFU
from 639.5 to 18930.75 for Md/2010, 971.25 to 24643 for Dk/2008, 864 to 29255.25 for
MS/5125, respectively). In addition, the binding avidities to Neu5Gc glycans vary among the
wild bird origin viruses. For instance, the mallard virus (rg-Md/12, Md/2010) had a lower
average RFU (2315.11) compared to Dk/2008 (4859.39) and MS/5125 (5372.39).
Further, we looked into the substructures of the glycans in the array and picked four pairs
of similar glycans as an example to show the pattern described above and detailed in the analysis
(Table 19). The difference of these four pairs of glycans (pairs of glycan No. 1 vs No. 2, No. 8 vs
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No. 9, No. 18 vs No. 19, No. 25 vs No. 26) are different Sias types (i.e. Neu5Ac, Neu5Gc). First
of all, we found that all the tested viruses bound strongly to SLex (glycan 2, 8) whereas only
waterfowl origin viruses bound both GLex (glycan 19, 25) and SLex.
In summary, we found that chicken origin H7 viruses did not have or largely reduced the
binding ability to Neu5Gc) and that some viruses from waterfowl origin viruses can bind both
Neu5Ac and Neu5Gc. The chicken origin H7 viruses bind to the glycans with SLex and with
Neu5Ac.
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Figure 18

N-glycan microarray binding profiles of H7 IAVs.

A) rg-CK/WX, B) rg-CK/3418, C) rg-CK/QL01, D) rg-CK/2015, E) rg-CK/2017, F) rg-Md/12,
G) Md/2010, H) Dk/2008, I) MS/5125. The data (y axis) is the mean relative fluorescent units ±
the standard deviations (vertical bars). The x axis represents the glycan number corresponding to
the array. Glycans include in purple rectangle contain the terminal structure of Neu5Ac(2-3)Gal
(glycan 1 to 17); glycans include in blue rectangle contain the terminal structure of Neu5Gc(23)Gal (glycan 18 to 28); glycans include in orange rectangle contain the terminal structure of
Neu5Ac(2-8)Neu5Ac (glycan 29, 30, 48, 49), 2,6-linked sialic acid (glycan 31 to 47), glycans
contain other modification of sialic acid (glycan 50, 51), glycans include in black rectangle are
non-sialyl glycans (glycan 52 to 75) (Appendix B).
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Table 19

Glycan binding analyses with glycans with Neu5Gc or Neu5Ac and with or without
SLex.

Virus

waterfowl IAVs

chicken IAVs

Glycan
rg-Md/12

Md/2010

Dk/2008

MS/5125

rg-

rg-

rg-

rg-

rg-

CK/WX

CK/3418

CK/QL01

CK/2015

CK/2017

1

6066

2946.5

2647.75

2989

8465

14421.25

5226.25

2046.75

5913.75

(Neu5Ac, SLex-)

9

2481.5

1300.75

896.75

639.5

3832.25

8820.75

11632.5

4310.75

12807.5

SLex

2

7539.5

4282.75

7658.75

4416.25

9723.25

3329.25

2260.25

1430.75

4582

8

6663

8942.5

1001.75

8210.5

2864.75

5324.25

12241.25

1201.75

14561

18

2987.75

639.5

5446.5

3564.5

<500

<500

<500

<500

<500

(Neu5Gc, SLex-)

26

1991.25

1249.25

5278.75

524.5

<500

<500

<500

<500

<500

GLex

19

3039.5

7173.25

2633

9973.5

<500

574.5

<500

<500

524.5

25

1859.5

18930.75

24643

29255.25

<500

<500

<500

<500

<500

3SLN

(Neu5Ac,
SLex+)

3GLN

(Neu5Ac,
SLex+)

Avian H7 receptor binding specificity analysis to Neu5Gc by the BLI assay confirmed
isolates from chicken, unlike wild bird stains, only bind to Neu5Ac but not Neu5Gc
To confirm the variations of H7 avian IAVs in binding to Neu5Ac and Neu5Gc as
observed in glycan array analyses, we used BLI assays to perform quantitative analyses on a set
of glycan analogs (Table 16). Rg-CK/WX, which exclusively bind to NeuAc (Figure 18A), and
rg-MS/5125, which binds both Neu5Ac and Neu5Gc (Figure 18I) were selected for the analyses;
to eliminate the potential effects of NA, both testing strains had HA from wild type virus, NA
and other six genes from PR8. Specifically, 100pM of the viruses were tested against seven
concentrations of glycan loads (0-0.5μg/ml) for 30 minutes at 25°C. We quantified and
compared the 50% relative sugar loading (RSL) concentration (RSL0.5) at half the fractional
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saturation (f = 0.5) of virus against glycan analogs. The higher the RSL0.5, the smaller the
binding avidity.
Results showed that rg-CK/WX binds strongly to Neu5Ac glycans [i.e., SLex (RSL0.5=
0.2230), 3’SLN (RSL0.5=0.2440), and 6’SLN (RSL0.5=0.2643)] but not to Neu5Gc glycans (i.e.,
3’GLN and GLex). In contract, rg-MS/5125 binds to all of the tested glycan analogs with a slight
decrease in the binding avidities to Neu5Gc: the RSL0.5 was 0.02126 for SLex, 0.07831 for
GLex, 0.0499 for 3’GLN, 0.02152 for 3’SLN, and 0.3530 for 6’SLN (Figure 19).
In summary, these results confirmed that chicken origin rg-CK/WX has a high binding
avidity to Neu5Ac but not to Neu5Gc whereas mute swan origin rg-MS/5125 showed a strong
binding avidity to both Neu5Ac and Neu5Gc. Also, both rg-CK/WX and rg-MS/5125 bound to
SLex stronger than 3’SLN.

A

B
1.5
Fractional saturation (f)

Fractional saturation (f)

1.5

1.0

0.5

0.0

3GLN
3SLN
Glex

1.0

Slex
6SLN

0.5

0.0
0.0

0.2

0.4
0.6
Glycan load (nm)

Figure 19

0.8

1.0

0.0

0.2

0.4
0.6
Glycan load (nm)

0.8

1.0

Glycan binding specificity of two subtype H7 IAVs.

Glycan binding specificity of (A) rg-MS5125 and (B) rg-CK/WX to glycan analogs (Table 16) as
determined by BLI using an Octet RED instrument (Pall FortéBio, Fremont, CA, USA).
Streptavidin-coated biosensors were immobilized with biotinylated glycans at different levels.
Sugar loading–dependent binding signals were captured in the association step and normalized to
the same background. Binding curves were fitted by using the saturation binding method in
GraphPad Prism 8 (https://www.graphpad.com/scientific-software/prism/).
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Distribution of N-Glycolylneuraminic acid in chicken and mallard
We performed the immunofluorescent staining for respiratory tract (trachea-upper,
trachea-middle and trachea-distal) and intestinal tract (duodenum, jejunum, ileum, colon, caeca
and cloaca) from chicken and mallard for expression of the Neu5Gc glycan. In tissues from
chicken, we detected no fluorescent signals but found slight to fine signals in mallard intestinal
tracts. We found fine Neu5Gc expression in colon and cloacal, and less signals in ileum and
caeca of mallards (Table 20, Figure 20).
Table 20

Summary of Neu5Gc glycan distribution among tissues in chicken and mallard#.

Glycan receptors
Neu5Gc

Tissue

Chicken
Mallard
Trachea-upper
Trachea-middle
Trachea-distal
Duodenum
Jejunum
+
Ileum
+
Caecum
+
Colon
++
Cloaca
++
#
, The staining score was graded as mild (+), strong (++) and negative (-).
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Figure 20

Neu5Gc expression in chicken and mallard.

Immunofluorescence staining of Neu5Gc was performed to test the distribution of Neu5Gc
(magenta) in the cloaca and colon of chicken (upper panel) and mallard (bottom panel). Nuclei
were stained with DAPI (blue). The scale bars are 75 m located at the right bottom of each
picture. The white arrows indicated staining signals.

Multiple amino acid changes of CK/WX could acquire binding ability to Neu5Gc
The binding specificity of Neu5Gc with the CK/WX mutants showed that multiple amino
acid changes (mutated from chicken to waterfowl [S174E, V179I], and from chicken to equine
[S128T, I130V, A135E, A159G, A160V, R172K, K173R, K193R], H3 numbering) can regain
binding ability to Neu5Gc but not reduce the binding avidities to Neu5Ac (Figure 21). Of
interests, results showed that 10 of 11 mutations (except A122N) facilitated the mutant to regain
binding avidities to Neu5Gc while maintaining binding to Neu5Ac.
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Figure 21

Binding specificity to Neu5Gc of CK/WX mutants.

Rescued viruses of CK/WX mutants were used to perform BLI with glycans analogs (3’SLN is
present as black bars, 3’GLN is present as white bars, SLex is present as deep grey bars, Glex is
present as grey bars, and 6’SLN is present as light yellow bars). Y axis is response value of the
binding while x axis represents different mutants. Mutations include those mutated from chicken
to waterfowl [S174E, V179I] and those mutated from chicken to equine [S128T, I130V, A135E,
A159G, A160V, R172K, K173R, K193R].
Discussion
In this study, to understand how H7 avian IAVs transmit from wild birds to domestic
poultry, we investigated the role of Neu5Gc binding with H7 IAVs. We found that chicken
viruses have greatly lost the hemagglutination ability to Neu5Gc-rich horse RBCs compared to
other waterfowl species (mallard, mute swan, blue winged teal, American green winged teal, and
northern shoveler). Our results showed that chicken H7 IAVs have exclusive binding specificity
to Neu5Ac whereas some waterfowl origin H7 viruses maintain binding to both Neu5Ac and
Neu5Gc. These results suggested that some viruses from wild birds are more likely to be
transmitted to chicken or that they can lose binding ability when being adapted to chickens since
chickens did not have Neu5Gc.

128

We profiled the binding specificity of avian IAVs from different species to Neu5Gc by
comparing the ability of agglutinating horse RBCs to turkey RBCs which have been reported to
express a large amount of Neu5Gc (horse) and Neu5Ac (turkey), respectively (Gentsch and
Pacitti 1987; Ustinov et al. 2017; Jankowski et al. 2019). The results indicated that binding
specificity to Neu5Gc is species related, as chicken isolates obviously have a most loss of HA
titer to these two RBCs compared to viruses from other wild bird species. Although horse RBCs
were used to validate virus binding specificity to Neu5Gc (Broszeit et al. 2019), the detailed
glycan structures present in the RBCs are not well characterized.
In order to characterize the receptor binding properties of these viruses in more details, a
glycan array contains isoform with different types of Sias (i.e. Neu5Ac and Neu5Gc). Glycan
array results of selected H7 IAVs reveal that the H7 chicken isolates bound exclusively to
Neu5Ac while wild bird isolates bound both Neu5Ac and Neu5Gc, which has been consistent
with what we observed in the HA test. To confirm this pattern, we found from the glycan array
as well as to quantify the binding avidity by a detail BLI binding assay with a rg-CK/WX and a
rg-MS/5125 as representative viruses from chicken and wild bird isolates, respectively. The BLI
applied the reverse genetic viruses with the same backbone (except HA) to exclude the possible
effects of other proteins. The result confirmed that the H7 chicken virus we tested does not bind
to 3GLN nor GLex but binds by the wild bird virus, as was identified from the glycan array.
Similar binding results have been reported for duck viruses of H1, H3 and H11 which recognized
both Sias through α2,3 linkage (Neu5Gcα2,3Gal and Neu5Acα2,3Gal), though prefer to
NeuAcα2,3Gal in most cases (Ito 2000). A separate study found that duck and gull IAVs from
different subtypes including H1, H2, H3, H4, H5, H6, H9, H11, H12, H13, H14 bound both
Neu5Gcα2,3Gal and Neu5Acα2,3Gal, of which the binding avidity of these viruses was stronger
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to Neu5Gcα2,3Gal (Gambaryan, Yamnikova, et al. 2005). However, studies about the binding
ability of chicken virus to Neu5Gc are extremely rare (Gambaryan et al. 2012; Gambaryan,
Yamnikova, et al. 2005), which showed chicken viruses have no/very weak binding avidity to
3GLN. These finding suggested that viruses from chicken do not favor Neu5Gc receptors.
Chickens have no detectable Neu5Gc expression whereas the mallard showed fine signals
in the intestinal tract by immunofluorescent staining. Neu5Gc was detected in duck intestine,
mainly on the crypt epithelial cells of duck colon (Ito et al. 2000), which is consistent with our
results. On the other hand, histological immunostaining could not detect Neu5Gc in chicken
trachea (Suzuki et al. 2000). These studies to some extent agree with our results of Neu5Gc
expression in chickens and mallards. In addition, directed-mutagenesis from rg-CK/WX to wild
bird stain suggested that it could gain its binding ability to Neu5Gc by mutation. It is possible
that these chicken viruses with no binding ability to Neu5Gc are well adapted in chicken because
there is no Neu5Gc expressed in chicken.
In addition, we found that viruses from waterfowl bound strongly to SLex from both
glycan array and BLI results, and SLex is expressed in the chicken trachea as previous described
in chapter III, which also supported that SLex in chicken trachea may facilitate H7 virus
infections from waterfowl. Taken together, the results of the receptor binding specificity to
Neu5Gc and SLex of chicken and waterfowl viruses and the presence of these glycan motifs in
chickens and mallards, it is likely that the glycan substructure facilitated the introduction of
waterfowl origin H7 viruses into the chicken, and that the introduced viruses gradually lost the
binding ability to Neu5Gc but remain the binding ability to Neu5Ac and SLex, both of which are
highly expressed in the upper and lower respiratory tracts of domestic poultry such as chickens.
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Taken together, our results showed that H7 IAVs from wild bird bind to both Neu5Ac and
Nue5Gc. Thus, we speculate avian IAVs circulating in waterfowl could bind to both Neu5Gc and
Neu5Ac but lose the binding affinity to Neu5Ac after acquiring adapted mutations in chickens or
another possible immediate host which could have less Neu5Gc but more Neu5Ac. Further
studies will be designed to determine glycan binding for those viruses isolated from poultry
immediately after being introduced to poultry. On the other hand, to identify the potential
intermediate host, the distribution of Neu5Gc and Neu5Ac in wild birds should be systematically
characterized.
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CHAPTER V
CONCLUSIONS

The studies in this dissertation have generated following conclusions:
First, in the fall of 2015, four H10N7 IAVs were recovered from gulls in Iceland, and
genomic analyses showed that the viruses were genetically related with the IAVs that caused
outbreaks among seals in Europe a year earlier. These gull-origin viruses showed high binding
avidity to human-like glycan receptors. Transmission studies in ferrets demonstrated that the
gull-origin IAV could infect ferrets, and that the virus could be transmitted between ferrets
through direct contact and aerosol droplets. This study demonstrated that avian H10 IAV can
infect mammals and be transmitted among them without adaptation. Thus, avian H10 IAV could
be a candidate for influenza pandemic preparedness and should be monitored in wildlife and at
the animal-human interface.
Second, we determined the glycan binding preference of H7 IAVs from wild birds and
domestic poultry, and our results showed that these viruses bound stronger to the SLex glycan
which is present in chicken and other susceptible poultry than to the conventional avian-like
receptors. These results indicated that SLex is the receptor facilitating the introduction of avian
H7 IAVs into poultry. The systematic characterization of SLex expression in wild birds’ species
is needed to further understand the transmission of avian H7 IAVs from wild birds to poultry.
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The study also shed a light on surveillance tactics of avian H7, which may need to be optimized
to focus on bird species that express SLex receptors. However, further studies are needed to
validate the correlations between SLex in host and viral replication.
Third, we performed the hemagglutination assay, glycan array, and the biolayer
interference assay to determine H7 avian IAVs binding specificity to Neu5Gc and Neu5Ac,
which suggested that isolates from North American waterfowl would bind to both Neu5Gc and
Neu5Ac, whereas the chicken origin IAVs bind exclusively to Neu5Ac. Furthermore, we
detected Neu5Gc expression in the intestinal tract of the mallard but not in chicken by
immunofluorescent staining assay. Combined with the results of SLex binding, these results
suggest that H7 avian IAVs have a diversity of binding to Neu5Gc, and during the transmission
and adaptation to chickens from waterfowl, these two glycan motifs play an important role. The
high binding avidity to SLex by the H7 IAVs could easily facilitate transmission of these viruses
into the chicken since SLex is widely expressed in tracheal epithelial cells. During adaptation in
the chicken, viruses would gradually lose the binding ability to Neu5Gc because no such glycan
was detected in chicken trachea and gastrointestinal tract.
Overall, this dissertation has evaluated the risk assessment, and the receptor binding
properties of the H7 subtypes of avian IAVs in mammalian and avian animal models.
Additionally, the inner structures of avian-like receptors, and modification of Sias were
investigated in affecting the viral receptor binding properties and their distribution among avian
species, especially chicken and mallard. This study has shed light on understanding the
correlations between IAV infections and the distribution of glycan receptors in hosts. These
results will be useful in understanding IAVs host/tissue tropisms.
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The future direction of this study will be to focus on understanding: 1) The biological
functions of these glycan motifs in IAVs infection. For instance, growth kinetics of Neu5Gc- or
Neu5Ac-binding viruses in the Neu5Gc-expressed cell lines; 2) The molecular mechanisms
behind the binding of H7 IAVs to SLex and Neu5Gc; 3) Explore other subtypes of IAVs and 4)
systematically characterize the distribution of glycan motifs (i.e. SLex, Neu5Gc) in more bird
species.
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APPENDIX A
IHC STAINING FOR INFLUENZA ANTIGEN OF CHICKEN COLONS
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Anti-NP monoclonal antibody was applied to detect the presence of antigens in infection
birds. The negative control represents the non-infected tissues while infected indicated infected
bird tissues. The pictures were taken under 100× magnification. Black arrows and blown staining
at the right panel indicated the positive staining.
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APPENDIX B
LIST OF GLYCAN STRUCTURES ON THE GLYCAN MICROARRAY
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Glycan
ID
1

Sequences

10

Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-3)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a23)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc-AEAB
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b12)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b12)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-3)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a23)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc(b-)Asn
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a13)[Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

11

Neu5Ac(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

12

Neu5Ac(a2-3)Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB

13
14

Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcAEAB
Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr

15

Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr

16

Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)[Neu5Ac(a2-3)Gal(b1-4)GlcNAcb16)Man(a-)Thr
Neu5Ac(a2-3)[GalNAc(b1-4)]Gal(b1-4)Glc-AEAB

2
3
4
5
6
7
8
9

17
18
19
20

Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-3)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Gc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a23)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc-AEAB
Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
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Table APPENDIX B (continued)
21

27

Neu5Gc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b12)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b12)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-3)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Gc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a23)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc(b-)Asn
Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a13)[Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

28

Neu5Gc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr

29

Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a28)Neu5Ac(a2-3)Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b14)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-8)Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a28)Neu5Ac(a2-6)Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b14)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-6)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-6)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)[Neu5Ac(a2-6)Gal(b1-4)GlcNAcb16)Man(a-)Thr
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Neu5Ac(a2-6)]GlcNAc(b12)Man(a1-3)[Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Neu5Ac(a26)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-6)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a-)Thr

22
23
24
25
26

30
31
32
33
34
35
36
37
38
39
40

Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr
Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-6)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Neu5Gc(a2-6)Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
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Table APPENDIX B (continued)
41

44

Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Neu5Gc(a2-6)]GlcNAc(b12)Man(a1-3)[Neu5Gc(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Neu5Gc(a26)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

45

Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr

46

Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr

47

GlcNAc(b1-2)[Neu5Ac(a2-6)Gal(b1-4)GlcNAcb1-6)Man(a-)Thr

48

Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

49

Neu5Ac(a2-8)Neu5Ac(a2-3)[GalNAc(b1-4)]Gal(b1-4)Glc-AEAB

50

Kdn(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

51

Neu8Me(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

52

GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc-AEAB
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)[Fuc(a13)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b14)GlcNAc(b1-4)GlcNAc-AEAB
Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b14)GlcNAc(b1-4)GlcNAc-AEAB
GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b14)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc-AEAB
Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc-AEAB
Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a16)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn
Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b12)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b-)Asn

42
43

53
54
55
56
57
58
59
60
61
62
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Table APPENDIX B (continued)
63
64

Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b14)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b14)GlcNAc(b-)Asn
Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc-AEAB

65

Gal(b1-4)Gal(b1-4)Glc-AEAB

66

GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB

67

Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB

68

Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(b1-4)Gal(b1-4)Glc-AEAB

69

GlcNAc(b1-2)Man(a-)Thr

70

Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr

71

GlcA(a1-6)Gal(b1-4)GlcNAc(b1-2)Man(a-)Thr

72

GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr

73

Gal(b1-4)GlcNAc(b1-2)[GlcNAcb1-6)Man(a-)Thr

74

GlcNAc(b1-2)[Gal(b1-4)GlcNAcb1-6)Man(a-)Thr

75

Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAcb1-6)Man(a-)Thr
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